Document:

Exhibit 10.11 

   

   

   

  
     

    
      
 

  

   

  Section B - Supplies or Services and Prices

   

  	ITEM NO	SUPPLIES/SERVICES	QUANTITY	UNIT	UNIT PRICE	AMOUNT
	0001	 	1	Lot	$184,576,636.62	$184,576,636.62
	 	
          Industrial Expansion (FFP)FFP

          INDUSTRIAL EXPANSION IN ACCORDANCE WITH AWARD

              SPECIFICATIONS

          FOB: Origin (Shipping Point)

          PURCHASE REQUEST NUMBER: 0011560601

          PSC CD: AN14

        	 
	 	 	 
	 	NET AMT	$184,576,636.62
	 	ACRN AA	 
	 	CIN: GFEBS001156060100001	$184,576,636.62

   

  	ITEM NO	SUPPLIES/SERVICES	QUANTITY	UNIT	UNIT PRICE	AMOUNT
	0002	 	6,000,000	Each	$[**]	$[**]
	 	
          Test Cartridges (FFP)FFP

          COVID-19 TEST CARTRIDGES AS SPECIFIED IN AWARD NARRATIVE

          FOB: Orgin (Shipping Point)

          PURCHASE REQUEST NUMBER: 0011560601

          PSC CD: AN14

        	 
	 	 	 
	 	NET AMT	$[**]
	 	ACRN AA	 
	 	CIN: GFEBS001156060100002	$[**]

   

  
     

    
      
 

  

   

  	ITEM NO	SUPPLIES/SERVICES	QUANTITY	UNIT	UNIT PRICE	AMOUNT
	0003	 	30,000	Each	$[**]	$[**]
	 	
          Monitoring Systems (FFP)FFP

          MONITORING SYSTEMS AS SPECIFIED IN AWARD NARRATIVE

          FOB: Origin (Shipping Point)

          PURCHASE REQUEST NUMBER: 0011560601

          PSC CD: AN14

        	 
	 	 	 
	 	NET AMT	$[**]
	 	ACRN AA	 
	 	CIN: GFEBS001156060100003	$[**]
	 	 	 

  	ITEM NO	SUPPLIES/SERVICES	QUANTITY	UNIT	UNIT PRICE	AMOUNT
	0004	 	60,000	Each	$[**]	$[**]
	 	
          Swab Packs (FFP)FFP

          SWAB PACKS AS SPECIFIED IN AWARD NARRATIVE

          FOB: Origin (Shipping Point)

          PURCHASE REQUEST NUMBER: 0011560601

          PSC CD: AN14

        	 
	 	 	 
	 	NET AMT	$[**]
	 	ACRN AA	 
	 	CIN: GFEBS001156060100004	$[**]

   

  
     

    
      
 

  

   

  Section C - Descriptions and Specifications

   

  OTHER TRANSACTION AGREEMENT

   

  OTHER TRANSACTION AUTHORITY FOR PROTOTYPE

      AGREEMENT

      BETWEEN

   

  Cue Health, Inc. (Awardee)

      And

      Army Contracting Command - Aberdeen Proving Ground - Research Triangle Park, NC DIVISION

      (Government)

      800 Park Office Drive Research Triangle Park, NC 27529

   

  Effective Date: October 13, 2020

   

  Agreement No.: W911NF-21-9-0001

   

  Total Amount of the Agreement: $480,916,636

   

  	Awardee

            Signature	 	Government

            Signature
	
           

          Ayub Khattak

        	 	
	
          Printed Name

           

          CEO

        	 	
          Printed Name

           

          Agreements Officer

        

   

  
     

    
      
 

  

   

  TABLE OF CONTENTS

   

  ARTICLE 1: BACKGROUND, DEFINITIONS AND SCOPE OF THE AGREEMENT

  ARTICLE 2: TERM AND TERMINATION

  ARTICLE 3: PROJECT MANAGEMENT AND MODIFICATIONS

  ARTICLE 4: MANAGEMENT OF THE PROJECT

  ARTICLE 5: “PREP ACT” COVERAGE

  ARTICLE 6: FINANCIAL MATTERS

  ARTICLE 7: DISPUTES

  ARTICLE 8: CONFIDENTIAL INFORMATION

  ARTICLE 9: INTELLECTUAL PROPERTY RIGHTS

  ARTICLE 10: DATA RIGHTS

  ARTICLE 11: REGULATORY RIGHTS

  ARTICLE 12: FOREIGN ACCESS TO DATA

  ARTICLE 13: SCIENTIFIC PUBLICATIONS AND PRESS RELEASES

  ARTICLE 14: ENSURING SUFFICIENT SUPPLY OF THE PRODUCT

  ARTICLE 15: INSPECTION AND ACCEPTANCE

  ARTICLE 16: REPORTING REQUIREMENTS

  ARTICLE 17: MISCELLANEOUS CLAUSES

  ARTICLE 18: PROHIBITION ON THE USE OF CERTAIN TELECOMMUNICATIONS AND VIDEO SURVEILLANCE SERVICES OR EQUIPMENT

  APPENDIX A: STATEMENT OF WORK

  APPENDIX B: PROJECT SCHEDULE/MILESTONE PAYMENT SCHEDULE

  APPENDIX C: KEY PERSONNEL

  APPENDIX D: GOVERNMENT PROPERTY

   

  
     

    
      
 

  

   

  OTHER TRANSACTION AUTHORITY FOR PROTOTYPE

      AGREEMENT

   

  This Other Transaction Authority for Prototype Agreement is entered into between the United States of
      America, hereinafter called the “Government”, pursuant to and under U.S. Federal law and Cue Health Inc., a small business and non-traditional defense contractor, hereinafter called the “Awardee”. The United States of America and Awardee are
      sometimes referred to herein individually as a “Party” and collectively as the “Parties.”

   

  WHEREAS, the Awardee is eligible for an Other Transaction Authority for Prototype Agreement in
      accordance with 10 USC § 2371b(d)(1)(A) as amended by the National Defense Authorization Act for Fiscal Year 2018 as they are non-traditional defense contractor, attesting to “An entity that is not currently performing and has not performed, for at
      least the one-year period preceding the solicitation of sources by the Department of Defense for the procurement or transaction, any contract or subcontract for the Department of Defense that is subject to the full coverage under the cost accounting
      standards prescribed pursuant to Section 1502 of title 41 and the regulations implementing such section”;

   

  WHEREAS, the DoD currently has authority under 10 U.S.C. § 2371b to award “other transactions” (OTs) in
      certain circumstances for prototype projects that are directly relevant to enhancing the mission effectiveness of military personnel and the supporting platforms, systems, components, or materials proposed to be acquired or developed by the DoD, or
      to improve platforms, systems, components, or materials in use by the Armed Forces;

   

  WHEREAS, a prototype can generally be described as a physical or virtual model used to evaluate the
      technical or manufacturing feasibility or military utility of a particular technology or process, concept, end item, or system;

   

  WHEREAS, this Agreement meets the criteria for a prototype project;

   

  NOW THEREFORE, the Parties have agreed as follows:

   

  ARTICLE 1:   BACKGROUND, DEFINITIONS AND SCOPE OF THE AGREEMENT

   

  		A.	Background

   

  The Department of Health and Human Services through DoD requires the ability to procure reliable point of care
      testing assays and devices in sufficient quantities to meet the demand to respond to the on-going COVID-19 Pandemic. The unprecedented demand for rapid and accurate molecular diagnostic testing continues to exceed national testing capacity. Awardee,
      through funding provided by HHS, has already developed and received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a rapid, portable, point of care COVID-19 test capable of detecting SARS-CoV-2, the virus that
      causes COVID-19. The ability to deploy substantial quantities of the Cue POC COVID-19 test will not only increase national test capacity, but significantly reduce the time to inform patients of their result. The Cue Health test is anticipated to be
      used primarily in particular settings of concern, such as nursing homes, long term care facilities and schools. It will also be beneficial to the armed services and the US population at large, at other locations where a laboratory capability is not
      readily accessible. The Cue COVID-19 Test consists of: 1.) the Cue COVID-19 Test Cartridge pack which includes a single use test cartridge and a single use Sample Wand (swab); 2.) The Cue Health Monitoring System (reader); The Cue COVID-19 External
      Control Swabs Pack. Hereafter, the components of the test as necessary for a single use are collectively referred to as a “COVID-19 Test”.

   

  
     

    
      
 

  

   

  		B.	Definitions

   

  Agreement Invention: Any invention conceived or first actually reduced to practice in the performance of
      the Prototype Project under this Agreement.

   

  Agreements Officer or AO: Warranted contracting officer authorized to sign the final OTA for the
      Government.

   

  Agreement’s Officer’s Representative or AOR: The individual designated by the Government to monitor all
      technical aspects and assist in agreement administration of the Prototype Project. The AOR shall only assist in agreement administration of the Prototype Project to the extent delegated such administration authority in writing in the AOR delegation
      letter by the responsible Agreements Officer.

   

  Background Invention: Background Invention means any Invention, or improvement to any Invention, other
      than an Agreement Invention, that was conceived, designed, developed, produced, and/or reduced to practice prior to performance of this Agreement, or outside the scope of work performed under this Agreement.

   

  Cause: An event or issue that has been discovered that the Government believes may impact successful
      performance of the OTA.

   

  Date of Completion: The date on which all work is completed or the date on which the period of
      performance ends.

   

  		●	Deliverable(s): Any documentation (e.g. report, Executive Summary, Letter) given to the Government by the Awardee
            as described in the second column of Table 1 in Article I, Section C.7 under the heading “Deliverable.”

   

  		●	Effective Date: The date of execution of this Agreement by the Parties.

   

  		●	Field: COVID-19 Diagnostic testing.

   

  		●	Government: The United States of America, as represented by The Department of Defense and the Department of
            Health and Human Services.

   

  		●	Government Purpose Rights: As defined in DFARS 252.227-7013(a)(13).

   

  
     

    
      
 

  

   

  		●	Invention: Any invention or discovery which is or may be patentable or otherwise protectable under Title 35 of
            the United States Code.

   

  		●	Know-How: Information, practical knowledge, techniques, and skill development by Awardee in the performance of
            the Prototype Project and which is necessary for the Practical Application of an Agreement Invention within the Field.

   

  		●	Limited Rights: As defined in DFARS 252.227-7013(a)(14).

   

  		●	Party: Each of the Government and Awardee. (collectively, “Parties”).

   

  		●	Practical Application: With respect to an Agreement Invention, to manufacture, in the case of a composition of
            product; to practice, in the case of a process or method, or to operate, in the case of a machine or system; and, in each case, under such conditions so as to establish that the Agreement Invention is capable of being utilized.

   

  		●	Program: Prototype efforts being conducted by the Parties pursuant to this Agreement.

   

  		●	Prototype Project: Has the meaning given in Article 1.C.

   

  		●	Project Coordination Team or PCT: Agreements Officer, Agreements Officer’s Representative, Subject Matter Experts
            and Team Leader(s) acting in support of Operation Warp Speed and responsible for periodic and ad-hoc reporting to Operation Warp Speed Leadership.

   

  		●	Property: Any tangible personal property other than property actually consumed during the execution of work under
            this Agreement.

   

  		●	Under this Agreement: When used, for example but without limitation, in the definitions of Data, Know-How,
            Property, and Agreement Inventions, means activities conducted pursuant to this Agreement that are Government funded.

   

  Scope of the Agreement

   

  		1.	Prototype Project: The prototype project under this Agreement is the demonstration by Awardee of the rapid, large
            scale supply and logistics capability to manufacture and deliver to the Government within 5 months of the effective date of this Agreement 6 million Cue COVID-19 Assay Cartridges, 60,000 COVID-19 Control Swab Packs, and 30,000 Monitoring
            Systems by achieving a sustained average per day production rate of at least 100,000 EUA or 510(k) cleared Cue COVID-19 Assay Cartridges over the last 7 days of the 5 month delivery period. The expansion of Awardee’s manufacturing capability
            will likely entail several actions. The company will increase their overall output of assay cartridges by installing additional high capacity automated lines. Additionally the Awardee will upgrade their bio production capability to ensure
            enough reagent materials are available to meet end-state test cartridge manufacturing goals. In addition Awardee will perform activities required to onshore Monitoring System manufacturing to be performed either in-house, with a US-based
            contract manufacturing organization or both. The demonstrated manufacturing capability will be in compliance with ISO 13485 standards as well as the Quality System Regulations at 21 CFR Part 820.

   

  
     

    
      
 

  

   

  In order to ensure the successful and expeditious completion of this prototype project, Awardee agrees
      and represents that, commencing on the effective date of this Agreement, the Government will be the exclusive purchaser of the entire production of Awardee’s COVID-19 Test until the prototype project has been successfully completed. This exclusive
      purchaser condition is waived under the following circumstances: 1) Awardee may honor contractual commitments executed before the effective date of this Agreement and 2) Awardee may request a waiver from the Government to respond to other than U.S.
      Federal Government urgent diagnostic testing requirements and 3) Awardee may use a reasonable number of tests for internal workforce testing and diagnostic purposes and for marketing, demonstration and evaluation and business development. The
      prototype project will be successfully completed when Awardee has achieved a sustained average per day production rate of at least 100,000 EUA or 510(k) cleared COVID-19 Assay Cartridges over a 7 day period, and has delivered a total of 6 million Cue
      COVID-19 Assay Cartridges, 30,000 monitoring systems, and 60,000 control swab packs.

   

  		2.	Associated Production: It is the intention of the Parties to enter into a separate, but associated, sole-source
            FAR-based contract for the continued production of COVID-19 Tests. Subject to applicable law and regulation, the Parties shall take all steps necessary to negotiate and enter into such a FAR-based contract in good faith with the intent of
            promptly signing such FAR-based contract as soon as possible after this Agreement. Follow- on production pursuant to 10 USC 2371b is not anticipated for this project. In recognition of, and in consideration for, the Government’s significant
            funding for the development of Awardee’s enhanced manufacturing capability, the U.S. Government shall be entitled to purchase Awardee’s EUA or 510(k) cleared COVID-19 Test under a future FAR-based contract, in quantities not to exceed [**]
            percent ([**]%), measured on a quarterly basis, of Awardee’s COVID-19 Tests produced from the capacity as provided hereunder, at pricing that shall not exceed [**] percent ([**]%) below the lowest price then offered by Awardee to a commercial
            customer as of the date of the relevant order, for the same products, for equivalent quantities and under comparable delivery schedules and other terms of sale, provided, however, that Awardee shall have no obligation to accept any such
            discounted price less than $[**] per COVID-19 Test. Additionally, Awardee shall grant the Government the right to place such orders as Priority Orders (as defined below) for which Government purchase orders will be prioritized by Awardee as if
            they were “rated orders” subject to 15 CFR § 700.14, subject to the priority afforded to orders that are expressly identified as HRPAS or DPAS rated orders.

   

  		3.	Manufacturing Equipment Purchased With Government Funds: In recognition of, and in consideration for, the
            Government’s significant funding for the development of Awardee’s enhanced manufacturing capability, the Awardee agrees to never re-locate outside of the United States or its Territories any of the Automated Assembly Line equipment purchased
            with Government funds under this Agreement.

   

  		4.	Performance by Affiliates: The Government acknowledges and agrees that Awardee may perform its obligations under
            this Agreement through one or more of its affiliates and/or subcontractors, provided that Awardee will be responsible for the full and timely performance as and when due under, and observance of, all the covenants, terms, conditions and
            agreements set forth in this Agreement by its affiliates and/or subcontractors.

   

  
     

    
      
 

  

   

  		5.	Audits: Until such time as all tests, Monitoring Systems and control packs have been delivered under this
            Agreement, and in no event after expiration of the Period of Performance, audits under this Prototype Agreement may include Government Quality Assurance audits - periodic, ad hoc or for cause - of Awardee’s or sub-agreement holders’
            facilities included in the supply chain. The Government will provide notification of a periodic or ad hoc audit at least [**] prior to the intended audit date and both parties will work in good faith to accommodate the audit and
            determine scheduling. In all audits, the Government will comply with the Person in Plant requirements set forth in Article 1.C.7.

   

  		6.	Person in Plant: The Government may request to have a government representative in place at Awardee’s facility,
            with no fewer than [**] advance notice of the desired date for that person to be in place. The name, role, scope and duration will be mutually agreed between the Parties in writing in advance. The Government representative will adhere to the
            agreed scope and to the Awardee’s policies, procedures and instructions at all times. As determined by federal law, no Government representative shall publish, divulge, disclose, or make known in any manner, or to any extent not authorized by
            law, any information coming to him in the course of employment or official duties, while stationed in a Awardee plant.

   

  If considered for cause, the Government may place representatives in place at Awardee’s facility, with
      no fewer than [**] advance notice of the desired date for the person(s) to be in place, subject to applicable COVID protocols. The names, roles, scope, and duration will be provided to the Awardee in advance. The Government representative will adhere
      to the Awardee’s policies, procedures and instructions regarding facility regulations at all times. As determined by federal law, no Government representative shall publish, divulge, disclose, or make known in any manner, or to any extent not
      authorized by law, any information coming to him in the course of employment or official duties, while stationed in a Awardee plant.

   

  		7.	Deliverables: Deliverables under this Agreement are listed in Table 1.

            Variances: Awardee shall promptly notify the Government of any anticipated shortage in quantity or deviation from any delivery date specified herein. The Government and the Awardee shall cooperate in good faith to adjust Table 1 to
            reflect reasonable variations in the delivery schedule, provided that the total scheduled quantities are delivered and Awardee demonstrates a production capacity of 100,000 units per day within not more than [**] after award.

   

  
     

    
      
 

  

   

  Table 1: Deliverables

   

  	Item	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]
	COVID-19 Test Cartridges	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]
	Health Monitoring Systems	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]
	COVID-19 External Control Swab Packs	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]

   

  * Delivery dates and quantities subject to adjustment as provided herein.

   

  	Deliverable	Delivery

              Date	Method for Acceptance
	Increase

              Industrial Base Manufacturing Capability to 100K Cue COVID-19 Test cartridges per day	
          6 Million EUA or 510(k) cleared COVID-19 Test Cartridges 

          (per delivery schedule above) 

          30K Health Monitoring Systems

          (per delivery schedule above) 

          60K COVID-19 External Control Swab Packs 

          (per delivery schedule above)

        	Periodic Inspection & Random Sampling (DCMA and AOR)
	Monthly

              Progress Reports	[**] of the month, every month during PoP	Progress Report (AOR)
	Weekly Progress
              Meetings	Weekly, as agreed
              upon	Progress Meeting (AOR)
	Quarterly In
              Process Review	Every 90 days	Progress Meeting (AOR)
	Final Report	[**] after last
              scheduled delivery	Progress Report (AOR)
	Subcontractor Supply Chain Plans	[**]

              after award	Progress Report (AOR)
	Manufacturing Plan	[**] after award	Progress Report (AOR)
	Distribution Plan	[**] after award	Progress Report (AOR)
	Quality Management Plan	[**] after award	Progress Report (AOR)

   

  Monthly Progress Reports. The Awardee shall submit monthly progress reports no later than the [**] of the
      month. Awardee format acceptable. Electronic submission acceptable in MS Office or PDF format. Financial information shall be MS Excel format. Monthly reports shall NOT be marked proprietary, and shall have Distribution Statement C (US Government and
      their contractors). Each monthly report shall, at a minimum, contain the following:

   

  		●	Summary of monthly progress for each of the Awardee’s facilities/capabilities associated with this effort.

  		●	Summary of progress towards established milestones for each facility/capability.

  		●	Identification of any milestone that is slipping or missed, and discussion of path forward to bring milestone back to
            schedule, and impact on other milestones.

   

  
     

    
      
 

  

   

  		●	Summary of risks, discussion of potential impacts and efforts to mitigate.

  		●	Summary of overall schedule and changes from previous month.

  		●	Status updates from Manufacturing plan

  		●	Status updates from Distribution plan

  		●	Report any customer complaints

  		●	Report any known deficiencies of the materials and/or products

  		●	Financial summary of Awardee deliveries month to date, invoices submitted, and Government payments made.

   

  To the extent trade secret or other proprietary information is relevant to a monthly report, an appropriately
      marked supplement may be provided.

   

  Manufacturing Plan. The Awardee shall provide a detailed plan of action (contractor format acceptable) to
      increase cartridge-manufacturing capability to meet the government’s delivery schedule (i.e. ramp up to 100K cartridges per day) and associated on-shoring component manufacturing within [**] of contract award. The Awardee’s plan of action shall at a
      minimum, include the following:

   

  a.      Timeline, materials required and strategy to set up and begin V2.0 manufacturing lines
      to manufacture the cartridges;

   

  b.      Timeline, materials required and strategy to upgrade the bioproduction capability to
      manufacture sufficient cartridge reagents;

   

  c.      Timeline, materials required and strategy to onshore manufacturing of reagents and
      cartridge subcomponents;

   

  d.      Information on the US based manufacturing organization to replace existing
      organization;

   

  e.      Current GMP manufacturing status and plan to achieve GMP manufacturing, if not
      currently GMP;

   

  f.       Quality Assurance plan and Acceptance metrics;

   

  g.      Plan to comply with FDA EUA Letter of Authorization.

  

   

  Quality Management Plan. Cue Health, Inc. will, in the level of detail and format that Cue Health, Inc.
      solely elects (provided such format provides a reasonable and industry-standard level of detail), provide a quality management plan for manufacturing efforts that conform to ISO 13485 standards as well as the Quality System Regulations at 21 CFR Part
      820 which may include, but is not limited to, the quality policy and objectives, management review, competencies and training, process document control, feedback, evaluation, corrective action and preventive action, process improvement, measurement,
      and data analysis processes. The framework is normally divided into infrastructure, senior management responsibility, resource management, lifecycle management, and quality management system evaluation.

   

  
     

    
      
 

  

   

  Distribution Plan. Cue Health, Inc. will, in the level of detail and format that Cue Health, Inc. solely
      elects (provided such format provides a reasonable and industry-standard level of detail), provide a Distribution Plan within [**] of contract award, which shall provide a detailed distribution plan for how all Test Cartridge Packs, Monitoring
      Systems and External Control Swabs Packs will be shipped and delivered to required delivery locations within the United States and its Territories. The Awardee’s distribution plan shall at a minimum, include the following:

   

  

  a.       Current distribution processes;

  b.      Timeline and strategy to increase distribution process and shipping to handle the
      increase in number and volume of shipments.

   

  Subcontractor Supply Chain Plans. Cue Health Inc. will provide plans from key US subcontractors (swab
      manufacturer, fluid transfer automation, etc) describing how they plan to expand their production capacities in support of the Awardee. Cue Health Inc. will describe the source of capital such subcontractors expect to be utilized to increase their
      production rates.

   

  Final Report. Final Report shall NOT be marked proprietary, and shall have Distribution Statement C.

   

  Contractor format acceptable. Electronic submission acceptable in MS Office or PDF format. Financial information
      shall be MS Excel format. Final report summarizing stated objectives and the progress that was achieved in meeting those objectives; summary of risks incurred, impacts and mitigation; quantitative discussion of production throughput improvements
      achieved; financial summary of project; schedule summary for project, comparing original schedule to final schedule; lessons learned for future similar endeavors, and recommendations for path forward as applicable.

   

  		8.	Milestones: Payable milestones under this Agreement are listed in Table 2a and 2b.

   

  Payable Milestones

   

  Table 2a Industrial Expansion Milestones

   

  	Milestone

            #	Milestone

            Description	Due
            Date	Demonstration

            of Milestone	Total Funds
	1	Advance payment for upfront Industrial Expansion costs	Upon award	Award	$184,576,636

   

  Table 2b COVID-19 Test Delivery Milestones*

   

  	 	[**]	[**]	[**]	[**]	[**]	[**]
	Item	Qty	Payment	Qty	Payment	Qty	Payment	Qty	Payment	Qty	Payment	Qty	Payment
	COVID-19 Test Cartridges	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]
	
          Health

          Monitoring Systems

        	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]
	COVID-19 External Control Swab Packs	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]

   

  
     

    
      
 

  

   

  	 	[**]	[**]	[**]	[**]	[**]
	Item	Qty	Payment	Qty	Payment	Qty	Payment	Qty	Payment	Qty	Payment
	COVID-19 Test Cartridges	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]
	Health Monitoring Systems	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]
	COVID-19 External Control Swab Packs	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]	[**]

   

  ARTICLE 2:     TERM AND TERMINATION

   

  		A.	Term of this Agreement

   

  The Term of this Agreement commences upon the Effective Date and extends through final payment. This Agreement is
      anticipated to end 5 months after the Effective Date, subject to mutually agreed extensions pursuant to paragraph 2.D to facilitate the completion of the project(s). A transaction for a prototype project is complete upon the written determination of
      the appropriate official for the matter in question that efforts conducted under a Prototype OT: (1) met the key technical goals of a project, or (2) accomplished a particularly favorable or unexpected result that justifies the completion of the
      prototype.

   

  		B.	Rights of Termination

   

  ●            In the event that Awardee notifies the Government that, as a result of emerging
      safety or efficacy data, no further efforts will be undertaken towards the development of the COVID-19 Test manufacturing and delivery, then, either Party may notify the other Party of its intent to terminate this Agreement, which termination shall
      be effective thirty (30) days after the date of such notice.

   

  ●            Awardee shall have no liability to repay the Government for milestone payments
      made prior to the notification of termination, except as otherwise provided for under Article 14 or Termination for Cause below. With respect to milestones which have not been completed, Awardee shall be entitled to payment based on a percentage of
      the work performed toward said milestones, plus reasonable charges the Awardee can demonstrate to the satisfaction of the Government using its standard record keeping system, have resulted from the termination. By way of example, these costs may
      include, but are not necessarily limited to, costs associated with non-cancellable agreements with vendors to obtain manufacturing capacity or supplies in the performance of this prototype project agreement. Awardee shall not be required to comply
      with the cost accounting standards or contract cost principles for this purpose. This paragraph does not give the Government any right to audit Awardee’s records. Awardee shall not be paid for any work performed which reasonably could have been
      avoided.

   

  
     

    
      
 

  

   

  ●            From and after the effective date of any such termination, Awardee shall have no
      further obligation to deliver any test cartridges, Monitoring Systems or external controls, and the Government shall have no further obligation to accept any such deliverables.

   

  ●            The Government and the Awardee will negotiate in good faith a reasonable and
      timely adjustment of all outstanding issues between the Parties as a result of termination, including disposition of materials acquired for research use. Failure of the Parties to agree to a reasonable adjustment will be resolved pursuant to Article
      7, Disputes. In the event of termination, the Parties shall negotiate in good faith a reasonable wind-down plan and neither Party shall have any continuing obligations to perform under the Program except as otherwise specified herein.

   

  Termination for Convenience: The Government may terminate this Agreement for any or no reason by providing at
      least thirty (30) calendar days’ prior written notice to the Awardee. The Government and Awardee will negotiate in good faith a reasonable and timely adjustment of all outstanding issues between the Parties as a result of termination by the
      Government for convenience, provided that Awardee shall retain all payments for work performed prior to the effective date of the termination consistent with the terms of this Agreement, subject to the Government retaining the right to place Priority
      Orders for up to [**] after the date of such termination, as defined in Article 1, Paragraph C., subparagraph 2., for other diagnostic tests manufactured using the manufacturing equipment purchased with Government funds under this Agreement.

   

  Termination for Cause: If the Awardee materially fails to comply with the provisions of this Agreement, including
      unjustifiably failing to maintain EUA or advance to 510(k) clearance for Awardee’s COVID-19 Test, the Other Transaction Agreement Officer (OTAO), after issuance of a cure notice and failure of the Awardee to cure the defect within [**] or the time
      allowed by the OTAO after Awardee’s receipt of the cure notice, whichever is longer, may take one or more of the following actions as appropriate:

   

  		(i)	temporarily withhold payments pending correction of the deficiency,

  		(ii)	disallow all or part of the price attributable to the activity or action not in compliance,

  		(iii)	wholly or partly suspend or terminate this Agreement,

  		(iv)	withhold further funding, or

  		(v)	take any other legally available remedies.

   

  If this Agreement is terminated for Cause, Awardee will grant the Government a non-exclusive, paid up, perpetual
      license to the Awardee and subawardee patents and documentation necessary for the purpose of developing the Prototype. The Awardee shall provide the Government or its designee with a non-exclusive, paid up, license to any patent, copyright, technical
      data or regulatory information held by the Awardee that relates to the technology to permit the Government to pursue commercialization of the technology with a third party, on terms to be agreed between the Parties and subject to rights granted or
      held by third parties. The terms of this section and the obligations herein will be included in any exclusive license given by the Awardee to a third party for any intellectual property covered by this Agreement, on terms to be agreed between Awardee
      and such third party. This clause will survive the acquisition or merger of the Awardee by or with a third party.

   

  
     

    
      
 

  

   

  In addition to the Government’s remedies prescribed in this Article 2.B, Termination for Cause, after the
      finalization of a termination for default hereunder, where defaulted Awardee has exited or abandoned its business in the Field or has unreasonably abandoned its efforts to maintain EUA or advance to 510(k) clearance for Awardee’s COVID-19 Test, the
      Government may upon [**] written notice to Awardee, take possession of and title to all manufacturing equipment purchased using Government funds provided under this Agreement.

   

  		C.	Survival

   

  In the event of Termination, all rights, obligations, and duties hereunder, which by their nature or by their
      express terms extend beyond the expiration or termination of this Agreement, including but not limited to warranties, indemnifications, intellectual property (including rights to and protection of Intellectual Property and Proprietary Information),
      and product support obligations shall survive the expiration or termination of this Agreement.

   

  		D.	Stop Work Orders

   

  		●	Except as required by applicable law or regulation, or judicial or administrative order, the Government shall not have
            the authority to issue a stop work order to halt the work contemplated under the Statement of Work.

   

  		E.	Extension of Term

   

  The Parties may extend by mutual written agreement the Period of Performance if funding availability and research
      and development or prototype demonstration opportunities reasonably warrant.

   

  ARTICLE 3:     PROJECT MANAGEMENT AND MODIFICATIONS

   

  Technical and project management of the prototype project and associated scope within the Statement of Work shall
      be managed as detailed in this Article.

   

  		A.	Project Governance. Awardee is responsible for the overall management of the
              Prototype Project and related decisions. The Government and Awardee are bound to each other by a duty of good faith in achieving the Prototype Project as defined in Article 1. As such, the Government will have continuous involvement with
              Awardee shall provide project results in accordance with the Deliverables schedule identified in Table 1.

   

  		B.	Project Management. Awardee and the Government will each designate an
              individual responsible for facilitating the communications, reporting, and meetings between the Parties. For Awardee the individual will serve as PM, and for the Government the individual will be the AOR.

   

  
     

    
      
 

  

   

  		C.	Project Reviews. Awardee and the Government will hold periodic project review
              meetings as determined by the Awardee Project Manager and AOR, however, these meetings shall not occur more frequently than every [**].

   

  		D.	Reviews Resulting in Modifications. During the performance of this Prototype
              Agreement, as described above, it may be necessary to modify the scope of the Prototype Project or delivery timeframes. No communications, whether oral or in writing, that purport to change this Agreement are valid unless and until a
              modification is issued by the AO. The Parties hereby agree that any mutually agreed upon written request for modification shall be executed in an expedited timeframe. Modifications to subawards and/or new subcontracts under this Agreement
              that could reasonably impact the technical approach proposed and accepted by the Government require the approval of the AOR prior to being executed.

   

  		E.	Bilateral Modifications. Awardee or the Government may propose modifications to
              this Agreement. A modification that materially changes the obligations of either the Government or Awardee must be in writing and signed by the AO and Awardee authorized official. Awardee requests for modifications shall detail the technical,
              chronological and financial impact of the proposed change on the Statement of Work or delivery timeframes.

   

  		F.	Unilateral Modifications. The AO may ONLY issue minor or administrative
              modifications, which do not change the obligations of Awardee in any adverse manner, such as changes to the paying office or appropriations data, or changes to Government personnel identified in the Agreement. Unilateral modifications will
              only be signed by the AO.

   

  		G.	The AO has assigned an Agreements Officer’s Representative (AOR) for this agreement. The

              Awardee will receive a copy of the written designation outlining the roles and responsibilities of the AOR and specifying the extent of the AOR’s authority to act on behalf of the OTA. The AOR is not authorized to make any commitments or
              changes that will affect price, quality, quantity, delivery, or any other term or condition of the contract.

   

  		H.	Agreement Administration

   

  In no event shall any understanding or agreement, modification, change order, or other matter in
      deviation from the terms of this Agreement between the Awardee and a person other than the AO be effective or binding upon the Government. All such actions must be formalized by a proper contractual document executed by the AO.

   

  Government Points of Contact:

   

  Agreements Officer (AO)

   

  NAME: Vonetta G. McNeal 

    MAILING ADDRESS: 800 Park Office Drive, Research Triangle Park (RTP), NC 27529

   

  
     

    
      
 

  

   

  

    EMAIL: [**]

    PHONE: [**]

    AGENCY NAME/DIVISION/SECTION: Army Contracting Command - Aberdeen Proving Ground - RTP Division

   

  Agreements Officer Representative (AOR)

   

  NAME: [**] 

    MAILING ADDRESS: [**]

    EMAIL: [**]

    PHONE: [**]

   

  Cue Health, Inc. Points of Contact:

   

  Project Manager (PM)

   

  NAME:

      MAILING ADDRESS:

      EMAIL:

      PHONE:

   

  (will be provided within [**] after award)

   

  ARTICLE 4:     MANAGEMENT OF THE PROJECT

   

  		A.	Document Review

   

  		●	The Awardee shall provide the PCT sufficient opportunity to review study protocols, reports, and project plans. PCT’s comments on these documents will be viewed as
            advisory in nature.

   

  B.       Sub-agreement Holders

   

  ●             1. The Government acknowledges that, in order to combat the global
      pandemic and provide the test cartridges, Monitoring Systems and external controls as quickly as possible, Awardee has entered into a number of contracts prior to the Execution Date, and the Government agrees that it will not require these contracts
      to be renegotiated. Therefore, except as otherwise expressly set forth in this Article 4.B, any provision requiring Awardee to flow-down an obligation to its sub-agreement holders will apply only to sub-agreements executed by Awardee following the
      Execution Date of this Agreement.

   

  ●             2. For clarity, as detailed within the Articles themselves, the
      following Articles require flow-down to sub-agreements/contracts executed after the Execution Date:

   

  ●             (i) Article 8: Confidential Information.

   

  
     

    
      
 

  

   

  ●             (ii) Article 13.E: Subawards where the sub-agreement holder may propose
      publishing the results of its work under the subaward.

   

  ●             (iii) The Awardee will flow-down the provisions of Article 19
      (Prohibition on the Use of Certain Telecommunications and Video Surveillance Services or Equipment) to all of its sub-agreements/contracts as provided in Article 19.

   

  ARTICLE 5:     “PREP ACT” COVERAGE

   

  In accordance with the Public Readiness and Emergency Preparedness Act (“PREP Act”), Pub. L. No. 109-148,
      Division C, Section 2, as amended (codified at 42 U.S.C. § 247d-6d and 42 U.S.C. § 247d-6e), as well as the Secretary of Health and Human Service’s (“HHS”) Declaration Under the Public Readiness and Emergency Preparedness Act for Medical
      Countermeasures Against COVID-19, 85 Fed. Reg. 15198 (Mar. 17, 2020, effective Feb. 4, 2020), and amended on April 15, 2020, 85 Fed. Reg. 21012, and on June 8, 2020, 85 Fed. Reg. 34740 (together, the “Prep Act Declaration”):

   

  		(i)	This Agreement is being entered into for purposes of facilitating the manufacture, testing, development, distribution,
            administration, and use of “Covered Countermeasures” for responding to the COVID-19 public health emergency, in accordance with Section VI of the PREP Act Declaration;

   

  		(ii)	Awardee performance of this Agreement falls within the scope of the “Recommended Activities” for responding to the
            COVID-19 public health emergency in accordance with Section III of the PREP Act Declaration; and

   

  		(iii)	Awardee is a “Covered Person” per Section V of the PREP Act Declaration.

   

  Therefore, in accordance with Sections IV and VII of the PREP Act Declaration, as well as the PREP Act (42 U.S.C.
      § 247d-6d), the Department of Defense contracting via assisted acquisition on behalf of the HHS, expressly acknowledges and agrees that the HHS Declaration cited above, specifically its language providing immunity from suit and liability is
      applicable to this Agreement, as long as Awardee activities fall within the terms and conditions of the PREP Act and the PREP Act Declaration.

   

  The Government may not use, or authorize the use of, any products or materials provided under this Agreement,
      unless such use occurs in the United States (or a U.S. territory where U.S. law applies including, but not limited to, embassies, military installations and NATO installations) and is protected from liability under a declaration issued under the PREP
      Act, or a successor COVID-19 PREP Act Declaration of equal or greater scope. Any use where the application of the PREP Act is in question will be discussed with Awardee prior to use and, if the Parties disagree on such use, the dispute will be
      resolved according to Article 7, “Disputes.”

   

  ARTICLE 6:     FINANCIAL MATTERS - OBLIGATION AND PAYMENT

   

  This Agreement is fixed-price type Other Transaction Authority agreement. The payments provided under this
      Agreement are intended to compensate the Awardee on a fixed price basis for performance under this Agreement.

   

  
     

    
      
 

  

   

  		A.	Obligation

   

  Except as specified in Article 7: Disputes, the Government’s liability to make payments to the Awardee is limited
      only to those funds obligated under this Agreement or by modification to the Agreement. The ACC-APG Contracting Activity may incrementally fund this Agreement. If modification becomes necessary in performance of this Agreement, pursuant to Article 3
      of this Agreement, the AO and the Awardee shall establish and execute a mutually agreed upon revised Schedule of Payable Milestones consistent with the current SOW.

   

  		B.	Payments

   

  		1.	With the exception of test cartridges, Monitoring Systems and external control packs delivered either to Vendor-managed
            Inventory and/or Government distribution sites for which Government acceptance is detailed in Article 16, Awardee will provide AOR and AO notification of milestone success and any documentation that supports successful completion of the
            milestone. Within [**] of receipt, the AO will either, 1) confirm milestone completion and authorize the Awardee to invoice against the completed milestone or, 2) notify the Awardee of any deficiencies, additional documentation or
            clarifications reasonably needed by the Government to complete its review of the milestone. The Parties agree that payments will be made upon the AOR’s acceptance of completed milestones. These payments reflect value received by the Government
            toward the accomplishment of the Prototype Project goals.

   

  Payments are based on amounts generated from the Awardee’s financial or cost records. The Awardee shall
      be reimbursed for each element identified in the awarded cost proposal, executed and accomplished in accordance with the performance schedule.

   

  		2.	After accomplishment of each milestone, the Awardee will submit the corresponding invoice through a Government provided
            invoicing and payment system, as detailed in Article 18.

   

  		3.	Except as set forth in Article 7, Disputes, in no case shall the Government’s financial liability exceed the amount
            obligated under this Agreement.

   

  		4.	Payments will be made by the cognizant Defense Finance and Accounting Services office, as indicated below, in accordance
            with the Prompt Payment Act. Article 18 details how to submit and process invoices.

   

  		5.	Payments shall be made in the amounts set forth in the SOW, provided the AOR has verified the completion of the
            applicable milestones. The Government will pay Awardee in US dollars.

   

  		6.	The amounts payable by the Government to the Awardee pursuant to this Agreement shall not be reduced on account of any
            Taxes unless required by applicable law. The Awardee alone shall be responsible for paying any and all Taxes (other than withholding Taxes required to be paid by the Government under applicable law) levied on account of, or measured in whole or
            in part by reference to, any payments it receives. If the Awardee is entitled under any applicable Tax treaty to a reduction of rate of, or the elimination of, or recovery of, applicable withholding Tax, it shall deliver to the Government or
            the appropriate governmental authority (with the assistance of the Government to the extent that this is reasonably required and is expressly requested in writing) the prescribed forms necessary to reduce the applicable rate of withholding or
            to relieve the Government of its obligation to withhold Tax, and the Government shall apply the reduced rate of withholding, or dispense with the withholding, as the case may be, to the extent it complies with the applicable Tax treaty. If, in
            accordance with the foregoing, the Government withholds any amount, it shall make timely payment to the proper Taxing Authority of the withheld amount, and send to the Awardee proof of such payment within 90 days following that payment.

   

  
     

    
      
 

  

   

  As used herein: Taxes means all taxes of any kind, and all charges, fees, customs, levies, duties,
      imposts, required deposits or other assessments, including all federal, state, local or foreign net income, capital gains, gross income, gross receipt, property, franchise, sales, use, excise, withholding, payroll, employment, social security,
      worker’s compensation, unemployment, occupation, capital stock, transfer, gains, windfall profits, net worth, asset, transaction and other taxes, and any interest, penalties or additions to tax with respect thereto, imposed upon any person by any
      Taxing Authority or other governmental authority under applicable law, whether disputed or not, and including any obligation to indemnify or otherwise assume or succeed to the Tax liability of any other person by law, by contract or otherwise. Taxing

        Authority means any governmental authority or any subdivision, agency, commission or authority thereof or any quasi-governmental body exercising tax regulatory authority.

   

  		7.	The Awardee shall maintain adequate records to account for all funding under this Agreement. Neither the Cost Accounting
            Standards nor any other aspect of the Federal Acquisition Regulation or its supplements apply to Awardee’s accounting of costs under this Agreement. Cost shall be accounted for in accordance with Awardee’s commercial accounting practices.
            Awardee has an established and agrees to maintain an established accounting system which complies with Financial Reporting Standards and the requirements of this Agreement, and shall ensure that appropriate arrangements have been made for
            receiving, distributing and accounting for Federal funds. An acceptable accounting system is one in which all costs, cash receipts and disbursements for which Awardee is entitled to reimbursement under Article 6 are controlled and documented
            properly.

   

  A.           Obligation. Under no circumstances shall the Government’s financial
      obligation exceed the amount obligated in this Agreement or by amendment to the Agreement. The amount of Government funds obligated by this Agreement and available for Payment is set forth on page 1, Line of Accounting and Appropriation. The
      Government may incrementally fund this agreement.

   

  B.            The Government is not obligated to provide payment to the Awardee for
      amounts in excess of the amount of obligated funds allotted by the Government.

   

  C.            The Government shall pay the Awardee, upon submission of proper
      invoices, the costs stipulated in this Agreement for work delivered or rendered and accepted, less any deductions provided in this Agreement. Unless otherwise specified, payment shall be made upon acceptance of any portion of the work delivered or
      rendered for which a price is separately stated in the Agreement. Payments will be made within [**] of receipt of a request for payment.

   

  
     

    
      
 

  

   

  D.           Prior written approval by the AO, or the AOR, is required for all travel
      directly and identifiably funded by the Government under this agreement. The Awardee shall present to the AO or AOR, an itinerary for each planned trip, showing the name of the traveler, purpose of the trip, origin/destination, dates of travel, and
      estimated cost broken down by line item as far in advanced of the proposed travel as possible, but no less than [**] before travel is planned to commence. In the event that emergency travel is required (e.g. in the event of an outbreak) that would
      make two weeks’ notice impractical, travel requests may be submitted to the Government for an expedited review. Emergency travel requests shall be labelled as such and shall include a brief summary of the emergency situation and rationale for
      expedited review.

   

  E.            WIDE AREA WORKFLOW PAYMENT INSTRUCTIONS (MAY 2013)

   

  (a)           Definitions. As used in this clause-

   

  Department of Defense Activity Address Code (DoDAAC) is a six position code that uniquely identifies a
      unit, activity, or organization.

   

  Document type means the type of payment request or receiving report available for creation in Wide Area
      WorkFlow (WAWF).

   

  Local processing office (LPO) is the office responsible for payment certification when payment
      certification is done external to the entitlement system.

   

  (b)          Electronic invoicing. The WAWF system is the method to electronically
      process vendor payment requests and receiving reports, as authorized by DFARS 252.232-7003, Electronic Submission of Payment requests and Receiving Reports.

   

  (c)          WAWF access. To access WAWF, the Awardee shall (i) have a designated
      electronic business point of contact in the System for Award Management at https://www.acquisition.gov; and (ii) be registered to use WAWF at https://wawf.eb.mil/ following the step-by-step procedures for self-registration available at this website.

   

  (d)          WAWF training. The Awardee should follow the training instructions of
      the WAWF Web-Based Training Course and use the Practice Training Site before submitting payment requests through WAWF. Both can be accessed by selecting the “Web Based Training” link on the WAWF home page at https://wawf.eb.mil/.

   

  (e)           WAWF methods of document submission. Document submissions may be via
      Web entry, Electronic Data Interchange, or File Transfer Protocol.

   

  (f)           WAWF payment instructions. The Awardee must use the following
      information when submitting payment requests and receiving reports in WAWF for this Agreement:

   

  
     

    
      
 

  

   

  (1)           Document type. The Awardee shall use the following document type:
      Voucher

   

  (2)           Inspection/acceptance location. The Awardee shall select the following
      inspection/acceptance location(s) in WAWF, as specified by the contracting officer.

   

  (3)           Document routing. The Awardee shall use the information in the Routing
      Data Table below only to fill in applicable fields in WAWF when creating payment requests and receiving reports in the system.

   

  Routing Data Table

   

  	Field Name in WAWF	Data to be entered in WAWF
	Pay

            Official DoDAAC	HQ0339
	Issue

            By DoDAAC	W911NF
	Admin

            DoDAAC	S0514A
	Inspect By DoDAAC	W56XNH

   

  (4)           Payment request and supporting documentation. The Awardee shall ensure
      a payment request includes appropriate contract line item and subline item descriptions of the work performed or supplies delivered, costs, fee (if applicable), and all relevant back-up documentation In support of each payment request.

   

  (5)           WAWF email notifications. The Awardee shall enter the email address
      identified below in the “Send Additional Email Notifications” field of WAWF once a document is submitted in the system.

   

  AO: [**]

      AOR: [**]

   

  (g)           WAWF point of contact.

   

  (1)           The Awardee may obtain clarification regarding invoicing in WAWF from
      the following contracting activity’s WAWF point of contact.

   

  (2)           For technical WAWF help, contact the WAWF helpdesk at 866-618-5988.

      (End of Clause)

   

  1. The AOR identified in Supplement 4, “Agreement Administration” shall continue to formally inspect
      and accept the deliverables/milestones. To the maximum extent practicable, the AOR shall review the deliverable(s) milestone report(s) and either:

   

  i. provide a written notice of rejection to the Awardee which includes feedback regarding deficiencies
      requiring correction or

   

  ii. written notice of acceptance to the AO, and acceptance in the WAWF system.

   

  2. Acceptance within the WAWF system shall be performed by the AOR.

   

  
     

    
      
 

  

   

  Note for DFAS: The Agreement shall be entered into the DFAS system by CLIN -
      Milestone association (MS)/ACRN as delineated in Section B of the Award. The Agreement is to be paid out by CLIN (MS)/ACRN. Payments shall be made using the CLIN (MS)/ACRN association as delineated at Section B of this Award.

   

  Awardee Information: As identified at Central Contractor Registration, i.e.,
      Commercial and Government Entity (CAGE) Code, Dun & Bradstreet number (DUNS), and Tax Identification Number (TIN). Payments shall be made in the amounts set forth in the SOW, provided the AOR has verified the completion of the milestones.

   

  F.            Comptroller General Access to Records: To the extent that the total
      Government payments under this Agreement exceed $5,000,000, the Comptroller General, at its discretion, shall have access to and the right to examine records of any Party to the Agreement or any entity that participates in the performance of this
      Agreement that directly pertain to, and involve transactions relating to, the Agreement for a period of three (3) years after final payment is made. This requirement shall not apply with respect to any Party to this Agreement or any entity that
      participates in the performance of the Agreement, or any subordinate element of such Party or entity, that has not entered into any other agreement (contract, grant, cooperative agreement, or “other transaction”) that provides for audit access by a
      government entity in the year prior to the date of this Agreement. This paragraph only applies to any record that is created or maintained in the ordinary course of business or pursuant to a provision of law. The terms of this paragraph shall be
      included in all sub-agreements to the Agreement other than sub-agreements with a component of the U.S. Government. The Comptroller General may not examine records pursuant to a clause included in an agreement more than three years after the final
      payment is made by the United States under the agreement.

   

  		C.	Comptroller Access Financial Records and Reports:

   

  Awardee shall maintain adequate records to account for Federal funds received under this Agreement and shall
      maintain adequate records to account for funding provided under this Agreement. Awardee relevant financial records are subject to examination or audit by or on behalf of the Comptroller General, Contracting Activity AO, or other Government Official
      for a period not to exceed three (3) years after expiration of the term of the Agreement. The Comptroller General, AO or designee shall have direct access to sufficient records and information of any party to this agreement or any entity that
      participates in the performance of this agreement to ensure full accountability for all funding under this Agreement. Such audit, examination or access shall be performed during business hours on business days upon prior written notice and shall be
      subject to the security requirements of the audited party. Any audit required during the course of the program may be conducted by the Comptroller General or other Government Official using Government auditors or, at the request of Awardee’s external
      CPA accounting firm at the expense of the Awardee.

   

  		1.	Lower Tier Agreements

   

  The Performer shall include this Article, suitably modified to identify the Parties, in all subcontracts or lower
      tier agreements entered into solely in connection with this Agreement.

   

  
     

    
      
 

  

   

  ARTICLE 7:     DISPUTES

   

  		A.	General

   

  The Parties shall communicate with one another in good faith and in a timely, responsive, and cooperative manner
      when raising issues under this Article.

   

  		B.	Dispute Resolution Procedures

   

  		1.	Any claim or dispute between the Government and Awardee concerning questions of fact or law arising from or in connection
            with this Agreement, and, whether or not involving an alleged breach of this Agreement, shall be raised and resolved under this Article.

   

  		2.	Whenever legal disputes or claims arise, the Parties shall attempt to resolve the issue(s) by discussion and come to
            mutual agreement on a resolution as soon as practicable. In no event shall a dispute, disagreement or misunderstanding of which the aggrieved Party became aware more than [**] prior to the notification made under sub-section B.3 of this Article
            constitute the basis for relief under this Article unless one level above the AO, in the interests of justice, waives this requirement.

   

  		3.	Failing resolution by mutual agreement, the aggrieved Party shall document the dispute, disagreement, or misunderstanding
            by notifying the other Party (through the AO Awardee s POC, as the case may be) in writing of the relevant facts, identifying unresolved issues, and specifying the clarification or remedy sought. Within [**] after providing notice to the other
            Party, the aggrieved Party may, in writing, request a joint decision by the ACC-APG Division Chief for and senior executive appointed by Awardee The other Party shall submit a written response on the matter(s) in dispute within [**] after being
            notified that a decision has been requested. The Division Chief and the Awardee senior executive shall conduct a review of the matter(s) in dispute and attempt to render a mutually agreeable decision in writing within [**] of receipt of such
            written position. Any such joint decision is final and binding.

   

  		4.	In the absence of a joint decision, upon written request to the ACC-APG Associate Director made within [**] of the
            expiration of the time for a decision under sub-section B.3 above, the dispute shall be further reviewed. The Associate Director may elect to conduct this review personally or through a designee or jointly with a senior executive appointed by
            Awardee Following the review, the Associate Director or designee will resolve the issue(s) and notify the Parties in writing. This decision may be appealed to any federal court of competent jurisdiction.

   

  		5.	Notwithstanding any other provisions of this Article, the Parties agree that Awardee shall have the right to pursue any
            contract dispute arising under this Agreement in any federal court of competent jurisdiction, including the appropriate Court of Appeals, or the Supreme Court, at any time without any administrative exhaustion requirements, and the timing
            requirements described above will not limit any claim in such tribunals.

   

  
     

    
      
 

  

   

  		C.	Limitation of Damages

   

  Claims for damages of any nature whatsoever pursued under this Agreement shall be limited to direct damages only
      up to the aggregate amount of Government funding obligated as of the time the dispute arises, except with respect to violations of Articles 5, 8, 9, or 10 of this Agreement.

   

  ARTICLE 8:     CONFIDENTIAL INFORMATION

   

  		A.	“Confidential Information,” as used in this Article, means information or data
              of a personal nature about an individual, or proprietary information or data submitted by or pertaining to an institution or organization.

   

  		B.	The Agreements Officer and the Awardee may, by mutual consent, identify elsewhere in this Agreement
            specific information and/or categories of information which the Government will furnish to the Awardee or that the Awardee is expected to generate which is confidential. Similarly, the Agreements Officer and the Awardee may, by mutual consent,
            identify such Confidential Information from time to time during the Period of Performance. Failure to agree will be settled pursuant to the “Disputes” clause.

   

  		C.	If it is established elsewhere in this Agreement that information to be utilized under this
            Agreement, or a portion thereof, is subject to the Privacy Act, the Awardee will follow the rules and procedures of disclosure set forth in the Privacy Act of 1974, 5 U.S.C. § 552a, and implementing regulations and policies, with respect to
            systems of records determined to be subject to the Privacy Act.

   

  		D.	The Receiving Party shall not directly or indirectly, divulge or reveal to any person or entity any
            Confidential Information of another Party without the Disclosing Party’s prior written consent, or use such Confidential Information except as permitted under this Agreement. Confidential Information shall be subject to the same prohibitions on
            disclosure as provided for under FAR Part 24.202. Further, any reproduction of Confidential Information or portions thereof that is disseminated within the Government, CMF, or Awardee, shall be shared strictly on a need to know basis for the
            purposes of this Agreement and is subject to the restrictions of this provision. In addition to the above, Confidential Information is subject to the protections of the Trade Secrets Act as well as any other remedies available under this
            Agreement or the law.

   

  		E.	Such obligation of confidentiality shall not apply to information which the Receiving Party can
            demonstrate through competent evidence: (i) was at the time of disclosure in the public domain; (ii) has come into the public domain after disclosure through no breach of this contract; (iii) was known to the Receiving Party prior to disclosure
            thereof by the Disclosing Party; (iv) was lawfully disclosed to the Receiving Party by a Third Party which was not under an obligation of confidence to the Disclosing Party with respect thereto; or (v) was approved for public release by prior
            written permission of the Disclosing Party.

   

  
     

    
      
 

  

   

  		F.	Whenever the Awardee is uncertain with regard to the proper handling of material under the
            Agreement, or if the material in question is subject to the Privacy Act or is Confidential Information subject to the provisions of this Article, the Awardee shall obtain a written determination from the Agreements Officer prior to any release,
            disclosure, dissemination, or publication.

   

  		G.	Agreements Officer Determinations will reflect the result of internal coordination with appropriate
            program and legal officials.

   

  		H.	The provisions of paragraph (D) of this Article shall not supersede conflicting or overlapping
            provisions applicable Federal, State or local laws.

   

  		I.	The obligations of the Receiving Party under this Article shall continue for a period of [**] from
            conveyance of the Confidential Information.

   

  Subject to Article 4.B, all above requirements MUST be passed to all Sub-awards.

   

  ARTICLE 9:     INTELLECTUAL PROPERTY RIGHTS

   

  		A.	Awardee represents that, to its knowledge, the intellectual property license(s) and other rights
            held by or granted to Awardee, are sufficient to enable Awardee to perform its obligations under this Agreement.

   

  		B.	Background IP and Materials. Awardee and the Government each retain any
              intellectual property (IP) rights to their own materials, technical data (as defined in 48 DFARS 252.227-7013), technology, information, documents, or Know-How—or potential rights, such as issued patents, patent applications, invention
              disclosures, copyrighted works, or other written documentation—that exist prior to execution of this Agreement or are developed outside the scope of this Agreement (“Background IP”). For avoidance of
              confusion, Background IP includes but is not limited to Background Inventions. Awardee agrees to provide, within [**] of the effective date of this Agreement, a list of all Background Inventions relevant to Awardee’s performance of the
              prototype project. Any material defect identified in the Background Invention disclosure that could materially negatively impact performance of the prototype project, will be addressed between the AOR and the Awardee’s designee.

   

  		C.	Government’s Background IP. The Government has Background IP as constituted
              under contract number HHSO100201800016C, including all executed modifications.

   

  		D.	Agreement Inventions. In the unlikely event that an invention is conceived or
              first actually reduced to practice in the performance of this Agreement (“Agreement Invention”), ownership of any Agreement Invention, regardless of whether it is not patentable, or is patentable under U.S. patent law that is conceived or
              first reduced to practice under this Agreement will follow inventorship in accordance with U.S. patent law. Neither the Government nor Awardee anticipate the conception or reduction to practice of any Agreement Invention. The Government
              acknowledges that in the absence of any Agreement Invention, the Bayh-Dole Act (35 U.S.C. §§ 200-212) does not apply to, nor govern, this Agreement. Since, in the absence of any Agreement Invention, the Bayh-Dole Act, does not apply to this
              Agreement, as such, title to Agreement Invention will accrue to the inventor or inventor-organization. In the absence of any Agreement Invention, the Government shall not have any rights to “march-in,” as that term is defined in 35 U.S.C. §
              203, and Awardee is not subject to the manufacturing requirements of 35 U.S.C. § 204.

   

  
     

    
      
 

  

   

  In the event an Agreement Invention arises, the Parties represent and warrant that each inventor will
      assign his or her rights in any such Agreement Inventions to his or her employing organization. If an Agreement Invention is made either by a Awardee employee (“Sole Recipient Agreement Invention”) or made by a Government employee (“Sole
        Government Agreement Invention”) the entire rights to that sole Awardee Agreement Invention or Sole Government Agreement Invention will be respectively assigned to the Awardee or to the Government. If an Awardee employee and a Government
      employee jointly make an Agreement invention (“Joint Agreement Invention”), it will be owned jointly by the Awardee and the Government. Ownership of inventions made in whole or in part with sub-Awardee or collaborator employees, including
      employees of other components of the Government, will be determined solely pursuant to an agreement between the Awardee and the applicable sub-Awardee or collaborator. Notwithstanding the foregoing, neither the Government nor Awardee anticipate the
      Government making a Sole Government Agreement Invention, nor the Parties jointly making a Joint Agreement Invention, as Awardee employees are solely responsible, as between the Parties, for performing the Prototype Project under this Agreement.

   

  		E.	Patent Applications. Each Party shall report any Agreement Inventions to the
              other Party within [**] of the time the inventor discloses it in writing to its personnel responsible for patent matters. The Parties will respectively have the option, in their discretion, to file a patent application claiming any Agreement
              Invention made solely by their respective employees (but, for clarity, are not obligated to file patent applications claiming any Agreement Invention, and will not forfeit title by electing to hold an Agreement Invention as a trade secret).
              The Parties will consult with each other regarding the options for filing a patent application claiming a joint Agreement Invention. Within [**] of being notified of the discovery of an Agreement Invention, each Party will provide notice of
              any filing of a patent application to the other Party. The Parties will reasonably cooperate with each other in the preparation, filing, and prosecution of any patent application claiming a Joint Agreement Invention. Any Party filing a patent
              application will bear expenses associated with filing and prosecuting the application, as well as maintaining any patents that issue from the application, unless otherwise agreed by the Parties. Executive Order No. 9424 of 18 February 1944
              requires all executive Departments and agencies of the Government to forward through appropriate channels to the Commissioner of Patents and Trademarks, for recording, all Government interests in patents or applications for patents.

   

  		F.	Patent Prosecution. Awardee agrees to take responsibility for the preparation,
              filing, prosecution, and maintenance of any and all patents and patent applications that are relevant to the work performed under this Agreement. Awardee shall keep the Government reasonably advised on the status of Awardee Background IP by
              providing an annual report on the status of Awardee Background IP. With respect to a Sole Awardee Agreement Invention or a Joint Agreement Invention, prior to acting on a decision by Awardee to abandon or not file in any country a patent or
              patent application covering a Sole Awardee Agreement Invention or a Joint Agreement Invention, Awardee shall so inform the Government in a timely manner to allow Awardee to thoughtfully consider the Government’s comments regarding such a
              proposed decision.

   

  
     

    
      
 

  

   

  If the Licensor shall continue the prosecution of any application for, to pay the maintenance fees on,
      or defend in reexamination or opposition proceedings on, a Joint Agreement Invention on behalf of Awardee, Awardee shall notify the Government within [**]. If the Licensor notifies Awardee that it declines to continue prosecution of any application
      for, to pay the maintenance fees on, or defend in reexamination or opposition proceedings on, a Joint Agreement Invention, Awardee shall notify the Government within [**] after receipt of such notice.

   

  		G.	Patent Enforcement. Awardee will have the first option to enforce any patent
              rights covering a Joint Agreement Invention at Awardee’s expense. If Awardee chooses not to exercise this option, the Government may enforce patent rights covering a Joint Agreement Invention.

   

  		H.	Licenses.

   

  Background IP. The Government has the rights in Background IP constituted under contract number
      HHSO100201800016C, including all executed modifications.

   

  Agreement Inventions. Any Sole Awardee Agreement Invention is subject to a nonexclusive,
      nontransferable, irrevocable, paid-up license for the Government, to practice and have practiced the Agreement Invention on behalf of the Government. For any Sole Government Agreement Invention, upon the Awardee’s request, the Government agrees to
      enter into good faith negotiations with the Awardee regarding the Awardee’s receipt of a nonexclusive commercialization license covering the Government’s interest in any Sole Government Agreement Invention.

   

  ARTICLE 10:       DATA RIGHTS

   

  		A.	Background Data. “Background Data” shall mean all data, that exists prior to
              execution of this Agreement, or are developed outside the scope of this Agreement. Awardee’s Background Data includes, but is not limited to, the following technical data, to the extent such data exists prior to execution of this
                Agreement or is developed outside the scope of this Agreement:

   

  		1.	Technical data as defined at DFARS 252.227-7013 (“Technical Data”),

  		2.	All data relating to the development, commercialization, manufacture of the test kits,

  		3.	All data relating to the manufacturing, quality control testing (including in-process, release and stability testing),
            processing, releasing, or packaging of the test kits; and

  		4.	Any and all data relating to preparatory work for distributing, importing, exporting, selling, offering for sale,
            supplying, offering for supply or otherwise exploiting the Awardee COVID 19 tests.

   

  
     

    
      
 

  

   

  All Background Data shall be owned by the Awardee, subject to the Government’s rights in Background Data
      developed or produced in the performance of contract number HHSO100201800016C, including all executed modifications thereto. Awardee hereby grants the Government a non-exclusive license subject to the limitations specified in Article 10.C to use any
      Background Data, other than clinical data, or financial, administrative, cost, pricing or management information, solely to the extent necessary for the Government to perform its obligations under this Agreement and meet its objective of facilitating
      administration of the COVID-19 Tests delivered under this Agreement in accordance with FDA and other applicable regulations.

   

  		B.	Subject Data. “Subject Data” is defined as all Technical Data generated by or
              on behalf of Awardee in the performance of this Agreement. Subject Data shall be owned by the Awardee. The Government shall obtain “Unlimited rights”, as this term is defined in DFARS 252.227-7013(a)(16) in Subject Data specified for delivery
              under this Agreement and Government Purpose Rights, as the term is defined in DFARS 252.227-7013(a)(13), in Subject Data not specified for delivery under this Agreement. . The Awardee agrees to retain and maintain in a clear and readable
              manner, until [**] after completion or termination of this Agreement, all Subject Data.

   

  		C.	Restrictions on Government License Rights. Subject to the Government’s
              pre-existing rights under contract HHSO100201800016C as modified:

   

  		a.	Background Data other than computer software in which the Government has rights under Article 10. A shall be received by
            the Government subject to Limited Rights as defined at DFARS 252.227-7013.

   

  		b.	Background Data that is computer software in which the Government has rights under Article 10.A shall be received by
            Government subject to Restricted Rights as defined at DFARS 252.227-7014, except that the Government shall instead receive commercial software license rights in such software that is a commercial item as defined at FAR 2.101.

   

  		D.	Marking of Data. The Awardee will mark any Data delivered under this Agreement
              with the following legend:

   

  “Use, duplication, or disclosure is subject to the restrictions as stated in Agreement No.
      W911NF-21-9-0001 between the Government and the Awardee.”

   

  The Awardee may further mark Data furnished with the rights specified in Article 10.C as “Limited
      Rights Data,” “Restricted Rights Software,” or “Commercial-Rights Software,” as appropriate. Any rights that the Awardee or the Government may have in Data delivered under this Agreement, whether arising under this Agreement or otherwise, will not be
      affected by Awardee’s failure to mark Data pursuant to this Article.

   

  All Subject Data, Technical Data and Software (each term as defined under DFARS 252.227-7013) which
      shall be delivered under this Agreement with less than Unlimited Rights shall be identified in reasonable specificity and particular rights granted (Government Purpose, Limited or Restricted (all as defined in DFARS 252.227-7013)). If the data is
      marked “Limited Rights”, the Awardee shall provide, upon request by the Government, an explanation to the Government as to why the data does not fall within the deliverables, and thus should not be accorded Unlimited Rights status.

   

  
     

    
      
 

  

   

  ARTICLE 11:       REGULATORY RIGHTS

   

  The Awardee shall provide the Government with all material communications and summaries thereof, both
      formal and informal, to or from FDA, regarding the Awardee’s EUA for its COVID-19 Test or the prototype project within [**], and make best efforts to ensure that the Government representatives are invited to participate in any formal or informal
      meetings with FDA. Awardee shall (1) ensure that the Government representatives are consulted and are invited to participate in any formal or informal meetings with FDA related to Awardee’s COVID-19 Test and the prototype project; and (2) notify the
      FDA that the Government has the right to discuss with FDA any development efforts regarding the prototype project. In addition to the foregoing, Awardee shall use diligent efforts to notify the Government within [**] of any event, risk, formal or
      informal FDA communication, or other issue that would be reasonably expected to materially impact the Awardee’s EUA For the COIVD-19 Test or ability to advance to final 510(k) clearance of the Awardee’s COVID-19 Test.

   

  ARTICLE 12:       FOREIGN ACCESS TO DATA

   

  		A.	The Parties will comply with any applicable U.S. export control statutes and regulations in
            performing this Agreement.

   

  ARTICLE 13:       SCIENTIFIC PUBLICATIONS AND PRESS RELEASES

   

  		A.	Neither Awardee nor the Government shall make, or permit any person to make, any public announcement
            concerning the existence, subject matter or terms of this Agreement, the transactions contemplated by it, or the relationship between the Awardee and the Government hereunder, without the prior written consent of the other, such consent not to
            be unreasonably withheld or delayed, except as required by law, any governmental or regulatory authority (including, without limitation, any relevant securities exchange), any court or other authority of competent jurisdiction.

   

  		B.	Notwithstanding the foregoing, Awardee and (its upstream licensor) retains the right, but not the
            obligation, to prepare and submit scientific publications and release information to the public about its COVID-19 development program, without the Government’s consent or involvement. The Awardee shall inform the AOR when any abstract article
            or other publication is published, and furnish a copy of it as finally published.

   

  		C.	Unless authorized in writing by the AO, the Awardee shall not display Government logos including
            Operating Division or Staff Division logos on any publications.

   

  		D.	The Awardee shall not reference the products(s) or services(s) awarded under this contract in
            commercial advertising, as defined in FAR 31.205-1, in any manner which states or implies Government approval or endorsement of the product(s) or service(s) provided.

   

  
     

    
      
 

  

   

  		E.	Subject to Article 4.B, the Awardee shall include this clause, including this section (d) in all
            subawards where the sub-agreement holder may propose publishing the results of its work under the subaward. The Awardee shall acknowledge the support of the Government whenever publicizing the work under this Agreement in any written media by
            including an acknowledgement substantially as follows:

   

  “This project has been funded in whole or in part by the U.S. Government under Agreement No.
      W911NF-21-9-00XX. The US Government is authorized to reproduce and distribute reprints for Governmental purposes notwithstanding any copyright notation thereon.”

   

  ARTICLE 14:       ENSURING SUFFICIENT SUPPLY OF THE PRODUCT

   

  		A.	In recognition of the Government’s significant funding for the development and manufacturing of the
            COVID- 19 Test and the Government’s need to provide sufficient quantities of a COVID-19 tests to protect the United States population, the Government shall have the remedy described in this section to ensure sufficient supply of test kits to
            meet the needs of the public health or national security. This remedy is not available to the Government unless and until any of the following conditions is met, and is not available as a result of a termination under Article 2(B) of this
            Agreement:

   

  		i.	Awardee gives notice, required to be submitted to the Government no later than [**], following any formal management
            decision to terminate the product development effort, including a decision not to maintain EUA or proceed to 510(k) clearance during the term of this Agreement or [**] thereafter;

   

  		ii.	Awardee gives written notice, required to be submitted to the Government no later than [**], of any filing that
            anticipates Federal bankruptcy protection during the term of this Agreement or [**] thereafter.

   

  		B.	If one or more of the conditions listed in Section 14.A occurs, Awardee, upon the request of the
            Government, subject to the terms of the pre-existing agreement with Licensor, shall provide the following items necessary for the Government to pursue licensure/authorization and manufacturing of the Technology with a third party for exclusive
            sale to the U.S. Government:

   

  		i.	a writing evidencing a non-exclusive, nontransferable, irrevocable (except for cause), royalty-free paid-up license to
            practice or have practiced for or on behalf of the U.S. Government any Awardee Background IP and Background Data, as those terms are defined in of this Agreement, necessary to manufacture or have manufactured the Technology;

   

  		ii.	any outstanding Deliverables contemplated or materials and possession of and title to manufacturing equipment purchased
            with Government funds under this Agreement.

   

  		C.	This Article will survive the acquisition or merger of the Awardee by or with a third party. This
            Article will survive the expiration of this agreement.

   

  
     

    
      
 

  

   

  ARTICLE 15:       ARTICLE 15: INSPECTION AND ACCEPTANCE

   

  		A.	Delivery and Acceptance. Awardee shall notify the AO and AOR at least [**]
              prior to initial delivery of first shipment of test kits. Exceptions are permitted if approved by the AO. Upon notification, the AOR will instruct the Awardee to deliver kits to either up to three centralized Government-designated
              distribution sites within the continental United States or up to three additional specific individual final destinations within the continental United States. Upon delivery of product, notification of delivery quantities shall be made to the
              AOR.

   

  Upon receipt of the provided certificates and any inspection of product at the origin or destination
      site(s) that was timely requested (physical or representative, i.e., pictures), the AOR will review and recommend acceptance or rejection. The Government shall accept product that conforms to contract requirements based on Certificates of Analysis
      and certificate(s) of cGMP conformity provided by Awardee and review of temperature monitoring data. The AO will correspondingly notify Awardee of acceptance or rejection. However, the Government’s acceptance of product will be deemed to have
      occurred if the Government does not provide written notice of acceptance or rejection within [**] of Awardee’s provision of all applicable certificates.

   

  A. Inspection: The Government has the right to inspect and test all work called for by this Agreement,
      to the extent practicable at all places and times, including the period of performance, and in any event before acceptance. The Government may also inspect the premises of the Awardee. The Government shall perform inspections and tests in a manner
      that will not unduly delay the work. If the Government performs any inspection or test on the premises of the Awardee, the Awardee shall furnish, at no increase in price, all reasonable facilities and assistance for the safe and convenient
      performance of these duties. Except as otherwise provided in the Agreement, the Government shall bear the expense of Government inspections or tests made at other than the Awardee’s premises.

   

  B. The Government shall inspect/accept or reject the work as promptly as practicable after
      completion/delivery, unless otherwise specified in the Agreement. Government failure to inspect and accept or reject the work shall not relieve the Awardee from responsibility, nor impose liability on the Government, for nonconforming work. Work is
      nonconforming when it is defective in material or workmanship or is otherwise not in conformity with Agreement requirements. The Government has the right to reject nonconforming work. Inspection/Acceptance of the Prototype performed should not exceed
      [**] after completion.

   

  		B.	Vendor-managed Inventory. Product to be stored as VMI will be shipped to
              Awardee’s own warehouse locations or its third party vendor’s site, and may be stored for a period not longer than [**]. Prior to expiration of this [**] period, the Government must either (a) provide Awardee with disposition instructions in
              sufficient time to transfer and take possession of physical material from Awardee, (b) bilaterally modify this agreement to extend the period of vendor management of storage, or (c) bilaterally modify this Agreement to include destruction of
              remaining doses.

   

  
     

    
      
 

  

   

  When held in VMI, these materials will be maintained in Awardee’s or its designated representative’s
      quality and inventory systems. Product held in VMI is subject to the following requirements:

   

  		i.	Provide temperature controlled storage at the manufacturer’s site approved by the Government, according to cGMP and
            product specifications.

  		ii.	Where possible, store Project Agreement products physically segregated from other products. If physical separation is not
            possible, separation of Project Agreement products must be controlled by a logical warehouse management system (WMS) at the case and pallet level.

  		iii.	Ensure proper labeling of stored materials as USG property.

  		iv.	Provide the Government access to review the security systems in place and request updates as needed in accordance with
            the Security Plan.

  		v.	Make appropriate updates to the regulatory documentation supporting the continued use of the stored material for pandemic
            response.

  		vi.	If using a storage site, provide the quality agreement, specify the location and terms of the storage contract and
            receive approval by the Government.

   

  For accepted product in VMI, Awardee must notify the AOR of any proposed movement of the product. Any
      deviations, out of specification (“OOS”) results, or other product issues, shall be reported to the USG within [**] of Awardee identification.

   

  		C.	Government Sites. Product to be shipped to Government Sites shall be shipped
              trackable by GPS. Awardee will include the following information on the packing lists provided with bulk shipments to the centralized depots:

   

  		i.	Transaction Information (TI)

  		ii.	Transaction History (TH)

  		iii.	Transaction Statement (TS)

   

  		D.	Title and Physical Risk of Loss. Risk of loss or damage to the supplies
              provided under this contract shall remain with the Contractor until, and shall pass to the Government upon delivery of the supplies to the Government at the destination specified in the contract, i.e., F.O.B. Destination.

   

  Awardee will notify the AO and AOR of any storage or quality deviation for product held in VMI, within
      [**]. To the extent that Awardee is responsible for the correction, repair or replacement of Government property held in VMI and replacement upon loss or damage is feasible, the Government will accept replacement of such property. The Government
      understands that storage costs identified in this contract include insurance costs applicable to material that will become Government property, including product stored as VMI.

   

  The AO and/or the AOR may perform inspection of materials and services. Inspections of material created
      under this Project Agreement may be made by a duly authorized Government representative, and with reasonable notice.

   

  
     

    
      
 

  

   

  		E.	Risk of Loss Due to Expiry. Both parties acknowledge that risk of loss due to
              expiry is retained by the Government for all product accepted under this Agreement. In order to mitigate this risk, the Awardee will make kits available for delivery to VMI or Government distribution sites within [**] of the date of
              manufacture. Provided this condition is met, the Awardee will have no obligation to replace product that has been accepted by the Government and expires prior to use.

   

  ARTICLE 16:       ARTICLE 16: REPORTING REQUIREMENTS

   

  The Government will have continuous involvement with Awardee throughout the duration of the Period of Performance
      and is entitled to periodic reports as outlined below. Required components and frequency of such reporting is as follows:

   

  		A.	Weekly Progress Meetings: Scheduled on a weekly basis, virtual format (either
              telephone or videoconference), between the Contractor and the Government. Duration: [**] max. Review of previous weeks activities. Informative in nature to keep the USG apprised of project progress and to discuss issues that may require joint
              resolution, such as milestone changes, political impacts on objectives, schedule, funding and deliverables.

   

  On a quarterly basis, at the request of the AOR, the Weekly Teleconference may be expanded in scope to allow for
      a progress review of the preceding three months and planning for the remainder of the period of performance.

   

  		B.	Daily and Ad hoc check-in, as requested by the PCT: A program specific designee
              of the Awardee will hold a daily check-in with the AOR or AOR designee to discuss the performance of the Agreement. No agenda, presentation, or official minutes need to be maintained for the regular meeting. The AOR may cancel the daily
              check-in or substitute a technical or program specific meeting as a replacement. Daily check-ins are expected only on business days during normal business hours.

   

  		C.	Confirmed, critical programmatic concerns, issues or probable risks that are likely to impact project
              schedule/cost/performance: The Awardee will communicate and document all confirmed programmatic risks to the AOR within [**] of Awardee’s awareness. Awardee shall communicate via email or telephone.
              Following resolution, Awardee will provide all associated deviation reports and corrective and preventative action plans to the AOR within [**] of finalization.

   

  In addition, the Awardee will report to the government any activity or incident that is in violation of
      established security standards or indicates the loss or theft of government products within [**] of Awardee’s awareness of the activity or incident. Awardee will communicate via email, oral or written communication.

   

  		D.	Supply chain resiliency, including Awardee locations: Within [**] of award, the
              Awardee will provide the AOR with a supply chain resiliency plan. For each of the Awardee locations - including sub-agreement holders, the Awardee will provide address, point(s) of contact and a summary of work performed at the location.

   

  
     

    
      
 

  

   

  		E.	Quarterly Financial Status Report:

   

  The Awardee shall submit a Quarterly Financial Status Report no later than [**] after the end of each
      quarter of performance. The Government will have

  [**] to respond to the report with any comments and the Awardee will have an additional [**] to revise
      the deliverable or respond to those comments. Reports will cover work performed every three (3) months for the duration of the Period of Performance (PoP).

   

  For the industrial expansion effort, the Quarterly Financial Status Report shall include quarterly
      expenditure forecasts with both the quarterly planned accrual and the cumulative total. Expenditure forecast submissions shall include analysis of the cost drivers for Estimate to Complete changes, if any, from the previous projection. The Awardee
      shall provide all submissions in Excel format, including all formulas.

   

  ARTICLE 17:    Miscellaneous Clauses.

   

  A.           No Consent. Nothing in the terms of this Agreement constitutes
      express or implied Government authorization and consent for Awardee or its subawardee(s) to utilize, manufacture or practice inventions covered by United States or foreign patents in the performance of work under this Agreement.

   

  B.            Patent Infringement. Each Party will advise the other Party
      promptly and in reasonable written detail, of each claim or lawsuit of patent infringement based on the performance of this Agreement. When requested by either Party, all evidence and information in possession of the Party pertaining to such claim or
      lawsuit will be provided to the other at no cost to the requesting Party.

   

  C.            Limitation of Liability. In no event will either Party be liable
      to the other Party or any third party claiming through such Party for any indirect, incidental, consequential or punitive damages, or claims for lost profits, arising under or relating to this Agreement, whether based in contract, tort or otherwise,
      even if the other Party has been advised of the possibility of such damages.

   

  D.            Disclosure of Information. Subject to Article 10, the Awardee
      shall not release to anyone outside the Awardee’s organization any unclassified information, regardless of medium (e.g., film, tape, document), pertaining to any part of this Agreement or any program related to this Agreement, unless (i) the OTAO has
      given prior written approval or (ii) the information is otherwise in the public domain before the date of release. For purposes of this clause, Awardee’s Organization includes entities identified as Collaborators in

   

  E.             Force Majeure. Neither Party will be liable to the other Party
      for failure or delay in performing its obligations hereunder if such failure or delay arises from circumstances beyond the control and without the fault or negligence of the Party (a Force Majeure event). Examples of such circumstances are:
      authorized acts of the government in either its sovereign or contractual capacity, war, insurrection, freight embargos, fire, flood, or strikes. The Party asserting Force Majeure as an excuse must take reasonable steps to minimize delay or damages
      caused by unforeseeable events.

   

  
     

    
      
 

  

   

  F.             Severability. If any provision of this Agreement, or the
      application of any such provision to any person or set of circumstances, is determined to be invalid, unlawful, void or unenforceable to any extent, the remainder of this Agreement, and the application of such provision to persons or circumstances
      other than those as to which it is determined to be invalid, unlawful, void or unenforceable, will not be impaired or otherwise affected and will continue to be valid and enforceable to the fullest extent permitted by law.

   

  G.            Choice of Law. This Agreement and the resolution of disputes
      hereunder will be governed, construed, and interpreted by the statutes, regulations, and/or legal precedent applicable to the Government of the United States of America. Unless explicitly stated, the Parties do not intend that this Agreement be
      subject to the Federal Acquisition Regulation either directly or indirectly or by operation of law. When a specific FAR requirement is incorporated by reference in this Agreement, the text of the clause alone will apply without application or
      incorporation of other provisions of these regulations.

   

  H.            Order of Precedence. In the event of a conflict between the
      terms of this Agreement and the attachments incorporated herein, the conflict shall be resolved by giving precedence in descending order as follows: (i) the Articles of this Agreement, and the Appendices to the Agreement.

   

  ARTICLE 18:     PROHIBITION ON THE USE OF CERTAIN TELECOMMUNICATIONS AND VIDEO
      SURVEILLANCE SERVICES OR EQUIPMENT

   

  a) Definitions. As used in this clause—

   

  Backhaul means intermediate links between the core network, or backbone network, and the small
      subnetworks at the edge of the network (e.g., connecting cell phones/towers to the core telephone network). Backhaul can be wireless (e.g., microwave) or wired (e.g., fiber optic, coaxial cable, Ethernet).

   

  Covered foreign country means The People’s Republic of China.

   

  Covered telecommunications equipment or services means-

   

  		(1)	Telecommunications equipment produced by Huawei Technologies Company or ZTE Corporation (or any subsidiary or affiliate
            of such entities);

   

  		(2)	For the purpose of public safety, security of Government facilities, physical security surveillance of critical
            infrastructure, and other national security purposes, video surveillance and telecommunications equipment produced by Hytera Communications Corporation, Hangzhou Hikvision Digital Technology Company, or Dahua Technology Company (or any
            subsidiary or affiliate of such entities);

   

  
     

    
      
 

  

   

  		(3)	Telecommunications or video surveillance services provided by such entities or using such equipment; or

   

  		(4)	Telecommunications or video surveillance equipment or services produced or provided by an entity that the Secretary of
            Defense, in consultation with the Director of National Intelligence or the Director of the Federal Bureau of Investigation, reasonably believes to be an entity owned or controlled by, or otherwise connected to, the government of a covered
            foreign country.

   

  Critical technology means-

   

  		(1)	Defense articles or defense services included on the United States Munitions List set forth in the International Traffic
            in Arms Regulations under subchapter M of chapter I of title 22, Code of Federal Regulations;

   

  		(2)	Items included on the Commerce Control List set forth in Supplement No. 1 to part 774 of the Export Administration
            Regulations under subchapter C of chapter VII of title 15, Code of Federal Regulations, and controlled-

   

  		(i)	Pursuant to multilateral regimes, including for reasons relating to national security, chemical and biological weapons
            proliferation, nuclear nonproliferation, or missile technology; or

   

  		(ii)	For reasons relating to regional stability or surreptitious listening;

   

  		(3)	Specially designed and prepared nuclear equipment, parts and components, materials, software, and technology covered by
            part 810 of title 10, Code of Federal Regulations (relating to assistance to foreign atomic energy activities);

   

  		(4)	Nuclear facilities, equipment, and material covered by part 110 of title 10, Code of Federal Regulations (relating to
            export and import of nuclear equipment and material);

   

  		(5)	Select agents and toxins covered by part 331 of title 7, Code of Federal Regulations, part 121 of title 9 of such Code,
            or part 73 of title 42 of such Code; or

   

  		(6)	Emerging and foundational technologies controlled pursuant to section 1758 of the Export Control Reform Act of 2018 (50
            U.S.C. 4817).

   

  Interconnection arrangements means arrangements governing the physical connection of two or more
      networks to allow the use of another’s network to hand off traffic where it is ultimately delivered (e.g., connection of a customer of telephone provider A to a customer of telephone company B) or sharing data and other information resources.

   

  Reasonable inquiry means an inquiry designed to uncover any information in the entity’s
      possession about the identity of the producer or provider of covered telecommunications equipment or services used by the entity that excludes the need to include an internal or third-party audit.

   

  
     

    
      
 

  

   

  Roaming means cellular communications services (e.g., voice, video, data) received from
      a visited network when unable to connect to the facilities of the home network either because signal coverage is too weak or because traffic is too high.

   

  Substantial or essential component means any component necessary for the proper function or
      performance of a piece of equipment, system, or service.

   

  		(b)	Prohibition.

   

  (1) Section 889(a)(1)(A) of the John S. McCain National Defense Authorization Act for Fiscal Year 2019
      (Pub. L. 115-232) prohibits the head of an executive agency on or after August 13, 2019, from procuring or obtaining, or extending or renewing a contract to procure or obtain, any equipment, system, or service that uses covered telecommunications
      equipment or services as a substantial or essential component of any system, or as critical technology as part of any system. The Contractor is prohibited from providing to the Government any equipment, system, or service that uses covered
      telecommunications equipment or services as a substantial or essential component of any system, or as critical technology as part of any system, unless an exception at paragraph (c) of this clause applies or the covered telecommunication equipment or
      services are covered by a waiver described in FAR 4.2104.

   

  (2) Section 889(a)(1)(B) of the John S. McCain National Defense Authorization Act for Fiscal Year 2019
      (Pub. L. 115-232) prohibits the head of an executive agency on or after August 13, 2020, from entering into a contract or agreement, or extending or renewing a contract or agreement, with an entity that uses any equipment, system, or service that
      uses covered telecommunications equipment or services as a substantial or essential component of any system, or as critical technology as part of any system, unless an exception at paragraph (c) of this clause applies or the covered telecommunication
      equipment or services are covered by a waiver described in FAR 4.2104. This prohibition applies to the use of covered telecommunications equipment or services, regardless of whether that use is in performance of work under a Federal contract
      or agreement.

   

  		(c)	Exceptions. This clause does not prohibit contractors from providing—

   

  (1)  A service that connects to the facilities of a third-party, such as backhaul, roaming, or
      interconnection arrangements; or

   

  (2)   Telecommunications equipment that cannot route or redirect user data traffic or permit
      visibility into any user data or packets that such equipment transmits or otherwise handles.

   

  		(d)	Reporting requirement

   

  (1)   In the event the Contractor identifies covered telecommunications equipment or services used as
      a substantial or essential component of any system, or as critical technology as part of any system, during contract or agreement performance, or the Contractor is notified of such by a subcontractor at any tier or by any other source, the Contractor
      shall report the information in paragraph (d)(2) of this clause to the Agreements Officer, unless elsewhere in this contract or agreement are established procedures for reporting the information; in the case of the Department of Defense, the
      Contractor shall report to the website at https://dibnet.dod.mil.

   

  
     

    
      
 

  

   

  (2)   The Contractor shall report the following information pursuant to paragraph (d)(1) of this
      clause

   

  (i)       Within [**] from the date of such identification or notification: the contract number; the
      order number(s), if applicable; supplier name; supplier unique entity identifier (if known); supplier Commercial and Government Entity (CAGE) code (if known); brand; model number (original equipment manufacturer number, manufacturer part number, or
      wholesaler number); item description; and any readily available information about mitigation actions undertaken or recommended.

   

  (ii)       Within [**] of submitting the information in paragraph (d)(2)(i) of this clause: any further
      available information about mitigation actions undertaken or recommended. In addition, the Contractor shall describe the efforts it undertook to prevent use or submission of covered telecommunications equipment or services, and any additional efforts
      that will be incorporated to prevent future use or submission of covered telecommunications equipment or services.

   

  (e)          Subcontracts. The Contractor shall insert the substance of this clause, including this
      paragraph (e) and excluding paragraph (b)(2), in all subcontracts, subagreements and other contractual instruments, including subcontracts for the acquisition of commercial items.

   

  
     

    
      
 

  

   

  Appendix A Statement of Work

   

  Statement of Work (SOW): Point-of-Care (POC) Tests and Diagnostics

   

  C.1. General Objectives.

   

  The U.S. Government (USG) requires additional POC diagnostic test capacity, as the level of demand for diagnostic
      resources during this COVID-19 Pandemic is unprecedented. There is a need to secure additional POC diagnostics to test the US population in response to the Pandemic. The Government seeks to expand the production capacity for Monitoring Systems and
      COVID-19 Test Cartridges. The end deliverable of this effort is to provide the capacity to manufacture 100,000 cartridges per day.

   

  As part of this effort, there shall result in an increase to its industrial base manufacturing capability for
      COVID-19 Test Cartridges within the U.S., to include critical supply chain providers to 100,000 cartridges per day. The Awardee shall also onshore its cartridge and reader subcomponents manufacturing to the maximum extent possible, to further reduce
      supply chain risk. The Awardee shall also develop a distribution process and increase shipping capability in order to ship all materials directly to the customer location.

   

  C.2. Prototype Delivery.

   

  C.2.2. The Awardee shall increase its industrial base manufacturing capability to manufacture 100,000 cartridges
      per day.

   

  C.2.2.1. The Awardee shall increase the manufacturing capability for the COVID-19 Test Cartridges to
      100,000 cartridges per day.

   

  C.2.2.2. The Awardee shall onshore its cartridge and reader subcomponents manufacturing.

   

  C.2.2.3. The Awardee shall develop and expand its distribution process in order to ship all materials
      directly to the customer location within the United States and its Territories.

   

  C.3. Demonstration of Prototype Delivery.

   

  C.3.1. The Awardee shall deliver 6 million COVID-19 Test Cartridge Packs.

   

  C.3.2. The Awardee shall deliver 30,000 Health Monitoring Systems.

   

  C.3.3. The Awardee shall deliver 60,000 COVID-19 External Control Swabs Packs.

   

  C.3.4. The Awardee shall ship all deliverables to locations (TBD) within the United States.

   

  C.3.5. The Awardee shall ensure appropriate quality assurance certification is supplied with each shipment.

   

  
     

    
      
 

  

   

  C.4. Overall Management Objectives.

   

  C.4.1. The Awardee shall be responsible for overall management and oversight of the work necessary to achieve the
      objectives of this contract. The Contractor shall provide the overall management, integration, and coordination of all contractual activities, including a technical and administrative infrastructure to ensure the efficient planning, initiation,
      implementation, and direction of all contractual activities.

   

  The Contractor shall establish project milestones for each manufacturing capability/capacity for which expansion
      is planned. The Awardee shall provide incremental progress against each milestone to the USG in accordance with established deliverables (see C.6 below). The Awardee shall report to the USG any changes or deviations planned or incurred by the
      Contractor in pursuing the objectives of this contract. While primary responsibility for management and execution of the effort resides with the Awardee, the USG shall have input to the milestone review process and any changes to the objectives of
      the agreement.

   

  C.5. Risk Management Objectives.

   

  The Awardee shall identify all anticipated project risks categorized as moderate or high and report them to the
      USG in accordance with reporting requirements (see C.6 below). The Awardee shall manage all project risks using its in- house risk management capabilities, and report to the USG changes to all identified risks as they occur/arise. The USG shall be
      permitted to participate in the risk management and mitigation processes associated with this project.

   

  C.6. Status Reporting.

   

  C.6.1. Monthly Progress Reports. The Awardee shall submit monthly progress reports no later than the [**] of the
      month. Awardee format acceptable. Electronic submission acceptable in MS Office or PDF format. Financial information shall be MS Excel format. Monthly reports shall NOT be marked proprietary, and shall have Distribution Statement C (US Government and
      their contractors). Each monthly report shall, at a minimum, contain the following:

  		●	Summary of monthly progress for each of the Awardee’s facilities/capabilities associated with this effort.

  		●	Summary of progress towards established milestones for each facility/capability.

  		●	Identification of any milestone that is slipping or missed, and discussion of path forward to bring milestone back to
            schedule, and impact on other milestones.

  		●	Summary of risks, discussion of potential impacts and efforts to mitigate.

  		●	Summary of overall schedule and changes from previous month.

  		●	Status updates from Manufacturing plan

  		●	Status updates from Distribution plan

  		●	Report any customer complaints

  		●	Report any known deficiencies of the materials and/or products

  		●	Financial summary of Awardee costs incurred by month to date, invoices submitted, and Government payments made.

   

  C.6.2. Weekly Progress Meetings. Scheduled on a weekly basis, virtual format (either telephone or
      videoconference), between the Contractor and the Government. Duration: [**] max. Review of previous weeks activities. Informative in nature to keep the USG apprised of project progress and to discuss issues that may require joint resolution, such as
      milestone changes, political impacts on objectives, schedule, funding and deliverables. Meeting minutes provided by the Awardee delivered to the USG within [**] of the meeting.

   

  
     

    
      
 

  

   

  C.6.3. Quarterly In Process Reviews. Scheduled as needed, generally not more frequently than quarterly, virtual
      format (either telephone or videoconference). Duration: [**] max. Review of previous quarter’s activities. Informative in nature to keep the USG apprised of project progress and to discuss issues that may require joint resolution, such as milestone
      changes, political impacts on objectives, schedule, funding. An agenda for the meeting provided by the Awardee [**] prior to the scheduled meeting. Meeting minutes provided by the Awardee delivered to the USG within [**] of the meeting.

   

  C.6.4. Final Report. Final Report shall NOT be marked proprietary, and shall have Distribution Statement C.
      Contractor format acceptable. Electronic submission acceptable in MS Office or PDF format. Financial information shall be MS Excel format. Final report summarizing stated objectives and the progress that was achieved in meeting those objectives;
      summary of risks incurred, impacts and mitigation; quantitative discussion of production throughput improvements achieved; financial summary of project; schedule summary for project, comparing original schedule to final schedule; recommendations for
      path forward as applicable. Final Report due [**] after the last scheduled delivery for prototype demonstration.

   

  C.6.5. Manufacturing Plan. The Awardee shall provide a detailed plan of action (contractor format acceptable) to
      increase cartridge-manufacturing capability to meet the government’s delivery schedule (i.e. ramp up to 100K cartridges per day) and associated on-shoring component manufacturing within [**] of contract award.

   

  The Awardee’s plan of action shall at a minimum, include the following:

   

  		a	Timeline, materials required and strategy to set up and begin V2.0 manufacturing lines to manufacture the cartridges;

  		b	Timeline, materials required and strategy to upgrade the bioproduction capability to manufacture sufficient cartridge
            reagents;

   

  		c	Timeline, materials required and strategy to onshore manufacturing of reagents and cartridge subcomponents;

  		d	Information on the US based manufacturing organization to replace existing organization;

  		e	Current GMP manufacturing status and plan to achieve GMP manufacturing, if not currently GMP;

  		f	Quality Assurance plan and Acceptance metrics;

  		g	Plan to comply with FDA EUA Letter of Authorization.

   

  C.6.6. Distribution Plan. The Awardee shall provide a detailed distribution plan for how all Test
      Cartridge Packs, Monitoring Systems and External Control Swabs Packs will be shipped and delivered to required delivery locations within the United States and its Territories within [**] of contract award.

   

  
     

    
      
 

  

   

  The Awardee’s distribution plan shall at a minimum, include the following: a Current distribution
      processes; b Timeline and strategy to increase distribution process and shipping to handle the increase in number and volume of shipments.

   

  C.6.7 Quality Management Plan. The Awardee shall provide (contractor format acceptable) within [**] of
      contract award, a quality management plan for manufacturing efforts that conform to ISO 13485 standards as well as the Quality System Regulations at 21 CFR Part 820 which may include, but is not limited to, the quality policy and objectives,
      management review, competencies and training, process document control, feedback, evaluation, corrective action and preventive action, process improvement, measurement, and data analysis processes. The framework is normally divided into
      infrastructure, senior management responsibility, resource management, lifecycle management, and quality management system evaluation.

   

  Appendix B

      Project Schedule/Milestone Payment Schedule

   

  The Government shall pay the Awardee, upon the submission of proper invoices or vouchers, the prices stipulated
      in this Agreement for supplies delivered and accepted or services rendered and accepted, less any deductions provided in this Agreement.

   

  For the industrial expansion, expenditures shall be submitted based on the awarded budget. Federal funds are to
      be used only for work that a reasonable and prudent person would incur in carrying out the prototype project. An invoice will be submitted through Wide Area Work Flow (WAWF) in accordance with agreement requirements. Final payment of the Agreement
      shall be determined upon mutual agreement and settlement of any outstanding deliverables.

   

  The Awardee shall proceed with the performance in accordance with the terms and conditions of this Agreement and
      its Appendices. However, the Government may require the Awardee to cease performance at any time prior to the commencement of any milestone or task. Such notice to cease performance must be from the OTAO and be in writing, of which email is an
      acceptable form.

   

  The Parties acknowledge that the nature of this Prototype Project requires flexibility and the ability to react
      to changing circumstances. Although the Statement of Work sets the scope for activities the Government may require under this Agreement, it is not intended to, and does not, prescribe with specificity each task that Awardee will perform. Instead, the
      Government shall direct Awardee to perform specific tasks under the framework established in Articles 3 and 8 of the Agreement, with Government-approved tasks, funding, and deadlines. Awardee shall not perform any tasks that have not been explicitly
      authorized by the Government.

   

  Awardee will be responsible for submission of SOW’s, quotes, and proposals for price, performance, and schedule
      for those efforts not already identified, priced or otherwise negotiated. Government approval will be required prior to commencing work.

   

  
     

    
      
 

  

   

  Appendix C

      Key Personnel

   

  1.       Awardee’s Organization and Key Personnel.

   

  a.       The Awardee’s organization shall be established with authority to effectively accomplish the objectives
      of the Statement of Work. This organization shall become effective upon award of the Agreement and its integrity shall be maintained for the duration of the effort.

   

  b.       The key personnel listed below are considered to be critical to the successful performance of this
      Agreement. Prior to replacing these key personnel, the Awardee shall obtain the written consent of the OTAO. In order to obtain such consent, the Awardee shall provide advance notice of the proposed changes and shall demonstrate that the
      qualifications of the proposed substitute personnel are generally equivalent to or better than the qualifications of the personnel being replaced.

   

  c.       Prior to permanently removing any of the specified individuals to other contracts, the Awardee shall
      provide the OTAO not less than [**] advance notice and shall submit justification (including proposed substitutions) in sufficient detail to permit evaluation of the impact on the program. No reassignment shall be made by the Awardee without written
      consent of the OTAO. The “Key Personnel” list presented in Table 2 below may be amended from time to time during the course of the Agreement to either add or delete personnel, as appropriate.

   

  Table 2: Key Personnel Summary

   

  
     

    
      
 

  

   

  Appendix D

      Government Property

   

  Government Property: “Government Property” means any property (i) furnished by the Government and
      facilitating performance of this Agreement, (ii) acquired by the Awardee under cost reimbursement terms of this Agreement, or (iii) acquired by the Awardee under fixed price terms of this Agreement (FP-GP) if specifically identified in this
      Government Property Appendix. Except for commercial off the shelf software and licenses thereto, Government Property does not include intellectual property and software. The Government owns and holds title to all Government Property.

   

  The Government shall deliver to the Awardee any Government Property required to be furnished as described in this
      Agreement together with related data and information needed for its intended use. The delivery and/or performance dates specified in this Agreement are based upon the expectation that the Government-furnished property will be suitable for performance
      and will be delivered to the Awardee by the dates stated in the Agreement. If not so suitable, the Awardee shall give timely written request to the OTAO who will advise the Awardee on a course of action to remedy the problem.

   

  FPGP includes: [Mark N/A if none]:

   

  
    N/A

     

  

   

  The Awardee shall have, initiate and maintain a system of internal controls to manage, control, use, preserve, protect, repair,
      account for and maintain Government Property in its possession and shall initiate and maintain the processes, systems, procedures, records required control and maintain accountability of Government Property.

   

  The Awardee shall include this clause in all subcontracts under which Government Property comes into the
      possession of any subawardee. Unless otherwise provided for in this Agreement or approved by the OTAO, the Awardee shall not: (i) use Government Property for any purpose other than to fulfill the requirements of this Agreement, or (ii) alter the
      Government Property.

   

  The Awardee shall establish and implement property management plans, systems, and procedures regarding its
      acquisition of Government Property, its receipt of Government Property, in addition to, the status, dates furnished or acquired, identification, quantity, cost, marking, date placed in service, location, inventory and disposition of Government
      Property, to include a reporting process for all discrepancies, loss of Government Property, physical inventory results, audits and self-assessments, corrective actions, and other property related reports as directed by the OTAO.

   

  Upon conclusion or termination of the Agreement, the Awardee shall submit a request in writing to the OTAO, for
      disposition/disposal instructions and shall store Government Property not to exceed [**] pending receipt of such instructions. Storage shall be at no additional cost to the Government unless otherwise noted in the Agreement. The Government, upon
      written notice to the Awardee, may abandon any Government Property in place, at which time all obligations of the Government regarding such Government Property shall cease.

   

  
     

    
      
 

  

   

  Awardee Liability for Government Property. “Loss of Government Property” means the loss, damage or
      destruction to Government Property reducing the Government’s expected economic benefits of the property and includes loss of accountability but does not include planned and purposeful destructive testing, obsolescence, reasonable wear and tear or
      manufacturing defects. THE AWARDEE SHALL BE LIABLE FOR LOSS OF GOVERNMENT PROPERTY IN AWARDEE’S POSSESSION, EXCEPT WHEN ANY ONE OF THE FOLLOWING APPLIES: (I) OTAO GRANTS RELIEF OF RESPONSIBILITY AND LIABILITY FOR LOSS OF THE PARTICULAR GOVERNMENT
      PROPERTY; (II) GOVERNMENT PROPERTY IS DELIVERED OR SHIPPED UNDER THE GOVERNMENT’S INSTRUCTIONS AND SHIPPERS; OR (III) GOVERNMENT PROPERTY IS DISPOSED OF IN ACCORDANCE WITH THE GOVERNMENT’S DIRECTIONS.

   

  
     

    
      
 

  

   

  Section E - Inspection and Acceptance

   

  INSPECTION AND ACCEPTANCE TERMS

   

  Supplies/services will be inspected/accepted at:

   

  	CLIN	INSPECT AT	INSPECT BY	ACCEPT AT	ACCEPT BY
	0001	N/A	N/A	N/A	Government
	0002	N/A	N/A	N/A	Government
	0003	N/A	N/A	N/A	Government
	0004	N/A	N/A	N/A	Government

   

  
     

    
      
 

  

   

  Section F - Deliveries or Performance

   

  DELIVERY INFORMATION

   

  	CLIN	DELIVERY DATE	QUANTITY	SHIP TO ADDRESS	DODAAC / CAGE
	0001	08-APR-2021	1	
          JPM MEDICAL

          JPM CBRN MEDICAL

          1564 FREEDMAN DRIVE

          FORT DETRICK, MD MD 21702 240-675-3192

          FOB: Origin (Shipping Point)

        	W56XNH
	0002	11-MAR-2021	6,000,000	(SAME AS PREVIOUS LOCATION) FOB: Origin (Shipping Point)	W56XNH
	0003	11-MAR-2021	30,000	(SAME AS PREVIOUS LOCATION) FOB: Origin (Shipping Point)	W56XNH
	0004	11-MAR-2021	60,000	(SAME AS PREVIOUS LOCATION) FOB: Origin (Shipping Point)	W56XNH

   

  
     

    
      
 

  

   

  Section G - Contract Administration Data

   

  ACCOUNTING AND APPROPRIATION DATA

   

  AA: 0212020202120400000664643255 S.0074658.5.22 6100.9000021001

  COST CODE: A5XAH

  AMOUNT: $480,916,636.62

   

  	
          ACRN

        	
          CLIN/SLIN

        	
          CIN

        	
          AMOUNT

        
	 	 	 	 
	AA	0001	GFEBS001156060100001	$184,576,636.62
	 	0002	GFEBS001156060100002	[**]
	 	0003	GFEBS001156060100003	[**]
	 	0004	GFEBS001156060100004	[**]

   

  
     

    
      
 

  

   

   

   

   

  
     

    
      
 

  

   

  Contract Modification Continuation Page

  Page 2 of 2

  Contract W911NF2190001

  Modification Number: A00002

  Modification Effective Date: 28 DEC 2020

   

  PURPOSE OF MODIFICATION:

  This Unilateral Other Administrative Action Modification is issued pursuant to: FAR 42.302(a).

   

  The purpose of this no-cost unilateral modification is to incorporate the approved Health Resources Priority and
      Allocations System (HRPAS) to aid in the procurement of supplies in support of Operation Warp Speed (OWS). The HRPAS Rating memo dated 22 December 2020 is attached herein.

   

  Ship To location is changed as follows: from: W56XNH to: SW3100, [**], and SW3200, [**] for CLINS 0002, 0003, and
      0004. Delivery quantities stated on Table 2B to each location are to be determined in advance of shipment by AOR [**].

   

  CLOSING REMARKS:

  The USD Cost Amount is USD 0.00.

  The USD Fee Amount is USD 0.00.

  The total funds obligated to this Contract equal USD 480,916,636.62.

  The USD Total Contract Amount is USD 480,916,636.62.

   

  As a result of this modification, the total obligated amount of this contract is unchanged.

      The total contract amount of this contract is unchanged.

   

  List of Attachments

   

  CUE_HRPAS_Signed_Memo_122220.pdf   HRPAS Signed Memo 122220

      Ship_To_Locations_email_122820.pdf         ShipTo Locations email

   

  Except as provided by this contract modification, all terms and conditions of this contract remain unchanged
        and in full force and effect.

   

  
     

    
      
 

  

   

   

  

   

   

  
     

    
      
 

  

   

  Contract Modification Continuation Page

  Page 2 of 2

  Contract W911NF2190001

  Modification Number: A00003

  Modification Effective Date: 03 FEB 2021

   

  PURPOSE OF MODIFICATION:

  This Bilateral Other Administrative Action Modification is issued pursuant to:

      FAR 42.302(a) The purpose of this bilateral modification is to make administrative revisions to this OTA as follows:

   

  1.       Remove Articles # 16 D AND 16 E as redundant or no longer required on this OTA.

   

  Article 16, D, Supply chain resiliency plan

  Article 16, E Quarterly Financial Status Report

   

  2.       This is a DO-HR rated order for the purpose of emergency preparedness and the
      Contractor shall follow all the provisions of the Health Resources Priorities and Allocations System regulation (45 CFR Part 101). If the contractor needs to utilize industrial resources to fulfill this rated order for a health resource, it is
      authorized pursuant to 45 CFR §101.35(b) to place the same priority rating and program identification symbol for health resources on its orders for industrial resources with its suppliers. The HRPAS Rating Memo dated 22 December 2020 authorized the
      rating of DO-HR to aid in the procurement of supplies in support of Operation Warp Speed (OWS). The priority rating must be included on each successive order placed to obtain items or services needed to fill a customer's rated order. This continues
      from contractor to subcontractor to supplier throughout the entire procurement chain.”

   

  CLOSING REMARKS:

   

  The USD Cost Amount is USD 0.00.

  The USD Fee Amount is USD 0.00.

  The total funds obligated to this Contract equal USD 480,916,636.62.

  The USD Total Contract Amount is USD 480,916,636.62.

   

  As a result of this modification, the total obligated amount of this contract is unchanged.

  The total contract amount of this contract is unchanged.

  Except as provided by this contract modification, all terms and conditions of this contract remain unchanged
        and in full force and effect.

   

  
     

    
      
 

  

   

   

   

  
     

    
      
 

  

   

  Contract Modification Continuation Page

  Page 2 of 4

  Contract W911NF2190001

  Modification Number: A00003

  Modification Effective Date: 03 MAR 2021

   

  PURPOSE OF MODIFICATION:

  This Bilateral Other Administrative Action Modification is issued pursuant to:

      In accordance with the coordinated agreement to benefit both the Government and the Awardee to expand Cue's shipping and distribution capability, this modification is to effect the following changes:

   

  ARTICLE 15:

   

  1.) From: “A. Delivery and Acceptance. Awardee shall notify the AO and AOR at least [**] prior to initial
      delivery of first shipment of test kits. Exceptions are permitted if approved by the AO. Upon notification, the AOR will instruct the Awardee to deliver kits to either up to [**] centralized Government designated distribution sites within the
      continental United States or up to [**] additional specific individual final destinations within the continental United States. Upon delivery of product, notification of delivery quantities shall be made to the AOR.”

   

  To: “A. Delivery and Acceptance. Awardee shall notify the AO and AOR at least [**] prior to initial
      delivery of first shipment of test kits. Exceptions are permitted if approved by the AO. Upon notification, the AOR will instruct the Awardee to deliver kits to up to [**] centralized Government-designated distribution sites within the continental
      United States and up to [**] additional specific individual final destinations within the continental United States. The AOR and Awardee shall agree on the locations prior to each delivery. For locations without a CAGE code or DODAAC, the Awardee
      shall Ship In Place and use the Awardee's own CAGE code to invoice in WAWF. Upon acceptance by DCMA on site, the Awardee shall fill out an 1149 form to verify delivery of the product to each location for all Ship In Place deliveries. For locations
      with a valid CAGE code or DODAAC, the Awardee shall Ship to Destination with the location's CAGE code or DODAAC to invoice in WAWF. Upon delivery of product, notification of delivery quantities shall be made to the AOR.”

   

  2.) From: “The Government shall accept product that conforms to contract requirements based on Certificates of
      Analysis and certificate(s) of cGMP conformity provided by Awardee and review of temperature monitoring data.”

   

  To: “The Government shall accept product that conforms to agreement requirements based on Certificates of Analysis
      and/or certificate(s) of conformity provided by Awardee and review of temperature monitoring data .”

   

  ARTICLE 1 B.1

   

  3.) From: “The prototype project under this Agreement is the demonstration by Awardee of the rapid, large scale
      supply and logistics capability to manufacture and deliver to the Government within 5 months of the effective date of this Agreement 6 million Cue COVID-19 Assay Cartridges, 60,000 COVID-19 Control Swab Packs, and 30,000 Monitoring Systems by
      achieving a sustained average per day production rate of at least 100,000 EUA or 510(k) cleared Cue COVID-19 Assay Cartridges over the last 7 days of the 5 month delivery period.”

   

  To: “The prototype project under this Agreement is the demonstration by Awardee of the rapid, large scale supply
      and logistics capability to manufacture and deliver to the Government within 12 months of the effective date of this Agreement at least 6 million Cue COVID-19 Assay Cartridges, 60,000 COVID-19 Control Swab Packs, and 30,000 Monitoring Systems by
      achieving a sustained average per day production rate of approximately 100,000 EUA or 510(k) cleared Cue COVID-19 Assay Cartridges over a consecutive 7 day period during the 12 month delivery period.”

   

  4.) From: “The prototype project will be successfully completed when Awardee has achieved a sustained average per
      day production rate of at least 100,000 EUA or 510(k) cleared COVID-19 Assay Cartridges over a 7 day period, and has delivered a total of 6 million Cue COVID-19 Assay Cartridges, 30,000 monitoring systems, and 60,000 control swab packs.”

   

  
     

    
      
 

  

   

  Contract Modification Continuation Page

  Page 3 of 4

  Contract W911NF2190001

  Modification Number: A00003

  Modification Effective Date: 03 MAR 2021 

   

  To: “The prototype project will be successfully completed when Awardee has achieved a sustained average per day
      production rate of approximately 100,000 EUA or 510(k) cleared COVID-19 Assay Cartridges over a consecutive 7-day period during the 12 month delivery period, and has delivered a total of at least 6 million Cue COVID-19 Assay Cartridges, 30,000
      monitoring systems, and 60,000 control swab packs.”

   

  Article 1. B.7

   

  5.) From: “Deliverables: Deliverables under this Agreement are listed in Table 1.

      Variances: Awardee shall promptly notify the Government of any anticipated shortage in quantity or deviation from any delivery date specified herein. The Government and the Awardee shall cooperate in good faith to adjust
        Table 1 to reflect reasonable variations in the delivery schedule, provided that the total scheduled quantities are delivered and Awardee demonstrates a production capacity of 100,000 units per day within not more than [**] after award.”

   

  To: “Deliverables: Deliverables under this Agreement are listed in Table 1.

      Variances: Awardee shall promptly notify the Government of any anticipated shortage in quantity or deviation from any delivery date specified herein. The Government and the Awardee shall cooperate in good faith to adjust
        Table 1 to reflect reasonable variations in the delivery schedule, provided that the total scheduled quantities are delivered and Awardee demonstrates a sustained average per day production rate over a consecutive 7-day period of approximately
        100,000 EUA or 510(k) cleared units within not more than 12 months from the effective date of this agreement.”

   

  Article 2.A.

   

  6.) From: “The Term of this Agreement commences upon the Effective Date and extends through final payment. This
      Agreement is anticipated to end 5 months after the Effective Date, subject to mutually agreed extensions pursuant to paragraph 2.D to facilitate the completion of the project(s).”

   

  To: “The Term of this Agreement commences upon the Effective Date and extends through final payment. This
      Agreement is anticipated to end 12 months after the Effective Date, subject to mutually agreed extensions pursuant to paragraph 2.E to facilitate the completion of the project(s).” The period of performance is hereby extended to October 12, 2021.

   

  
     

    
      
 

  

   

  Contract Modification Continuation Page

  Page 4 of 4

  Contract W911NF2190001

  Modification Number: A00003

  Modification Effective Date: 03 MAR 2021

   

  CLOSING REMARKS:

  The USD Cost Amount is USD 0.00.

  The USD Fee Amount is USD 0.00.

  The total funds obligated to this Contract equal USD 480,916,636.62.

  The USD Total Contract Amount is USD 480,916,636.62.

   

  As a result of this modification, the total obligated amount of this contract is unchanged.

  The total contract amount of this contract is unchanged.

  Except as provided by this contract modification, all terms and conditions of this contract remain unchanged
        and in full force and effect.Exhibit 10.12 

   

  

  Certain identified information has been excluded from the exhibit because it is both (i) not
      material and (ii) is the type of information that the registrant treats as private or confidential. Double asterisks denote omissions.

   

  LOAN AND SECURITY AGREEMENT

   

  This LOAN AND SECURITY AGREEMENT (this “Agreement”)

      is entered into as of February 5, 2021, by and among CUE HEALTH INC., a Delaware corporation (“Borrower”), the financial institutions from time to time party to this Agreement (collectively, “Lenders” and individually, each a “Lender”)

      and EAST WEST BANK, as collateral and administrative agent for Lenders (in such capacity, “Agent”).

   

  RECITALS

   

  This Agreement sets forth the terms on which Lenders will
      advance credit to Borrower, and Borrower will repay the amounts owing to Lenders.

   

  AGREEMENT

   

  The parties agree as follows:

   

  		1.	DEFINITIONS AND CONSTRUCTION.

   

  1.1          Definitions. As used in this Agreement, all
      capitalized terms shall have the definitions set forth on Exhibit A. Any term used in the Code and not defined herein shall have the meaning given to the term in the Code.

   

  1.2          Accounting Terms. Any accounting term not
      specifically defined on Exhibit A shall be construed in accordance with GAAP and all calculations shall be made in accordance with GAAP. The term “financial statements” shall include the accompanying notes and schedules.

   

  1.3          Interpretation. Any references to “pro rata”,
      “pro rata share”, “ratably” or similar terms shall take into account the Revolving Loan Commitment Percentage of each Lender and any outstanding commitments, undrawn Letters of Credit, and reimbursement obligations related to any Letters of Credit.

   

  		2.	LOAN AND TERMS OF PAYMENT.

   

  		2.1	Credit Extensions.

   

  (a)                Promise to Pay. Borrower promises
      to pay to Agent for the benefit of Lenders, in lawful money of the United States of America, the aggregate unpaid principal amount of all Credit Extensions made by Lenders to Borrower, together with interest on the unpaid principal amount of such
      Credit Extensions at the times and at the interest rates in accordance with the terms hereof.

   

  
     

    
      
 

  

  
   

  		(b)	Advances Under Revolving Line.

   

  (i)                  Amount. Subject to and upon the
      terms and conditions of this Agreement, Borrower may request, and Lenders severally agree to make to Borrower, loans on a revolving credit basis (each a “Revolving Loan” and collectively the “Revolving Loans”) in an aggregate
      outstanding original principal amount for all Lenders at any time outstanding not to exceed the lesser of (i) the Revolving Line and (ii) such amount as Borrower would still be in compliance with the Asset Coverage Ratio set forth in Section 6.7;
      provided that in no event shall any Lender be obligated to make a Revolving Loan or participate in a Letter of Credit if after giving effect to such Revolving Loan or such participation the sum of such Lender’s (w) Revolving Loans outstanding,
      (x) Revolving Loan Commitment Percentage of the aggregate maximum amount to be drawn under all Letters of Credit outstanding and (y) Revolving Loan Commitment Percentage of the aggregate amount of unreimbursed drawings under all Letters of Credit
      outstanding, would exceed its Revolving Loan Commitment. Amounts borrowed pursuant to this Section 2.1(b) may be repaid and reborrowed at any time, from time to time, without penalty or premium prior to the Revolving Maturity Date, at which
      time all outstanding Advances under this Section 2.1(b) together with all accrued but unpaid interest and fees thereon shall be immediately due and payable.

   

  (ii)                Form of Request; Lender Funding of
        Advances. Whenever Borrower desires an Advance, Borrower will give the Agent irrevocable notice by facsimile transmission or telephone no later than 9:00 a.m., Pacific time, on the Business Day that the Advance is to be made. Each such
      notification shall be promptly confirmed by a Payment/Advance Form in substantially the form of Exhibit C and delivered by a Responsible Officer. Upon receipt of such notice, the Agent shall promptly notify each Lender thereof on the date of
      receipt of such notice. On the proposed borrowing date, not later than 1:00 p.m., Pacific time, each Lender shall make available to the Agent the amount of such Lender’s pro rata share of the aggregate borrowing amount (as determined in accordance
      with this Section 2.1(b)) in immediately available funds by wiring such amount to such account as the Agent shall specify. Agent and Lenders shall be entitled to rely on any facsimile or telephonic notice given by a person who Agent and/or Lender
      reasonably believes to be a Responsible Officer or a designee thereof, and Borrower shall indemnify and hold Agent and Lenders harmless for any damages or loss suffered by such Agent or Lender as a result of such reliance. Agent will credit the
      amount of Advances made under this Section 2.1(b) to a deposit account of the Borrower at the Agent as Borrower requests in writing; provided that such deposit account is subject to a perfected security interest in favor of the Agent for the
      benefit of the Lenders.

   

  (iii)               Defaulting Lenders. If and to the
      extent any Lender (a “Defaulting Lender”) shall not have made its pro rata share of the Revolving Loan available to the Agent in immediately available funds as set forth in this Section 2.1(b) and the Agent in such circumstances has made
      available to Borrower such amount, that Lender shall, on the Business Day following the date of such Advance (the “Funding Date”), make such amount available to the Agent; provided that Agent shall be entitled to any interest applicable to
      such Advance for each day during such period. A notice submitted by the Agent to any Lender with respect to amounts owing under this subsection shall be conclusive, absent demonstrable error. If such amount is so made available, such payment to the
      Agent shall constitute such Defaulting Lender’s Advance on the Funding Date of such Advance for all purposes of this Agreement. If such amount is not made available to the Agent on the Business Day following the Funding Date, the Agent will notify
      Borrower of such failure to fund and, upon demand by the Agent, Borrower shall pay such amount to the Agent for the Agent’s account, together with interest thereon for each day elapsed since the Funding Date of such Advance, at a rate per annum equal
      to the interest rate applicable at the time to the Advances composing such Advance, without in any way prejudicing the rights and remedies of Borrower against such Defaulting Lender. The failure of any Lender to make any Advance on any Funding Date
      shall not relieve any other Lender of any obligation hereunder to make a Loan on such Funding Date, but no Lender shall be responsible for the failure of any other Lender to make the Advance to be made by such other Lender on any Funding Date.

   

  
     

    2

    
      
 

  

   

  		(c)	Letters of Credit.

   

  (i)                  As a subfacility under the Revolving
      Line, the L/C Issuer agrees from time to time (subject to the terms and conditions of this Agreement) to issue or cause an Affiliate to issue commercial and standby letters of credit for the account of the Borrower (each a “Letter of Credit,”
      and collectively “Letters of Credit”) until thirty (30) days prior to the Revolving Maturity Date; provided, however, that the aggregate drawn and undrawn amount of all outstanding Letters of Credit (including the Existing Letters of Credit)
      shall not at any time exceed Twenty Million and 00/100 Dollars ($20,000,000) (the “L/C Sublimit”). For the avoidance of doubt, the L/C Sublimit shall be a part of, and not in addition to, the Revolving Line. The undrawn amount of all Letters
      of Credit shall be reserved under the Revolving Line and such amount shall not be available for borrowings. Borrower shall give Agent and the L/C Issuer notice prior to 10:00 a.m., Pacific time at least five (5) Business Days prior to the proposed
      date of issuance of each Letter of Credit, specifying the beneficiary, the proposed date of issuance and the expiry date of such Letter of Credit, and describing the proposed terms of such Letter of Credit and the nature of the transactions proposed
      to be supported thereby. The issuance by the L/C Issuer of any Letter of Credit shall, in addition to the conditions precedent set forth in Section 3, be subject to the conditions precedent that such Letter of Credit shall be satisfactory to
      the L/C Issuer and that Borrower shall have executed and delivered such application agreement and/or such other instruments and agreements relating to such Letter of Credit as the L/C Issuer shall have requested in its sole discretion (each, a “L/C

        Application”). The L/C Issuer shall deliver a copy of the L/C Application to the Agent. The form and substance of each Letter of Credit shall be subject to approval by the L/C Issuer, in its sole discretion. Each Letter of Credit shall be
      issued for a term, as designated by the Borrower, not to exceed three hundred and sixty-five (365) days; provided, however, that no Letter of Credit shall have an expiration date later than five (5) Business Days prior to the Revolving Maturity Date
      unless Borrower has posted on the date of issuance of such Letter of Credit cash collateral to an account at the L/C Issuer and in which the Borrower grants a security interest to the Agent (for the benefit of the Lenders) in an amount equal to [**]
      percent ([**]%) of the outstanding Letters of Credit on terms satisfactory to the Agent and the L/C Issuer in their sole discretion, in which case the expiry date of such cash collateralized Letters of Credit may be up to one (1) year later than the
      fifth (5th) Business Day prior to the Revolving Maturity Date. The Letters of Credit may include a provision providing that their expiry date will automatically be
      extended each year for an additional one (1) year period unless the L/C Issuer delivers written notice to the contrary. Each Letter of Credit shall be subject to the additional terms and conditions of the Letter of Credit agreements, applications and
      any related documents required by the L/C Issuer in connection with the issuance of Letters of Credit. The L/C Issuer shall deliver to the Agent, concurrently with or promptly following its issuance of any Letter of Credit, a true and complete copy
      of each Letter of Credit. Promptly upon its receipt thereof, the Agent shall give notice to each Lender of the issuance of each Letter of Credit, specifying the amount thereof and the amount of such Lender’s percentage thereof.

   

  
     

    3

    
      
 

  

   

  (ii)                If the L/C Issuer shall honor a draft or
      other demand for payment presented or made under any Letter of Credit, the Borrower agrees to pay to the L/C Issuer an amount equal to the amount paid by the L/C Issuer in respect of such draft or other demand under such Letter of Credit and all
      reasonable expenses paid or incurred by the Agent relative thereto not later than 1:00 p.m. Pacific time, in United States dollars, on (i) the Business Day that the Borrower received notice of such presentment and honor, if such notice is received
      prior to 11:00 a.m. Pacific time or (ii) the Business Day immediately following the day that the Borrower received such notice, if such notice is received after 11:00 a.m. Pacific time.

   

  (iii)               If the L/C Issuer shall honor a draft or
      other demand for payment presented or made under any Letter of Credit, but the Borrower does not reimburse the L/C Issuer as required under clause (ii) above and the Revolving Line has not been terminated (whether by maturity, acceleration or
      otherwise), such drawing paid under such Letter of Credit shall be deemed an Advance under the Revolving Line and shall be repaid by the Borrower in accordance with the terms and conditions of this Agreement applicable to such Advances and the Agent
      will promptly notify the Lenders of such deemed request, and each such Lender shall make available to the Agent an amount equal to its pro rata share (based on its Revolving Loan Commitment Percentage) of the amount of such Advance; provided,
      however, that if Advances under the Revolving Line are not available, for any reason, at the time any drawing is paid, then the Borrower shall immediately pay to the L/C Issuer the full amount drawn, together with interest from the date such drawing
      is paid to the date such amount is fully repaid by the Borrower, at the rate of interest applicable to Advances under the Revolving Line. In such event the Borrower agrees that the Agent, in its sole discretion, may debit any account maintained by
      the Borrower with the Agent for the amount of any such drawing. Amounts held in such cash collateral account shall be applied by the Agent to the payment of drafts drawn under such letters of credit and to the obligations and liabilities of the
      Borrower to the Agent, in such order of application as the Required Lenders may in their sole discretion elect. Notwithstanding anything herein to the contrary, the L/C Issuer shall have no obligation hereunder to issue any Letter of Credit the
      proceeds of which would be made available to any Person to fund any activity or business in any Prohibited Territory or with any Person organized under or doing business in a Prohibited Territory. In addition to the Letters of Credit issued hereunder
      after the Closing Date, the Existing Letters of Credit shall remain outstanding as of the date hereof, shall be deemed to have been issued pursuant hereto, and shall be considered Letters of Credit hereunder and from and after the Closing Date shall
      be subject to and governed by the terms and conditions hereof including all fees in respect thereof. Notwithstanding the foregoing, (i) Borrower shall not be required to pay any additional issuance fees with respect to the issuance of the Existing
      Letters of Credit solely as a result of such letters of credit being converted to Letters of Credit hereunder (but the Borrower shall pay the fees set forth in Section 6.12 hereof in connection with all Letters of Credit, including the Existing
      Letters of Credit), and (ii) no Existing Letter of Credit may be extended or renewed.

   

  
     

    4

    
      
 

  

   

  (iv)              Upon issuance by the L/C Issuer of each Letter
      of Credit hereunder (and on the Closing Date with respect to each Existing Letter of Credit), each Lender shall automatically acquire a pro rata participation interest in such Letter of Credit and related payments made by the L/C Issuer in connection
      with such Letter of Credit, based on its respective Revolving Loan Commitment Percentage.

   

  (v)               Each Lender agrees to reimburse the L/C Issuer
      on demand, pro rata in accordance with its respective Revolving Loan Commitment Percentage, for (i) the reasonable out-of-pocket costs and expenses of the L/C Issuer to be reimbursed by the Borrower pursuant to any Letter of Credit (or related
      agreement), to the extent not reimbursed by the Borrower or any other Loan Party and (ii) any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, fees, reasonable out-of-pocket expenses or disbursements of
      any kind and nature whatsoever which may be imposed on, incurred by or asserted against L/C Issuer in any way relating to or arising out of this Agreement, any Letter of Credit, any documentation or any transaction relating thereto, to the extent not
      reimbursed by the Borrower, except to the extent that such liabilities, losses, costs or expenses were incurred by L/C Issuer as a result of L/C Issuer’s gross negligence or willful misconduct as determined by a court of competent jurisdiction by
      final and nonappealable judgment or by the L/C Issuer’s wrongful dishonor of any Letter of Credit after the presentation to it by the beneficiary thereunder of a draft or other demand for payment and other documentation strictly complying with the
      terms and conditions of such Letter of Credit.

   

  2.2          Overadvances. If the aggregate principal
      amount of the outstanding Advances at any time exceeds the Revolving Line, Borrower shall promptly (but in any event within three (3) Business Days) after the occurrence of such event, pay to Agent for the benefit of the Lenders, in cash, the amount
      of such excess.

   

  
     

    5

    
      
 

  

   

  		2.3	Interest Rates, Payments, and Calculations.

   

  (a)                Interest Rate. Except as set forth in
      Section 2.3(b), the Advances shall bear interest, on the outstanding daily balance thereof, at a rate equal to three quarters of one percent (0.75%) above the Prime Rate but in no event shall the interest rate be less than four percent (4.0%).

   

  (b)               Default Rate. All outstanding
      Obligations shall bear interest, from and after the occurrence and during the continuance of an Event of Default, at a rate equal to [**] percentage points above the interest rate applicable immediately prior to the occurrence of the Event of Default
      or such lesser amount the Required Lenders elect to impose from time to time in their sole discretion.

   

  (c)                Payments. Interest hereunder shall be
      due and payable in arrears on the first calendar day of each calendar month during the term hereof. Agent shall, at its option, charge such interest, all Lender Expenses, and all Periodic Payments against any of Borrower’s deposit accounts (other
      than deposit accounts exclusively used for payroll, payroll taxes and other employee wage and benefit payments to or for the benefit of Borrower’s employees) or, to the extent sufficient funds are not present in Borrower’s deposit accounts, against
      the Revolving Line, and if charged against the Revolving Line those charges shall thereafter be deemed to be Advances and shall thereafter accrue interest at the rate then applicable hereunder. Without limiting the foregoing, any interest not paid
      when due shall become a part of the Obligations, and such interest shall thereafter accrue interest at the rate then applicable hereunder.

   

  (d)               Computation. In the event the Prime
      Rate is changed from time to time hereafter, the applicable rate of interest hereunder shall be increased or decreased, effective as of the day the Prime Rate is changed, by an amount equal to such change in the Prime Rate. Agent shall give Borrower
      prompt notice of such change in the Prime Rate. All interest chargeable under the Loan Documents shall be computed on the basis of a three hundred sixty (360) day year for the actual number of days elapsed.

   

  2.4          Pro Rata Treatment and Payments. Each
      payment (including each prepayment) by the Borrower on account of fees, principal of and interest on the Credit Extensions shall be made pro rata according to the respective Revolving Loan Commitment Percentages then held by the Lenders. All payments
      (including prepayments) to be made by the Borrower hereunder, whether on account of principal, interest, fees or otherwise, shall be made without set- off, deduction or counterclaim and shall be made prior to 12:00 noon, Pacific time, on the due date
      thereof to the Agent, for the account of the Lenders. The Agent shall distribute such payments to the applicable Lenders promptly upon receipt in like funds as received. Except during the continuance of an Event of Default, Agent shall credit a wire
      transfer of funds, check or other item of payment to such deposit account or Obligation as Borrower specifies. After the occurrence and during the continuance of an Event of Default, Agent shall (except as otherwise directed by the Required Lenders)
      immediately apply any wire transfer of funds, check, or other item of payment Agent may receive to reduce Obligations (on a pro rata basis), but such applications of funds shall not be considered a payment on account unless such payment is of
      immediately available federal funds or unless and until such check or other item of payment is honored when presented for payment. Notwithstanding anything to the contrary contained herein, any wire transfer or payment received by Agent after 12:00
      noon Pacific time shall be deemed to have been received by Agent as of the opening of business on the immediately following Business Day. Whenever any payment to Agent for the benefit of the Lenders under the Loan Documents would otherwise be due
      (except by reason of acceleration) on a date that is not a Business Day, such payment shall instead be due on the next Business Day, and additional fees or interest, as the case may be, shall accrue and be payable for the period of such extension.

   

  
     

    6

    
      
 

  

   

  2.5          Lender Expenses and Fees. Borrower shall pay
      to Agent on or prior to the Closing Date, all Lender Expenses incurred through the Closing Date and invoiced to Borrower on or prior to the Closing Date, and, after the Closing Date, shall pay to Agent all Lender Expenses invoiced to Borrower, as and
      when they become due. Lender Expenses due on the Closing Date may be paid by way of an Advance under the Revolving Line.

   

  2.6          Term. This Agreement shall become effective on
      the Closing Date and, subject to Section 12.8, shall continue in full force and effect for so long as any Obligations (other than inchoate indemnification or reimbursement obligations or other obligations which, by their terms, survive
      termination of this Agreement) remain outstanding or Lenders have any obligation to make Credit Extensions under this Agreement which obligation shall terminate on the Revolving Maturity Date. Notwithstanding the foregoing, Lenders shall have the
      right pursuant to Section 9.1(b) to terminate their obligation to make Credit Extensions under this Agreement immediately and without notice upon the occurrence and during the continuance of an Event of Default.

   

  		2.7	Increased Costs.

   

  		(a)	If any Change in Law shall:

   

  (i)                 impose, modify or deem applicable any
      reserve, special deposit, compulsory loan, insurance charge or similar requirement against assets of, deposits with or for the account of, or credit extended or participated in by, any Lender;

   

  (ii)                subject the Agent or any Lender to any Taxes
      (other than Indemnified Taxes and Excluded Taxes) on its loans, loan principal, commitments, or other obligations, or its deposits, reserves, other liabilities or capital attributable thereto; or

   

  (iii)               impose on any Lender any other condition, cost
      or expense (other than Taxes) affecting this Agreement or Advances made by such Lender;

   

  and the result of any of the foregoing shall be to increase the cost to the
      Agent, increase the cost to the L/C Issuer of issuing any Letter of Credit, or increase the cost to any such Lender of purchasing or maintaining any participation in a Letter of Credit, or the Agent or such Lender of making or maintaining any Advance
      or of maintaining its obligation to make any such Advance, or to reduce the amount of any sum received or receivable by the Agent or such Lender hereunder (whether of principal, interest or any other amount) then, upon request of the Agent or such
      Lender, the Borrower will pay to the Agent or such Lender, as the case may be, such additional amount or amounts as will compensate the Agent or such Lender, as the case may be, for such additional costs incurred or reduction suffered.

   

  
     

    7

    
      
 

  

   

  (b)           If any Lender determines that any Change in Law
      affecting such Lender or any lending office of such Lender or such Lender’s holding company, if any, regarding capital or liquidity requirements, has or would have the effect of reducing the rate of return on such Lender’s capital or on the capital
      of such Lender’s holding company, if any, as a consequence of this Agreement, the commitments of such Lender or the Revolving Loans or Letters of Credit made by such Lender, to a level below that which such Lender or such Lender’s holding company
      could have achieved but for such Change in Law (taking into consideration such Lender’s policies and the policies of such Lender’s holding company with respect to capital adequacy), then from time to time the Borrower will pay to such Lender, as the
      case may be, such additional amount or amounts as will compensate such Lender or such Lender’s holding company for any such reduction suffered. The agreements in this Section shall survive the termination of this Agreement, the expiration of the
      Letters of Credit and the payment of all Obligations (other than unasserted contingent indemnification obligations and unasserted expense reimbursement obligations).

   

  (c)           A certificate of a Lender setting forth the amount
      or amounts necessary to compensate such Lender or its holding company, as the case may be, as specified in paragraph (a) or (b) of this Section and delivered to the Borrower, including a calculation of the amount in reasonable detail, shall be
      conclusive absent manifest error. The Borrower shall pay such Lender the amount shown as due on any such certificate within ten (10) days after receipt thereof. Any such certificate must be delivered within six

  (6) months after the incurrence by the Lender or its holding company, as the case
      may be, of the amounts set forth therein (except that, if the Change in Law giving rise to such amounts is retroactive, then the six (6) month period referred to herein shall be extended to include the period of retroactive effect thereof).

   

  		3.	CONDITIONS OF LOANS.

   

  3.1            Conditions Precedent to Initial Credit Extension.
      The obligation of Lenders to make the initial Credit Extension is subject to the condition precedent that Agent, and Lenders where necessary, shall have received, in form and substance satisfactory to Agent and Lenders, the following:

   

  		(a)	this Agreement;

   

  		(b)	a promissory note for each Lender that requests one;

   

  (c)           an officer’s certificate of Borrower with respect
      to incumbency and resolutions authorizing the execution and delivery of this Agreement in the form of Exhibit G attached hereto;

   

  		(d)	UCC National Form Financing Statement;

   

  		(e)	intellectual property security agreements;

   

  
     

    8

    
      
 

  

   

  		(f)	such landlord and bailee waivers as requested by Agent;

   

  (g)           copies of insurance certificates evidencing the
      insurance coverage required under Section 6.4 hereof and the insurance endorsements required by such Section; 

   

  

  (h)           payment of fees and Lender Expenses then due as
      specified in Section 2.5;

   

  (i)            current SOS Reports indicating that except for
      Permitted Liens, there are no other security interests or Liens of record in the Collateral;

   

  (j)             current financial statements, including draft
      audited statements for Borrower’s fiscal year ended December 31, 2019, together with an unqualified opinion, company prepared consolidated and, if prepared by Borrower, consolidating financials, balance sheets and income statements for
      the most recently ended month in accordance with Section 6.2, and such other updated financial information as Agent may reasonably request;

   

  		(k)	current Compliance Certificate in accordance with Section 6.2;

   

  		(l)	a perfection certificate;

   

  (m)          subject to Section 4.2, securities and/or
      deposit account control agreements with respect to any accounts permitted hereunder to be maintained outside Agent;

    

    

  

  (n)           an Automatic Debit Authorization in the form of
      Exhibit H attached hereto;

   

  (o)           Agent shall have been provided the opportunity
      to inspect Borrower’s Books and to make copies thereof and to check, test, and appraise the Collateral in order to verify Borrower’s financial condition or the amount, condition of, or any other matter relating to, the Collateral;

   

  (p)           a payoff letter from Comerica Bank in respect of
      the Existing Indebtedness;

   

  (q)           evidence that (i) the Liens securing the
      Existing Indebtedness will be terminated and (ii) the documents and/or filings evidencing the perfection of such Liens, including without limitation any financing statements and/or control agreements, have or will, concurrently with the initial
      Credit Extension, be terminated;

   

  (r)            a fee letter between Agent and Borrower and
      payment of the fees specified therein; and

   

  (s)           such other documents or certificates, and
      completion of such other matters, as Agent or any Lender may reasonably request, including, without limitation, any such documents or certificates required in connection with customary “know your customer” requirements, USA Patriot Act, and
      beneficial ownership regulations.

   

  
     

    9

    
      
 

  

   

  3.2          Conditions Precedent to all Credit Extensions.
      The obligation of Lenders to make each Credit Extension, including the initial Credit Extension, is further subject to the following conditions:

   

  (a)           timely receipt by Lenders of the Payment/Advance
      Form as provided in Section 2.1;

   

  (b)           receipt by the Agent of an executed Disbursement
      Letter substantially in the form of Exhibit E attached hereto;

   

  (c)           the representations and warranties contained in
      Article 5 shall be true and correct in all material respects on and as of the date of such Payment/Advance Form and on the effective date of each Credit Extension as though made at and as of each such date, and no Default or Event of Default
      shall have occurred and be continuing, or would immediately exist after giving effect to such Credit Extension (provided, however, that those representations and warranties expressly referring to another date shall be true and correct in all material
      respects as of such date, and those representations and warranties already subject to materiality or a Material Adverse Effect condition shall be true and correct in all respects). The making of each Credit Extension shall be deemed to be a
      representation and warranty by Borrower on the date of such Credit Extension as to the accuracy of the facts referred to in this Section 3.2(c); and

   

  (d)           the financial covenants set forth in Section
        6.7 shall be met immediately prior to and after giving effect to such borrowing.

   

  		4.	CREATION OF SECURITY INTEREST AND GUARANTY.

   

  4.1          Grant of Security Interest. Each Loan Party
      grants and pledges to Agent (for the benefit of the Lenders) a continuing security interest in the Collateral to secure prompt repayment of any and all Obligations and to secure prompt performance by each Loan Party of each of its covenants and
      duties under the Loan Documents. Except as set forth in the Schedule related to Permitted Liens, such security interest constitutes a valid, first priority security interest in the presently existing Collateral, and will constitute a valid, first
      priority security interest in later-acquired Collateral. Each Loan Party also hereby agrees not to sell, transfer, assign, mortgage, pledge, lease, grant a security interest in, or encumber any of its Intellectual Property, except in connection with
      Permitted Liens and Permitted Transfers. Notwithstanding any termination of this Agreement, Agent’s Lien (for the benefit of the Lenders) on the Collateral shall remain in effect for so long as any Obligations (other than inchoate indemnification or
      reimbursement obligations or other obligations which, by their terms, survive termination of this Agreement) are outstanding or any Lender has any obligation to make Credit Extensions under this Agreement. At the sole expense of Borrower following
      termination of this Agreement, Agent shall deliver such documents as Borrower shall reasonably request to evidence such termination.

   

  
     

    10

    
      
 

  

   

  4.2          Perfection of Security Interest. Each Loan
      Party authorizes Agent to file at any time financing statements, continuation statements, and amendments thereto that (i) describe the Collateral as all assets of such Loan Party of the kind pledged hereunder, and (ii) contain any other information
      required by the Code for the sufficiency of filing office acceptance of any financing statement, continuation statement, or amendment, including whether such Loan Party is an organization, the type of organization and any organizational
      identification number issued to such Loan Party, if applicable. Any such financing statements may be filed by Agent at any time in any jurisdiction whether or not Revised Article 9 of the Code is then in effect in that jurisdiction. Each Loan Party
      shall from time to time endorse and deliver to Agent, at the request of Agent, all Negotiable Collateral and other documents that Agent may reasonably request, in form reasonably satisfactory to Agent, to perfect and continue perfection of Agent’s
      security interests (for the benefit of the Lenders) in the Collateral and in order to fully consummate all of the transactions contemplated under the Loan Documents. The Loan Parties shall have possession of the Collateral, except where expressly
      otherwise provided in this Agreement or where Agent chooses to perfect its security interest by possession in addition to the filing of a financing statement. Where Collateral with a value in excess of [**] Dollars ($[**]) is in possession of a third
      party or bailee, the applicable Loan Party shall take such steps as Agent reasonably requests for Agent to obtain an acknowledgment, in form and substance reasonably satisfactory to Agent, of the bailee that the bailee holds such Collateral for the
      benefit of Agent. Where Collateral with a value in excess of [**] Dollars ($[**]) is located at a property which is not owned by a Loan Party, the applicable Loan Party shall take such steps as Agent reasonably requests for Agent to obtain an
      agreement, in form and substance reasonably satisfactory to Agent, from the owner and/or mortgagee of such property that it agrees to, among other things, waive or subordinate any Lien it may have on the Collateral, and agrees to permit the Agent to
      enter upon the premises and remove the Collateral or to use the premises to store or dispose of the Collateral. The applicable Loan Party shall cause Agent obtain “control” of any Collateral consisting of investment property, securities accounts or
      deposit accounts (other than Excluded Accounts) (as such items and the term “control” are defined in Revised Article 9 of the Code) by causing the securities intermediary or depositary institution or issuing bank to execute a control agreement in
      form and substance reasonably satisfactory to Agent.

   

  4.3          Right to Inspect. Agent (through any of its
      officers, employees, or agents) shall have the right, upon reasonable prior written notice, from time to time at reasonable times during Loan Parties’ usual business hours to inspect each Loan Party’s Books and to make copies thereof and to check,
      test, and appraise the Collateral in order to verify such Loan Party’s financial condition or the amount, condition of, or any other matter relating to, the Collateral (the “Inspection”). For the avoidance of doubt, Lenders shall be entitled
      to accompany Agent on any Inspection. Notwithstanding the foregoing, unless an Event of Default has occurred and is continuing, the Loan Parties’ shall only be obligated to reimburse Agent for [**] in each calendar year.

   

  		4.4	Collection Account.

   

  (a)           On or prior to the Closing Date, the Borrower
      shall establish a deposit account maintained with the Agent (the “Collection Account”). Promptly after the Closing Date, the Borrower shall cause each Loan Party to (a) instruct all payments with respect to Accounts due to such Loan Party to
      be made directly to the Collection Account and (b) use commercially reasonable efforts to cause all such payments to be made by the relevant Account debtors directly to the Collection Account (and if any such payments are received other than through
      a direct payment to the Collection Account, Borrower shall cause such payment to be transferred to the Collection Account within two (2) Business Days of receipt) and while in Borrower’s possession such payments shall be held by Borrower in trust for
      Agent as Agent’s trustee, and Borrower shall deliver such payments to Agent in their original form as received, with proper endorsements for deposit.

   

  
     

    11

    
      
 

  

   

  (b)           All items or amounts remitted to the Collection
      Account or that Agent (or after an Event of Default, Required Lenders) has otherwise received shall be applied to the payment of the Obligations on a daily basis (or such lesser frequency, but not less than [**] times per month, as determined by
      Agent in consultation with Borrower), whether then due or not, in the order set forth in Section 12.11 and no amounts shall be swept to other accounts unless the Required Lenders agree in writing to such a sweep in their sole discretion. Any amount
      remaining in the Collection Account after payment in full of the Obligations, so long as no Event of Default exists, shall be transferred by Agent from the Collection Account to Borrower’s primary operating account maintained with Agent. Except to
      the extent (but only to the extent) caused by the Agent’s gross negligence or willful misconduct as determined by a court of competent jurisdiction by final and nonappealable judgment, Agent shall not be liable for any loss or damage which Borrower
      may suffer as a result of Agent’s processing of items or its exercise of any other rights or remedies under this Agreement, including without limitation indirect, special or consequential damages, loss of revenues or profits, or any claim, demand or
      action by any third party arising out of or in connection with the processing of items or the exercise of any other rights or remedies under this Agreement. Borrower shall indemnify and hold Agent and Lenders harmless from and against all such third
      party claims, demands or actions, and all related expenses or liabilities, including, without limitation, reasonable documented out-of-pocket attorney’s fees and including claims, damages, fines, expenses, liabilities or causes of action of whatever
      kind resulting from Agent’s own negligence except to the extent (but only to the extent) caused by Agent’s gross negligence or willful misconduct as determined by a court of competent jurisdiction by final and nonappealable judgment.

   

  		4.5	Guaranty.

   

  (a)           Unconditional Guaranty of Payment. In
      consideration of the foregoing, each Guarantor from time to time party hereto hereby irrevocably, absolutely and unconditionally guarantees to Agent and Lenders the prompt and complete payment and performance when due (whether at stated maturity, by
      acceleration or otherwise) of all Obligations. Guarantor agrees that it shall execute such other documents or agreements and take such action as Agent or the Required Lenders shall reasonably request to effect the purposes of its guaranty. If there
      is more than one Guarantor hereunder, such Guarantors shall be jointly and severally obligated for such guarantees provided for herein.

   

  (b)           Separate Obligations. These obligations are
      independent of Borrower’s obligations and separate actions may be brought against Guarantor (whether action is brought against Borrower or whether Borrower is joined in the action).

   

  
     

    12

    
      
 

  

   

  		5.	REPRESENTATIONS AND WARRANTIES.

   

  Each Loan Party represents and warrants as follows:

   

  5.1          Due Organization and Qualification. Each Loan
      Party and each Subsidiary is an entity duly existing under the laws of the jurisdiction in which it is organized and qualified and licensed to do business in any state in which the conduct of its business or its ownership of property requires that it
      be so qualified, except where the failure to do so could not reasonably be expected to cause a Material Adverse Effect.

   

  5.2          Due Authorization; No Conflict. The
      execution, delivery, and performance of the Loan Documents are within such Loan Party’s powers, have been duly authorized, and are not in conflict with nor constitute a breach of any provision contained in such Loan Party’s organizational documents,
      nor will they constitute an event of default under any material agreement by which any Loan Party is bound. No Loan Party is in default under any agreement by which it is bound, except to the extent such default would not reasonably be expected to
      cause a Material Adverse Effect.

   

  5.3           Collateral. The Loan Parties have rights in
      or the power to transfer the Collateral, and their title to the Collateral is free and clear of Liens, adverse claims, and restrictions on transfer or pledge except, in each case, for Permitted Liens. Except as disclosed in writing by Borrower to
      Agent from time to time, all tangible Collateral in excess of [**] Dollars ($[**]) is located solely in the Collateral State. The Eligible Accounts are bona fide existing obligations. The property or services giving rise to such Eligible Accounts has
      been delivered or rendered to the account debtor or its agent for immediate shipment to and unconditional acceptance by the account debtor. Except as disclosed in writing to Agent, Borrower has not received notice of actual or imminent Insolvency
      Proceeding of any account debtor whose accounts are included in any Eligible Account. No licenses or agreements giving rise to such Eligible Accounts is with any Prohibited Territory or with any Person organized under or doing business in a
      Prohibited Territory.

   

  5.4          Name; Location of Chief Executive Office.
      Except as disclosed in the Schedule, during the last five (5) years prior to the Closing Date, no Loan Party has done business under any name other than that specified on the signature page hereof, and its exact legal name is as set forth in the
      first paragraph of this Agreement. The chief executive office of each Loan Party is located in the Chief Executive Office State at the address indicated in Section 10 hereof or such other location as Borrower has notified Agent of pursuant to
      Section 7.2.

   

  5.5          Actions, Suits, Litigation, or Proceedings.
      Except as set forth in the Schedule, there are no actions, suits, litigation or proceedings, at law or in equity, pending by or against any Loan Party or any Subsidiary before any court, administrative agency, or arbitrator in which an adverse
      decision could reasonably be expected to have a Material Adverse Effect.

   

  5.6          No Material Adverse Change in Financial Statements.
      All consolidated and, if applicable, consolidating financial statements related to the Loan Parties that are delivered by Borrower to Agent fairly present, in all material respects, such Loan Party’s consolidated and, if applicable, consolidating
      financial condition as of the date thereof and such Loan Party’s consolidated and, if applicable, consolidating results of operations for the period then ended (subject, in the case of unaudited financial statements, to the absence of footnotes and
      normal year- end audit adjustments). There has not occurred a Material Adverse Effect since December 31, 2019.

   

  
     

    13

    
      
 

  

   

  5.7          Solvency, Payment of Debts. The Borrower is
      and the Loan Parties, taken as a whole on a consolidated basis, are able to pay its debts (including trade debts) as they mature in the ordinary course of business; the value of the balance sheet sets of the Borrower’s and the Loan Parties’, taken as
      a whole on a consolidated basis (minus disposition costs) exceeds the fair value of its liabilities; and the Borrower is not and the Loan Parties, taken as a whole on a consolidated basis, are not left with unreasonably small capital after the
      transactions contemplated by this Agreement.

   

  5.8          Compliance with Laws and Regulations. The Loan
      Parties and each Subsidiary have met the minimum funding requirements of ERISA with respect to any employee benefit plans subject to ERISA. No event has occurred resulting from any Loan Party’s failure to comply with ERISA that is reasonably likely
      to result in incurring any liability that could reasonably be expected to have a Material Adverse Effect. No Loan Party is an “investment company” or a company “controlled” by an “investment company” within the meaning of the Investment Company Act
      of 1940. No Loan Party is engaged principally, or as one of the important activities, in the business of extending credit for the purpose of purchasing or carrying margin stock (within the meaning of Regulations T and U of the Board of Governors of
      the Federal Reserve System). Each Loan Party has complied in all material respects with all the applicable provisions of the Federal Fair Labor Standards Act. Each Loan Party is in compliance with all applicable Environmental Laws, regulations and
      ordinances except where the failure to comply would not reasonably be expected to have a Material Adverse Effect. No Loan Party has violated any statutes, laws, ordinances or rules applicable to it, the violation of which could reasonably be expected
      to have a Material Adverse Effect. Each Loan Party and each Subsidiary have filed or caused to be filed all tax returns required to be filed by such Loan Party or such Subsidiary, and have paid, or have made adequate provision for the payment of, all
      taxes reflected therein except those being contested in good faith with adequate reserves under GAAP or where the failure to file such returns or pay such taxes could not reasonably be expected to have a Material Adverse Effect or result in any Lien
      which is not a Permitted Lien.

   

  5.9          Subsidiaries. No Loan Party owns any stock,
      partnership interest or other equity securities of any Person, except for Permitted Investments.

   

  5.10        Government Consents. Each Loan Party and
      each Subsidiary have obtained all consents, approvals and authorizations of, made all declarations or filings with, and given all notices to, all governmental authorities that are necessary for the continued operation of such Person’s business as
      currently conducted.

   

  5.11        Inbound Licenses. Except as disclosed on the
      Schedule , no Loan Party is a party to, nor is bound by, any inbound license, the failure, breach, or termination of which could reasonably be expected to cause a Material Adverse Effect, that prohibits such Loan Party from granting a security
      interest in such Loan Party’s interest in such license or any other property (other than commercial off-the- shelf software).

   

  
     

    14

    
      
 

  

   

  5.12        Full Disclosure. No representation, warranty
      or other statement made by any Loan Party in connection with the Loan Documents or the transactions contemplated thereby in any certificate or signed written statement furnished to Agent by any Loan Party taken together with all such certificates and
      written statements furnished to Agent by any Loan Party contains any untrue statement of a material fact or omits to state a material fact necessary in order to make the statements contained in such certificates or statements not misleading in light
      of the circumstances under which they are made.

   

  		6.	AFFIRMATIVE COVENANTS.

   

  Each Loan Party covenants that, until payment in full of all
      outstanding Obligations (other than inchoate indemnification or reimbursement obligations or other obligations which, by their terms, survive termination of this Agreement), and for so long as Lenders may have any commitment to make a Credit
      Extension hereunder, they shall do all of the following:

   

  6.1          Good Standing and Government Compliance. Each
      Loan Party shall maintain its organizational existence and good standing in its state of incorporation or formation, and shall cause each of its Subsidiaries to maintain its organizational existence and good standing in its state of incorporation or
      formation, as applicable, and each shall maintain qualification and good standing in each other jurisdiction in which the failure to so qualify could reasonably be expected to have a Material Adverse Effect, and shall furnish to Agent the
      organizational identification number issued to such Loan Party by the authorities of the jurisdiction in which it is organized, if applicable. Each Loan Party shall meet, and shall cause each Subsidiary to meet, the minimum funding requirements of
      ERISA with respect to any employee benefit plans subject to ERISA. Each Loan Party shall comply in all material respects with all applicable Environmental Laws, and maintain all material permits, licenses and approvals required thereunder where the
      failure to do so could reasonably be expected to have a Material Adverse Effect. Each Loan Party shall comply in all material respects, and shall cause each Subsidiary to comply, with all material statutes, laws, ordinances and government rules and
      regulations to which it is subject, and shall maintain, and shall cause each of its Subsidiaries to maintain, in force all licenses, approvals and agreements, in each case, the loss of which or failure to comply with which would reasonably be
      expected to have a Material Adverse Effect.

   

  6.2          Financial Statements, Reports, Certificates.
      Borrower shall deliver to Agent: (i) as soon as available, but in any event within twenty-five (25) days after the end of each calendar month (which shall be extended to thirty (30) days for deliveries to be made in the first two months following the
      Closing Date), a company prepared consolidated and, if prepared by the Borrower, consolidating balance sheet and income statement covering the Loan Parties’ operations during such period, in a form reasonably acceptable to Agent and certified by a
      Responsible Officer; (ii) as soon as available, but in any event within one hundred twenty (120) days after the end of Borrower’s fiscal year, company prepared consolidated and, if prepared by the Borrower, consolidating financial statements of
      Borrower and its consolidated Subsidiaries prepared in accordance with GAAP, consistently applied, and audited by a certified public accountant, which, following a SPAC Business Combination may be satisfied by audited financial statements of a parent
      company of Borrower; (iii) if applicable, copies of all statements, reports and notices sent or made available generally by any Loan Party to its security holders or to any holders of Subordinated Debt and all reports on Forms 10-K and 10-Q filed
      with the Securities and Exchange Commission; (iv) promptly upon receipt of notice thereof by any Loan Party, a report of any legal actions pending or threatened in writing against any Loan Party or any Subsidiary that could reasonably be expected to
      result in damages or costs to any Loan Party or any Subsidiary of [**] Dollars ($[**]) or more; (v) promptly upon receipt by any Loan Party, each management letter prepared by such Loan Party’s independent certified public accounting firm regarding
      such Loan Party’s management control systems; (vi) as soon as available, but in any event within sixty (60) days after the end of Borrower’s fiscal year, Borrower’s financial and business projections and budget for the immediately following year,
      with evidence of approval thereof by Borrower’s board of directors; and (vii) such budgets, sales projections, operating plans or other financial information generally prepared by Borrower in the ordinary course of business as Agent may reasonably
      request from time to time.

   

  
     

    15

    
      
 

  

   

  (a)           Not later than twenty-five (25) days after the
      last day of each calendar month (which shall be extended to thirty (30) days for any such deliveries to be made within the first two months following the Closing Date), the Borrower shall deliver to Agent, in a form reasonably acceptable to Agent,
      (i) reconciliations of all of the Loan Parties’ Accounts as shown on the report for the immediately preceding month to Loan Parties’ accounts receivable agings, to Loan Parties’ general ledger and to Loan Parties’ most recent financial statements,
      (ii) a detailed aged trial balance of all Accounts as of the end of the preceding fiscal month, specifying each Account’s debtor name and address, amount, invoice date and due date, showing any discount, allowance, credit, authorized return or
      dispute, and including such proof of delivery, copies of invoices and invoice registers, copies of related documents, repayment histories, status reports and other information as Agent may reasonably request, (iii) accounts payable agings, and (iv)
      accounts receivable agings.

   

  (b)           In connection with the deliveries under Sections

        6.2(i) and (ii) above, Borrower shall deliver to Agent a Compliance Certificate certified as of the last day of the applicable month and signed by a Responsible Officer in substantially the form of Exhibit D hereto, which shall
      include agings of Borrower’s accounts receivable and accounts payable.

   

  (c)           Promptly upon, but in any event within three (3)
      Business Days of becoming aware of the occurrence or existence of an Event of Default hereunder, Borrower shall deliver to Agent a written statement of a Responsible Officer setting forth details of the Event of Default, and the action which the Loan
      Parties have taken or proposes to take with respect thereto.

   

  Borrower may deliver to Agent on an electronic basis any
      certificates, reports or information required pursuant to this Section 6.2, and Agent shall be entitled to rely on the information contained in the electronic files, provided that Agent in good faith believes that the files were delivered by
      a Responsible Officer. If Borrower delivers this information electronically, it shall also deliver to Agent by U.S. Mail, reputable overnight courier service, hand delivery, facsimile or .pdf file within five (5) Business Days of submission of the
      unsigned electronic copy the certification of monthly financial statements and the Compliance Certificate, each bearing the physical signature of the Responsible Officer.

   

  
     

    16

    
      
 

  

   

  6.3              Taxes. Each Loan Party shall make, and
      cause each Subsidiary to make, due and timely payment or deposit of all material federal, state, and local Taxes, assessments, or contributions required of it by law, including, but not limited to, those laws concerning income taxes, F.I.C.A.,
      F.U.T.A. and state disability, and will execute and deliver to Agent, on demand, proof reasonably satisfactory to Agent indicating that Borrower or a Subsidiary has made such payments or deposits and any appropriate certificates attesting to the
      payment or deposit thereof; provided that Borrower or a Subsidiary need not make any payment if the amount or validity of such payment is contested in good faith by appropriate proceedings and is reserved against (to the extent required by GAAP) by
      Borrower and such non-payment does not result in a Lien which is not a Permitted Lien.

   

  		6.4	Insurance.

   

  (a)           The Loan Parties, at their expense, shall keep the
      Collateral insured against such hazards and risks, and in such amounts, as customarily insured against by other owners in similar businesses conducted in the locations where each Loan Party’s business is conducted on the date hereof. The Loan Parties
      shall also maintain liability and other insurance in amounts and of a type that are customary to businesses similar to the Loan Parties’ business.

   

  (b)           All such policies of insurance shall be in such
      form, with such companies, and in such amounts as reasonably satisfactory to Agent. All policies of property insurance shall contain a lender’s loss payable endorsement, in a form reasonably satisfactory to Agent, showing Agent as lender’s loss
      payee, and all liability insurance policies shall show Agent as an additional insured and all such policies shall specify that the insurer must give at least thirty (30) days’ notice to Agent before canceling its policy for any reason (or ten (10)
      days’ notice in the event of cancellation for nonpayment). All policies of insurance shall be addressed to Agent as follows: East West Bank as Agent for the Lenders, its Successors and / or Assigns, P.O. Box 60021, City of Industry, CA 91716,
      Attention: Cue Health Inc. Account Manager. Upon Agent’s reasonable request, Borrower shall deliver to Agent certified copies of the policies of insurance and evidence of all premium payments. All proceeds payable under any such policy shall, unless
      Agent otherwise consents, be payable to Agent to be applied on account of the Obligations. Notwithstanding the foregoing sentence, if no Event of Default has occurred and is continuing, proceeds payable under any insurance policy will, at Borrower’s
      option, be payable to Borrower to repair or replace the property subject to the claim, provided that any such replacement property shall be deemed Collateral in which Agent has been granted a first priority security interest (subject to Permitted
      Liens); provided further, however, that the aggregate amount of all such proceeds paid directly to Borrower pursuant to this Section shall not exceed [**] Dollars ($[**]) per fiscal year.

   

  6.5          Accounts. Each Loan Party shall maintain all
      of its primary depository and operating accounts with Agent and its primary investment accounts with Lender or Lenders’ Affiliates (covered by reasonably satisfactory control agreements). All accounts, other than Excluded Accounts, shall be subject
      to control agreements in form and content reasonably acceptable to Agent.

   

  
     

    17

    
      
 

  

   

  		6.6	Reserved.

   

  		6.7	Financial Covenants.

   

  (a)           Asset Coverage Ratio. At all times,
      Borrower shall have a minimum asset coverage ratio of not less than 1.25 to 1.00 measured as (i) the sum of cash maintained in deposit accounts with Agent not subject to any Lien other than the Liens in favor Agent plus fifty percent (50%)
      of Eligible Accounts as Required Lenders determine are eligible, to (ii) all Obligations outstanding hereunder.

   

  (b)           Minimum Remaining Months Liquidity. As
      measured on the last day of each calendar month, Borrower shall maintain a minimum of six (6) months remaining liquidity measured as (i) cash maintained in deposit accounts with Agent not subject to any Lien other than the Liens in favor Agent,
      divided by (ii) the average of, for the last three (3) calendar months, net income (inclusive of grants received but not yet recognized per GAAP, if applicable and approved by Lenders, to be subtracted once recognized as income per GAAP), plus, to
      the extent deducted in determining net income, depreciation expense, amortization expense, and less unfunded capital expenditures, all for the Borrower and all as determined in accordance with GAAP.

   

  (c)           Minimum Liquidity. At all times, Borrower
      shall have a minimum liquidity measured as cash maintained in deposit accounts with Agent not subject to any Lien other than the Liens in favor Agent, of at least $80,000,000.00.

   

  		6.8	Registration of Intellectual Property Rights.

   

  (a)           Borrower shall register or cause to be
      registered (to the extent not already registered) with the United States Patent and Trademark Office or the United States Copyright Office, as the case may be, those registrable intellectual property rights now owned or hereafter developed or
      acquired by Borrower, to the extent that Borrower, in its reasonable business judgment, deems it appropriate to so protect such intellectual property rights.

   

  (b)           Borrower shall promptly, but in any event within
      thirty (30) days after filing, give Agent written notice of any applications or registrations of intellectual property rights filed with the United States Patent and Trademark Office, including the date of such filing and the registration or
      application numbers, if any.

   

  (c)           Borrower shall (i) promptly, but in any event
      within thirty (30) days after filing, give Agent written notice of the filing of any applications or registrations with the United States Copyright Office, including the title of such intellectual property rights to be registered, as such title will
      appear on such applications or registrations, and the date such applications or registrations will be filed; (ii) promptly, but in any event within thirty (30) days after filing, execute such documents as Agent may reasonably request for Agent to
      maintain its perfection in such intellectual property rights to be registered by Borrower; (iii)     upon the request of Agent, either deliver to Agent or file such documents promptly, but in any event within thirty (30) days after filing any such
      applications or registrations with the United States Copyright Office; (iv) promptly, but in any event within thirty (30) days after filing, provide Agent with a copy of such applications or registrations together with any exhibits, evidence of the
      filing of any documents requested by Agent to be filed for Agent to maintain the perfection and priority of its security interest in such intellectual property rights, and the date of such filing.

   

  
     

    18

    
      
 

  

   

  (d)          Borrower shall execute and deliver such additional
      instruments and documents from time to time as Agent shall reasonably request to perfect and maintain the perfection and priority of Agent’s security interest in the Intellectual Property Collateral.

   

  (e)           Borrower shall use commercially reasonably efforts
      to (i) protect, defend and maintain the validity and enforceability of Borrower’s trademarks, patents, copyrights, and trade secrets, (ii) detect infringements of the copyrights, trademarks and patents and promptly advise Agent in writing of material
      infringements detected and (iii) not allow any material copyrights, trademarks and patents to be abandoned, forfeited or dedicated to the public without the written consent of Agent, which shall not be unreasonably withheld.

   

  (f)            Agent may audit Borrower’s Intellectual
      Property Collateral to confirm compliance with this Section 6.8. Notwithstanding the foregoing, unless an Event of Default has occurred and is continuing, the Loan Parties’ shall only be obligated to reimburse Agent for one (1) such
      Intellectual Property Collateral audit in each calendar year. Agent shall have the right, but not the obligation, to take, at Borrower’s sole expense, any actions that Borrower is required under this Section 6.8 to take but which Borrower
      fails to take, after fifteen (15) days’ notice to Borrower. Borrower shall reimburse and indemnify Agent for all reasonable costs and reasonable expenses incurred in the reasonable exercise of its rights under this Section 6.8.

   

  6.9          Consent of Inbound Licensors. Prior to
      entering into or becoming bound by any inbound license or agreement (other than over-the-counter software that is commercially available to the public), the failure, breach, or termination of which could reasonably be expected to cause a Material
      Adverse Effect, Borrower shall: (a) provide written notice to Agent of the material terms of such license or agreement with a description of its likely impact on Borrower’s business or financial condition; and (b) in good faith take such actions as
      Agent may reasonably request to obtain the consent of, or waiver by, any person whose consent or waiver is necessary for (i) Borrower’s interest in such licenses or contract rights to be deemed Collateral and for Agent (on behalf of the Lenders) to
      have a security interest in it that might otherwise be restricted by the terms of the applicable license or agreement, whether now existing or entered into in the future, and (ii) Agent to have the ability in the event of a liquidation of any
      Collateral to dispose of such Collateral in accordance with Agent’s and Lenders’ rights and remedies under this Agreement and the other Loan Documents.

   

  6.10        Creation/Acquisition of Subsidiaries and Other
        Equity Interests. With respect to each Formed Subsidiary or Acquired Subsidiary, such Loan Party and such Subsidiary, as applicable, shall promptly notify Agent of the creation or acquisition of such new Subsidiary or other equity interests and
      take all such action as may be reasonably required by Agent to cause each such domestic Subsidiary to guarantee the Obligations of Borrower under the Loan Documents and grant a continuing pledge and security interest in and to the collateral of such
      Subsidiary (substantially as described on Exhibit B hereto), and such Loan Party shall grant and pledge to Agent a perfected security interest in the stock, units or other evidence of ownership of each Subsidiary or other equity interest
      acquired (whether foreign or domestic, but subject to the limitations in the definition of Collateral), deliver any and all certificates or other evidence of ownership of such Subsidiary or other equity interest acquired, together with stock or unit
      powers executed in blank, and take any other action in furtherance of the foregoing reasonably requested by Agent. For the avoidance of doubt, no direct or indirect parent company of the Borrower or any equity holder in the Borrower after giving
      effect to any SPAC Business Combination shall be required to guaranty the Obligations or pledge assets securing repayment of the Obligations.

   

  
     

    19

    
      
 

  

   

  6.11         Use of Proceeds. The proceeds of the Advances
      under the Revolving Line shall, unless otherwise consented to in writing by Agent, be used solely for (A) payment of interest, legal fees and Lender fees, (B) working capital needs and general corporate purposes of the Borrower (including, without
      limitation, costs, expense or other payables related to or required in connection with a SPAC Business Combination) and (C) paying off the Existing Indebtedness on the date hereof.

   

  		6.12	Fees.

   

  (a)           Borrower shall pay to Agent for the ratable
      benefit of each Lender having a commitment hereunder (i) an unused availability fee equal to one-quarter of one percent (0.25%) per annum of the daily unused portion of the Revolving Line which shall be calculated by subtracting the amount
      outstanding hereunder from the Revolving Line, which fee shall be payable quarterly in arrears on the last day of each calendar quarter, commencing with the quarter ending March 31, 2021 and (ii) a commitment fee equal to one-quarter of one percent
      (0.25%) of the commitment hereunder, which fee shall be due and payable on the date hereof.

   

  (b)           The Borrower shall pay (i) to Agent for
      distribution to the Lenders in accordance with their Revolving Loan Commitment Percentages, a non-refundable fee equal to [**] percentage points ([**]%) per annum of the outstanding undrawn amount of each standby Letter of Credit (including, for the
      avoidance of doubt, the Existing Letters of Credit), payable annually in advance, calculated on the basis of the face amount outstanding on the day the fee is calculated, and (ii) to Agent, for distribution to the L/C Issuer of the applicable Letter
      of Credit, such L/C Issuer’s standard fees in connection with each commercial Letter of Credit, which fees shall be non-refundable under all circumstances.

   

  (c)           If Borrower terminates or permanently reduces
      the commitment, in whole or in part at any time before the Revolving Maturity Date, Borrower shall pay to Agent for the ratable benefit of each Lender having a commitment hereunder a prepayment fee equal to the amount by which the commitment is
      permanently reduced, or the outstanding commitment if terminated in full, times one percent (1.00%). The prepayment fee described in this Section is deemed fully earned and non-refundable as of the Closing Date and due and payable on the date of such
      termination or permanent reduction. Notwithstanding the foregoing, in the event that the Borrower, Agent and Lenders are not able to agree to a mutually acceptable amendment to permit a SPAC Business Combination pursuant to Section 12.10
      hereof within one hundred twenty (120) days of the Closing Date, the Borrower shall be permitted to prepay any amounts outstanding hereunder and terminate the Commitment in full with no prepayment fee. All reductions in commitments pursuant to this
      paragraph shall be pro rata among the Lenders.

   

  
     

    20

    
      
 

  

   

  6.13        Further Assurances. At any time, and from time
      to time, the Loan Parties shall execute and deliver such further instruments and take such further action as may reasonably be requested by Agent and Lenders to effect the purposes of this Agreement.

   

  6.14        Post-Closing Obligations. The Loan Parties
      shall complete each of the post- closing obligations and/or deliver to Agent each of the documents, instruments, agreements and information listed on the Post-Closing Obligations Schedule attached hereto as Exhibit F, on or before the date
      set forth for each such item thereon (as may be extended by the Agent in writing in its sole discretion), each of which shall be completed or provided in form and substance reasonably satisfactory to Agent and Lenders.

   

  		7.	NEGATIVE COVENANTS.

   

  Each Loan Party covenants and agrees that, so long as any credit
      hereunder shall be available and until the outstanding Obligations (other than inchoate indemnification or reimbursement obligations or other obligations which, by their terms, survive termination of this Agreement) are paid in full or for so long as
      any Lender may have any commitment to make any Credit Extensions, each Loan Party will not do any of the following without Required Lenders’ prior written consent:

   

  7.1          Dispositions. Convey, sell, lease, license,
      transfer or otherwise dispose of (collectively, to “Transfer”), or permit any of its Subsidiaries to Transfer, all or any part of its business or property, or subject to Section 6.5 of the Agreement, move cash balances on deposit with
      Agent to accounts opened at another financial institution, other than Permitted Transfers.

   

  7.2          Change in Name, Location, Executive Office, or
      Executive Management; Change in Business; Change in Fiscal Year; Change in Control. Change its name or the Borrower State or relocate its chief executive office without ten (10) days prior written notification to Agent; replace its chief executive
      officer or chief financial officer without providing written notification to Agent as soon as possible and in any event within ten (10) Business Days; engage in any business, or permit any of its Subsidiaries to engage in any business, other than
      reasonably related, ancillary, complementary or incidental businesses to the businesses currently engaged in by Borrower or a natural extension thereof; change its fiscal year end; have a Change in Control.

   

  7.3          Mergers or Acquisitions. Merge or consolidate,
      or permit any of its Subsidiaries to merge or consolidate, with or into any other business organization (other than mergers or consolidations of a Subsidiary into Borrower, or a Subsidiary into another Subsidiary), or acquire, or permit any of its
      Subsidiaries to acquire, all or substantially all of the capital stock or property of another Person, except (i) where such transactions constitute a Permitted Investment, (ii) no Event of Default has occurred, is continuing or would immediately
      exist after giving effect to such transactions, (iii) such transactions do not result in a Change in Control, and (iv) in any transaction involving Borrower, Borrower is the surviving entity.

   

  
     

    21

    
      
 

  

   

  7.4          Indebtedness. Create, incur, assume,
      guarantee or be or remain liable with respect to any Indebtedness, or permit any Subsidiary so to do, other than Permitted Indebtedness, or prepay any Indebtedness or take any actions which impose on a Loan Party an obligation to prepay any
      Indebtedness, except Indebtedness to Lenders.

   

  7.5          Encumbrances. Create, incur, assume or
      allow any Lien with respect to any of its property (including any equity interests owned by it), or assign or otherwise convey any right to receive income, including the sale of any Accounts, or permit any of its Subsidiaries so to do, in each case,
      except for Permitted Liens, or covenant to any other Person that in the future it will refrain from creating, incurring, assuming or allowing any Lien with respect to any property.

   

  7.6          Distributions. Pay any dividends or make any
      other distribution or payment on account of or in redemption, retirement or purchase of any capital stock, except that Borrower may (i) repurchase the stock of existing or former employees, officers and directors (their spouses, trusts, heirs and
      estates) pursuant to stock repurchase agreements in an amount not to exceed [**] Dollars ($[**]) in the aggregate per fiscal year as long as an Event of Default does not exist prior to such repurchase or would not immediately exist after giving
      effect to such repurchase, (ii) declare and make dividend payments or other distributions payable in stock or other equity interests, (iii) pay dividends or distributions in an aggregate amount equal to [**]% of the net cash proceeds of any sale of
      new common equity by the Borrower; and (iv) pay other dividends or distributions in an aggregate amount not to exceed $[**] per calendar year, provided that (A) no Event of Default shall exist before or after giving effect thereto, and (B) Borrower
      shall be in pro forma compliance with the financial covenants set forth in Section 6.7 hereof prior to and after giving effect to such dividends or distributions.

   

  7.7          Investments. Directly or indirectly acquire
      or own, or make any Investment in or to any Person, or permit any of its Subsidiaries to do so, other than Permitted Investments and then so long as the Borrower is in compliance with Section 6.5 and 6.7 hereof prior to and upon
      giving effect to such investment, or maintain or invest any of its investment property with a Person other than a Lender or a Lender’s Affiliates or permit any Subsidiary to do so unless such Person has entered into a control agreement with Agent on
      behalf of Lenders or Lenders otherwise have a perfected security interest in such property, in form and substance reasonably satisfactory to Agent, or suffer or permit any Subsidiary to be a party to, or be bound by, an agreement that restricts such
      Subsidiary from paying dividends or otherwise distributing property to a Loan Party (other than restrictions existing under the Loan Documents). Further, Borrower shall not enter into any license or agreement with any Prohibited Territory or with any
      Person organized under or doing business in a Prohibited Territory.

   

  7.8          Transactions with Affiliates. Directly or
      indirectly enter into or permit to exist any transaction with any Affiliate except for transactions that are in the ordinary course of business, upon fair and reasonable terms that are no less favorable to such Loan Party than would be obtained in an
      arm’s length transaction with a non-affiliated Person.

   

  7.9          Subordinated Debt. Make any payment in respect
      of any Subordinated Debt, or permit any of its Subsidiaries to make any such payment, except in compliance with the terms of such Subordinated Debt and the terms of the subordination agreement relating to such Subordinated Debt, or amend, terminate
      or release any provision of any document evidencing such Subordinated Debt, except with Required Lenders’ prior written consent and except in compliance with the terms of the subordination agreement relating to such Subordinated Debt, or amend any
      provision affecting Agent and Lenders’ rights contained in any documentation, or in any way that is more restrictive on any Loan Party, relating to the Subordinated Debt, and each of the foregoing, except as noted above, without Agent’s prior written
      consent.

   

  
     

    22

    
      
 

  

   

  7.10        No Investment Company; Margin Regulation.
      Become or be controlled by an “investment company,” within the meaning of the Investment Company Act of 1940, or become principally engaged in, or undertake as one of its important activities, the business of extending credit for the purpose of
      purchasing or carrying margin stock, or use the proceeds of any Credit Extension for such purpose.

   

  		8.	EVENTS OF DEFAULT.

   

  Any one or more of the following events shall constitute an Event of Default by
      Borrower under this Agreement:

   

  		8.1	Payment Default. If Borrower fails to pay any of the Obligations when due.

   

  		8.2	Covenant Default.

   

  (a)           If Borrower or Guarantor fails to perform any
      obligation under Sections 6.2, 6.3, 6.4, 6.5, or 6.7 or violates any of the covenants contained in Article 7 of this Agreement; or

   

  (b)           If any Loan Party fails or neglects to perform or observe any other term, provision, condition, covenant contained in this Agreement, in any of the Loan Documents, and as to any default under such other
      term, provision, condition or covenant that can be cured, has failed to cure such default within [**] after the earlier of the date Borrower receives notice thereof or any officer of any Loan Party becomes aware thereof; provided, however, that if
      the default cannot by its nature be cured within the [**] period or cannot after diligent attempts by Borrower be cured within such [**] period, and such default is likely to be cured within a reasonable time, then Borrower shall have an additional
      reasonable period (which shall not in any case exceed [**]) to attempt to cure such default, so long as Borrower continues to diligently attempt to cure such default, and within such reasonable time period the failure to have cured such default shall
      not be deemed an Event of Default but the Lenders shall not be required to make any Credit Extensions (and shall be permitted in their sole discretion to decline to make any Credit Extension) unless and until such default is cured.

   

  8.3          Material Adverse Change. If there occurs any
      circumstance or circumstances that results in a Material Adverse Effect as determined by Agent or Required Lender in their reasonable credit judgment.

   

  8.4          Defective Perfection. If Agent shall receive
      at any time following the Closing Date an SOS Report indicating that Agent’s security interest in the Collateral is not prior to all other security interests or Liens of record reflected in the report other than as a result of Agent’s failure to file
      or maintain its Lien or Liens securing Permitted Indebtedness that is allowed to be prior to Agent’s security interest.

   

  
     

    23

    
      
 

  

   

  8.5          Attachment. If any material portion of any
      Loan Party’s assets is attached, seized, subjected to a writ or distress warrant, or is levied upon, or comes into the possession of any trustee, receiver or person acting in a similar capacity and such attachment, seizure, writ or distress warrant
      or levy has not been removed, discharged or rescinded within thirty (30) days, or if any Loan Party is enjoined, restrained, or in any way prevented by court order from continuing to conduct all or any material part of its business affairs, or if a
      judgment or other claim becomes a lien or encumbrance upon any material portion of any Loan Party’s assets, or if a notice of lien, levy, or assessment is filed of record with respect to any of any Loan Party’s assets by the United States Government,
      or any department, agency, or instrumentality thereof, or by any state, county, municipal, or governmental agency, and the same is not paid within thirty (30) days after such Loan Party receives notice thereof, provided that none of the foregoing
      shall constitute an Event of Default where such action or event is stayed or an adequate bond has been posted pending a good faith contest by such Loan Party (provided that no Credit Extensions will be made during such cure period).

   

  8.6          Insolvency. If the Loan Parties, taken as a
      whole on a consolidated basis, become insolvent, or if an Insolvency Proceeding is commenced by any Loan Party, or if an Insolvency Proceeding is commenced against any Loan Party and is not dismissed or stayed within forty-five (45) days (provided
      that no Credit Extensions will be made prior to the dismissal of such Insolvency Proceeding).

   

  8.7          Other Agreements. (a) If there is a payment or
      bankruptcy default by any Loan Party in any agreement to which any Loan Party, as applicable, is a party with a third party or parties which either (i) is a material contract, or (ii) related to Indebtedness in an amount in excess of [**] Dollars
      ($[**]), or (b) there exists a right by a third party or parties, whether or not exercised, to accelerate the maturity of any Indebtedness of a Loan Party in an amount in excess of [**] Dollars ($[**]).

   

  8.8          Subordinated Debt. If any Loan Party makes any
      payment on account of Subordinated Debt, except to the extent the payment is allowed under any subordination agreement entered into with Agent or otherwise permitted by this Agreement.

   

  8.9          Judgments. If one or more final judgments,
      orders, or decrees for the payment of money in an amount, individually or in the aggregate, of at least [**] Dollars ($[**]) (not covered by independent third-party insurance as to which liability has been accepted in writing by such insurance
      carrier) shall be rendered against any Loan Party or any Subsidiary and the same are not, within thirty (30) days after the entry thereof, discharged or execution thereof stayed or bonded pending appeal, or such judgments are not discharged prior to
      the expiration of any such stay (provided that the Lenders shall not be required to make any Credit Extensions (and shall be permitted in their sole discretion to decline to make any Credit Extension) prior to the discharge, stay, or bonding of such
      judgment, order, or decree).

   

  8.10        Misrepresentations. If any material
      misrepresentation or material misstatement exists now or hereafter in any warranty or representation set forth herein or in any certificate delivered to Agent by any Responsible Officer pursuant to this Agreement or to induce Lenders to enter into
      this Agreement or any other Loan Document.

   

  
     

    24

    
      
 

  

   

  8.11        Guaranty. If any guaranty of all or a
      portion of the Obligations including, without limitation, the guaranty provided in Section 4.5 hereof (each, a “Guaranty”) ceases for any reason to be in full force and effect, or any guarantor fails to perform any obligation under
      any Guaranty or a security agreement securing any Guaranty (collectively, the “Guaranty Documents”) and as to any default under such other term, provision, condition or covenant that can be cured, has failed to cure such default within any
      applicable cure periods, or any event of default occurs under any Guaranty Document or any guarantor revokes or purports to revoke a Guaranty, or any material misrepresentation or material misstatement exists now or hereafter in any warranty or
      representation set forth in any Guaranty Document or in any certificate delivered to Agent in connection with any Guaranty Document, or if any of the circumstances described in Sections 8.3 through 8.9 occur with respect to any
      guarantor.

   

  8.12        Invalidity of Loan Documents. If any Loan
      Document, including for the avoidance of doubt, and subordination agreement with respect to any Subordinated Debt, ceases for any reason to be in full force and effect, or any party thereto contests in any manner the validity or enforceability of any
      Loan Document or any Lien granted pursuant thereto, denies that it has any or further liability or obligation thereunder, or purports to revoke, terminate or rescind any Loan Document.

   

  8.13        Emergency Use Authorization. Borrower shall
      fail to have in place its emergency use authorization from the U.S. Food & Drug Administrative as in effect on the Closing Date.

   

  		8.14	Change in Control. A Change in Control shall occur.

   

  		9.	LENDERS’ RIGHTS AND REMEDIES.

   

  9.1          Rights and Remedies. Upon the occurrence
      and during the continuance of an Event of Default, the Agent may, and at the direction Required Lenders, shall, at their election, without notice of their election and without demand, do any one or more of the following, all of which are authorized
      by the Loan Parties:

   

  (a)           Declare all Obligations, whether evidenced by
      this Agreement, by any of the other Loan Documents, or otherwise, immediately due and payable (provided that upon the occurrence of an Event of Default described in Section 8.6 (Insolvency), all Obligations shall become immediately due and
      payable without any action by Agent or Lenders);

   

  (b)           Cease advancing money or extending credit to or for
      the benefit of Borrower under this Agreement or under any other agreement between Borrower and Lenders;

   

  (c)           Settle or adjust disputes and claims directly with
      account debtors for amounts, upon terms and in whatever order that Agent reasonably considers advisable;

   

  
     

    25

    
      
 

  

   

  (d)           Make such payments and do such acts as Agent or
      Required Lenders consider necessary or reasonable to protect the Agent’s security interest (for the benefit of the Lenders) in the Collateral. The Loan Parties agree to assemble the Collateral if Agent so requires, and to make the Collateral
      available to Agent as Agent may designate in a location reasonably convenient to Agent. The Loan Parties authorize Agent to peaceably enter the premises where the Collateral is located, to take and maintain possession of the Collateral, or any part
      of it, and to pay, purchase, contest, or compromise any encumbrance, charge, or lien which in Agent’s determination appears to be prior or superior to its security interest and to pay all expenses incurred in connection therewith. With respect to any
      of the Loan Parties’ owned premises, such Loan Party hereby grants Agent a license to enter into possession of such premises and to occupy the same, without charge, in order to exercise any of Agent’s rights or remedies provided herein, at law, in
      equity, or otherwise;

   

  (e)           Set-off and apply to the Obligations any and all
      (i) balances and deposits of any Loan Party held by Agent or any Lender, and (ii) Indebtedness at any time owing to or for the credit or the account of any Loan Party held by Agent or any Lender;

   

  (f)            Ship, reclaim, recover, store, finish,
      maintain, repair, prepare for sale, advertise for sale, and sell (in the manner provided for herein) the Collateral. Agent, on behalf of Lenders, is hereby granted a license or other right, solely pursuant to the provisions of this Section 9.1,
      to use solely following the occurrence and during the continuance of an Event of Default, without charge, any Loan Party’s labels, patents, copyrights, rights of use of any name, trade secrets, trade names, trademarks, service marks, and advertising
      matter, or any property of a similar nature, as it pertains to the Collateral, in completing production of, advertising for sale, and selling any Collateral and, in connection with Agent’s exercise of its rights under this Section 9.1, any
      Loan Party’s rights under all licenses and all franchise agreements shall inure to Agent’s benefit;

   

  (g)           Except as otherwise provided in the Code, upon
      at least ten (10) days prior written notice, sell the Collateral at either a public or private sale, or both, by way of one or more contracts or transactions, for cash or on terms, in such manner and at such places (including any Loan Party’s
      premises) as are commercially reasonable, and apply any proceeds to the Obligations in whatever manner or order Agent deems appropriate. Agent may sell the Collateral without giving any warranties as to the Collateral. Agent may specifically disclaim
      any warranties of title or the like. This procedure will not be considered adversely to affect the commercial reasonableness of any sale of the Collateral. If Agent sells any of the Collateral upon credit, Borrower will be credited only with payments
      actually made by the purchaser, received by Agent, and applied to the indebtedness of the purchaser. If the purchaser fails to pay for the Collateral, Agent may resell the Collateral and Borrower shall be credited with the proceeds of such sale;

   

  (h)           Agent and/or any Lender may credit bid and
      purchase at any public sale;

   

  (i)            Apply for the appointment of a receiver,
      trustee, liquidator or conservator of the Collateral, without notice and without regard to the adequacy of the security for the Obligations and without regard to the solvency of any Loan Party or any other Person liable for any of the Obligations;
      and

   

  
     

    26

    
      
 

  

   

  (j)            Any deficiency that exists after disposition of
      the Collateral as provided above will be paid immediately by Borrower.

   

  Agent and Lenders may comply with any applicable state or
      federal law requirements in connection with a disposition of the Collateral and compliance will not be considered adversely to affect the commercial reasonableness of any sale of the Collateral.

   

  9.2          Power of Attorney. Each Loan Party hereby
      irrevocably appoints Agent (and any of Agent’s designated officers, or employees) as its true and lawful attorney to: (a) in consultation with Borrower, send requests for verification of Accounts or notify account debtors of Agent’s security interest
      in the Accounts; (b) endorse such Loan Party’s, as applicable, name on any checks or other forms of payment or security that may come into Agent’s possession;

  (a)   sign such Loan Party’s name, as applicable, on any invoice
      or bill of lading relating to any Account, drafts against account debtors, schedules and assignments of Accounts, verifications of Accounts, and notices to account debtors; (d) dispose of any Collateral; (e) make, settle, and adjust all claims under
      and decisions with respect to any Loan Party’s policies of insurance; (f) settle and adjust disputes and claims respecting the accounts directly with account debtors, for amounts and upon terms which Agent determines to be reasonable; and (g) file,
      in its sole discretion, one or more financing or continuation statements and amendments thereto, relative to any of the Collateral without the signature of any Loan Party; provided Agent may exercise such power of attorney to sign the name of any
      Loan Party, as applicable, on any of the documents described in clause (g) above, regardless of whether an Event of Default has occurred. The appointment of Agent as each Loan Party’s attorney in fact, and each and every one of Agent’s rights and
      powers, being coupled with an interest, is irrevocable until all of the Obligations (other than inchoate indemnification or reimbursement obligations or other obligations which, by their terms, survive termination of this Agreement) have been fully
      repaid and performed and Agent’s and each Lender’s obligation to provide Advances hereunder is terminated.

   

  9.3          Accounts Collection. In consultation with
      Borrower, Agent may notify any Person owing funds to any Loan Party of Agent’s security interest in such funds and verify the amount of such Account and direct that any payments with respect thereto be deposited directly into the Collection Account,
      if and to the extent not already so deposited pursuant to the instructions provided by the Borrower in accordance with Section 4.4. Borrower shall collect all amounts owing to Borrower for Agent, receive in trust all payments as Agent’s
      trustee, and immediately deliver such payments to Agent in their original form as received from the account debtor, with proper endorsements for deposit.

   

  9.4          Lender Expenses. If any Loan Party fails to
      pay any amounts or furnish any required proof of payment due to third persons or entities, as required under the terms of this Agreement, then Agent may do any or all of the following: (a) make payment of the same or any part thereof; (b) set up such
      reserves under the Revolving Line as Agent deems necessary to protect Lenders from the exposure created by such failure; or (c) obtain and maintain insurance policies of the type discussed in Section 6.4 of this Agreement, and take any action
      with respect to such policies as Agent reasonably deems prudent. Any amounts so paid or deposited by Agent shall constitute Lender Expenses, shall be immediately due and payable, and shall bear interest at the then applicable rate hereinabove
      provided, and shall be secured by the Collateral. Any payments made by Agent shall not constitute an agreement by Agent to make similar payments in the future or a waiver of any Event of Default under this Agreement.

   

  
     

    27

    
      
 

  

   

  9.5          Liability for Collateral. Neither Agent nor
      any Lender has any obligation to clean up or otherwise prepare the Collateral for sale. All risk of loss, damage or destruction of the Collateral shall be borne by the Loan Parties, absent gross negligence or willful misconduct as determined by a
      court of competent jurisdiction by final and nonappealable judgment on the part of the Agent.

   

  9.6          No Obligation to Pursue Others. Neither
      Agent nor any Lender has any obligation to attempt to satisfy the Obligations by collecting them from any other person liable for them and Agent may release, modify or waive any Collateral provided by any other Person to secure any of the
      Obligations, all without affecting Agent’s or Lenders’ rights against any Loan Party. Each Loan Party waives any right it may have to require Agent or any Lender to pursue any other Person for any of the Obligations.

   

  9.7          Remedies Cumulative. Agent’s and Lenders’
      rights and remedies under this Agreement, the Loan Documents, and all other agreements shall be cumulative. Agent and Lenders shall have all other rights and remedies not inconsistent herewith as provided under the Code, by law, or in equity. No
      exercise by Agent of one right or remedy shall be deemed an election, and no waiver by Agent of any Event of Default shall be deemed a continuing waiver. No delay by Agent shall constitute a waiver, election, or acquiescence by it. No waiver by Agent
      shall be effective unless made in a written document signed on behalf of Agent and then shall be effective only in the specific instance and for the specific purpose for which it was given. Each Loan Party expressly agrees that this Section 9.7
      may not be waived or modified by Agent by course of performance, conduct, estoppel or otherwise.

   

  9.8          Demand; Protest. Except as otherwise
      provided in this Agreement, each Loan Party waives demand, protest, notice of protest, notice of default or dishonor, notice of payment and nonpayment and any other notices relating to the Obligations.

   

  		10.	NOTICES.

   

  Unless otherwise provided in this Agreement, all notices or
      demands by any party relating to this Agreement or any other agreement entered into in connection herewith shall be in writing and (except for financial statements and other informational documents which may be sent by first- class mail, postage
      prepaid) shall be personally delivered or sent by a recognized overnight delivery service, certified mail, postage prepaid, return receipt requested, or by electronic mail to any Loan Party or to Agent, as the case may be, at its addresses set forth
      below:

   

  		If to any Loan Party:   	Cue Health Inc.

  4980 Carroll Canyon Rd., Suite 100

  San Diego, CA 92121

  Attn: Ayub Khattak, Chief Executive Officer

  Email: [**]

   

  
     

    28

    
      
 

  

   

  

  		If to Agent:	  East West Bank

    9378 Wilshire Blvd., Suite 100

    Beverly Hills, CA 90212

    Attn: Maytal Shainberg

    Email: [**]

   

  The parties hereto may change the address at which they are
      to receive notices hereunder, by notice in writing in the foregoing manner given to the other.

   

  11.              CHOICE OF LAW AND VENUE; JURY TRIAL WAIVER;
        JUDICIAL REFERENCE.

   

  California law governs the Loan Documents without regard to
      principles of conflicts of law. The Loan Parties, Agent and Lenders each submit to the exclusive jurisdiction of the State and Federal courts in Los Angeles County, California; provided, however, that nothing in this Agreement shall be deemed to
      operate to preclude Agent or Lenders from bringing suit or taking other legal action in any other jurisdiction to realize on the Collateral or any other security for the Obligations, or to enforce a judgment or other court order in favor of Agent
      and/or Lenders. Each Loan Party expressly submits and consents in advance to such jurisdiction in any action or suit commenced in any such court, and each Loan Party hereby waives any objection that it may have based upon lack of personal
      jurisdiction, improper venue, or forum non conveniens and hereby consents to the granting of such legal or equitable relief as is deemed appropriate by such court. Each Loan Party hereby waives personal service of the summons, complaints, and other
      process issued in such action or suit and agrees that service of such summons, complaints, and other process may be made by registered or certified mail addressed to Borrower at the address set forth in, or subsequently provided by Borrower in
      accordance with, Section 10 of this Agreement and that service so made shall be deemed completed upon the earlier to occur of Borrower’s actual receipt thereof or three (3) days after deposit in the U.S. mails, proper postage prepaid.

   

  IF AND ONLY TO THE EXTENT PERMITTED BY APPLICABLE LAW,
      THE LOAN PARTIES, AGENT AND LENDERS EACH WAIVE THEIR RIGHT TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION ARISING OUT OF OR BASED UPON THIS AGREEMENT, THE LOAN DOCUMENTS OR ANY CONTEMPLATED TRANSACTION, INCLUDING CONTRACT, TORT, BREACH OF DUTY AND
      ALL OTHER CLAIMS. THIS WAIVER IS A MATERIAL INDUCEMENT FOR BOTH PARTIES TO ENTER INTO THIS AGREEMENT. EACH PARTY HAS REVIEWED THIS WAIVER WITH ITS COUNSEL.

   

  
     

    29

    
      
 

  

   

  WITHOUT INTENDING IN ANY WAY TO LIMIT THE PARTIES’ AGREEMENT
      TO WAIVE THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY IF PERMITTED BY APPLICABLE LAW, if the above waiver of the right to a trial by jury is not enforceable, the parties hereto agree that any and all disputes or controversies of any nature between them
      arising at any time shall be decided by a reference to a private judge, who is a former or retired judge of any California Federal or State Court, mutually selected by the parties (or, if they cannot agree, by the Presiding Judge of the Santa Clara
      County, California Superior Court) appointed in accordance with California Code of Civil Procedure Section 638 (or pursuant to comparable provisions of federal law if the dispute falls within the exclusive jurisdiction of the federal courts), sitting
      without a jury, in Santa Clara County, California; and the parties hereby submit to the jurisdiction of such court. The reference proceedings shall be conducted pursuant to and in accordance with the provisions of California Code of Civil Procedure
      §§ 638 through 645.1, inclusive. The private judge shall have the power, among others, to grant provisional relief, including without limitation, entering temporary restraining orders, issuing preliminary and permanent injunctions and appointing
      receivers. All such proceedings shall be closed to the public and confidential and all records relating thereto shall be permanently sealed. If during the course of any dispute, a party desires to seek provisional relief, but a judge has not been
      appointed at that point pursuant to the judicial reference procedures, then such party may apply to the Santa Clara County, California Superior Court for such relief. The proceeding before the private judge shall be conducted in the same manner as it
      would be before a court under the rules of evidence applicable to judicial proceedings. The parties shall be entitled to discovery which shall be conducted in the same manner as it would be before a court under the rules of discovery applicable to
      judicial proceedings. The private judge shall oversee discovery and may enforce all discovery rules and orders applicable to judicial proceedings in the same manner as a trial court judge. The parties agree that the selected or appointed private
      judge shall have the power to decide all issues in the action or proceeding, whether of fact or of law, and shall report a statement of decision thereon pursuant to California Code of Civil Procedure § 644(a). Either party shall have the right to
      object to the decision of the private judge and to appeal as provided for in the California Code of Civil Procedure. Nothing in this paragraph shall limit the right of any party at any time to exercise self- help remedies, foreclose against
      collateral, or obtain provisional remedies. The private judge shall also determine all issues relating to the applicability, interpretation, and enforceability of this paragraph.

   

  		12.	GENERAL PROVISIONS.

   

  		12.1	Successors and Assigns.

   

  (a)           This Agreement shall bind and inure to the
      benefit of the respective successors and permitted assigns of each of the parties and shall bind all persons who become bound as a debtor to this Agreement; provided, however, that neither this Agreement nor any rights hereunder may be assigned by
      Borrower without the prior written consent of the Agent and each Lender, which each such consent may be granted or withheld in the Agent’s or such Lender’s sole discretion, as applicable. Subject to the restrictions set forth in clause (b) below,
      each Lender shall have the right to sell, transfer, assign negotiate, or grant participation in all or any part of, or any interest in, such Lender’s obligations, rights and benefits hereunder.

   

  (b)           No Lender may assign any or all of its interests
      hereunder to (i) the Borrower or any of the Borrower’s Affiliates or Subsidiaries, (ii) any Defaulting Lender, (iii) a natural person or an investment vehicle or trust
      for the benefit of a natural person. All assignments by a Lender shall be subject to the following consents:

  

  

  (i)                  unless an Event of Default has occurred,
      the consent of the Borrower (such consent not to be unreasonably withheld or delayed) shall be required for assignments to a Person that is not a Lender, an Affiliate of a Lender or an Approved Fund provided that the Borrower shall be deemed to have
      consented to any such assignment unless it shall object thereto by written notice to the Agent within five (5) Business Days after having received notice thereof and provided, further, that the Borrower’s consent shall not be required during the
      primary syndication of the Revolving Loan;

   

  
     

    30

    
      
 

  

   

  (ii)                the consent of the Agent (such consent not to
      be unreasonably withheld or delayed) shall be required for assignments to a Person that is not a Lender, an Affiliate of a Lender or an Approved Fund; and

   

  (iii)               the consent of each L/C Issuer (such consent
      not to be unreasonably withheld or delayed).

   

  (c)                Any Lender may at any time pledge or assign a
      security interest in all or any portion of its rights under this Agreement to secure obligations of such Lender, including any pledge or assignment to secure obligations to a Federal Reserve Bank; provided, no such pledge or assignment shall
      release such Lender from any of its obligations hereunder or substitute any such pledgee or assignee for such Lender as a party hereto.

   

  12.2         Indemnification. Borrower shall defend,
      indemnify and hold harmless Lenders and their respective officers, employees, and agents against: (a) all obligations, demands, claims, and liabilities claimed or asserted by any other party in connection with the transactions contemplated by this
      Agreement and/or the Loan Documents; and (b) all losses or Lender Expenses in any way suffered, incurred, or paid by any Lender, its officers, employees and agents as a result of or in any way arising out of, following, or consequential to
      transactions between Lenders and Borrower whether under this Agreement, or otherwise (including without limitation reasonable attorneys’ fees and expenses), except, in each case, for obligations, demands, claims, liabilities, losses and expenses
      caused by Agent and or Lenders’ gross negligence or willful misconduct as determined by a court of competent jurisdiction by final and nonappealable judgment.

   

  12.3         Time of Essence. Time is of the essence for
      the performance of all obligations set forth in this Agreement.

   

  12.4         Severability of Provisions. Each provision of
      this Agreement shall be severable from every other provision of this Agreement for the purpose of determining the legal enforceability of any specific provision.

   

  12.5         Correction of Loan Documents. Agent may
      correct patent errors and fill in any blanks in this Agreement and the other Loan Documents consistent with the agreement of the parties so long as Agent provides Borrower with written notice of such correction and allows Borrower at least ten (10)
      days to object to such correction.

   

  12.6         Amendments in Writing, Integration. All
      amendments, modifications, waivers and consents to or terminations of this Agreement or the other Loan Documents, must be in writing signed by the Loan Parties and the Required Lenders, and such additional Lenders as set forth below. All prior
      agreements, understandings, representations, warranties, and negotiations between the parties hereto with respect to the subject matter of this Agreement and the other Loan Documents, if any, are merged into this Agreement and the Loan Documents.

   

  
     

    31

    
      
 

  

   

  (a)           Lender Consent. Notwithstanding the
      foregoing, no amendment, modification, waiver or consent shall:

   

  (i)                 extend or increase any commitment of any
      Lender without the written consent of such Lender (it being understood that a waiver of any condition precedent set forth in Section 3 or the waiver of any Default shall not constitute an extension or increase of any commitment of any
      Lender);

   

  (ii)                reduce or forgive the principal of, or rate
      of interest specified herein on, any Advance or any fees or other amounts payable hereunder or under any other Loan Document, without the written consent of each Lender directly and adversely affected thereby (provided that only the consent of the
      Required Lenders shall be necessary (x) to amend the default rate set forth in Section 2.3(b) or to waive the obligation of the Borrower to pay interest at such default rate or (y) to amend any financial covenant (or any defined term directly
      or indirectly used therein), even if the effect of such amendment would be to reduce the rate of interest on any Advance or other Obligation or to reduce any fee payable hereunder);

   

  (iii)               postpone any date scheduled for any
      payment of principal of, or interest on, any Advance, or any fees or other amounts payable hereunder or under any other Loan Document, or reduce the amount of, waive or excuse any such payment, without the written consent of each Lender directly and
      adversely affected thereby;

   

  (iv)              change any provision of this Section or the
      percentage in the definition of “Required Lenders” or any other provision hereof specifying the number or percentage of Lenders required to amend, waive or otherwise modify any rights hereunder or make any determination or grant any consent
      hereunder, without the written consent of each Lender;

   

  (v)                affect the rights or duties hereunder or
      under any other Loan Document of the Agent, unless in writing executed by the Agent, in each case in addition to the Borrower and the Lenders required above; or

   

  (vi)              change or amend Section 12.11, Section

        12.12 or any other provision of this Agreement providing for pro rata treatment of Lenders, in each case, without the written consent of each Lender;

   

  (vii)              release any Guarantor from its obligation
      under its guaranty (except as otherwise permitted herein or in the other Loan Documents), without the written consent of each Lender;

   

  (viii)            release all or substantially all of the
      Collateral (except as otherwise expressly permitted herein or in the other Loan Documents) without the written consent of each Lender;

   

  
     

    32

    
      
 

  

   

  (ix)              subordinate the Obligations or the Liens
      granted under the Loan Documents, to any other Indebtedness or Liens, without the written consent of each Lender;

   

  (x)                amend, modify, terminate or waive any
      obligation of the Lenders relating to the purchase of participations in Letters of Credit as provided in Section 2.1 without the written consent of the Agent and each L/C Issuer;

   

  (xi)              change any component of the definition of
      Eligible Accounts to increase eligibility thereunder without the consent of Required Lenders, and each Lender as of the Closing Date (which, for the avoidance of doubt, is East West Bank, Comerica Bank, and Silicon Valley Bank); or

   

  (xii)             change or amend Section 6.7(b) without
      the written consent of Required Lenders, and each Lender as of the Closing Date (which, for the avoidance of doubt, is East West Bank, Comerica Bank, and Silicon Valley Bank).

   

  (b)           In addition, notwithstanding anything in this
      Section to the contrary, if the Agent and the Borrower shall have jointly identified an obvious error or any error or omission of a technical nature, in each case, in any provision of the Loan Documents, then the Agent and the Borrower shall be
      permitted to amend such provision, and, in each case, such amendment shall become effective without any further action or consent of any other party to any Loan Document if the same is not objected to in writing by the Required Lenders to the Agent
      within five (5) Business Days following receipt of notice thereof.

   

  (c)           Replacement of Lenders. If any Lender is
      a Non-Consenting Lender, then the Agent may upon notice to such Lender, require such Lender to assign and delegate, without recourse, all of its interests, rights (other than its existing rights to payments) and obligations under this Agreement and
      the related Loan Documents to an assignee permitted hereunder that shall assume such obligations (which assignee may be another Lender, if a Lender accepts such assignment); provided that:

   

  (i)                  such Non-Consenting Lender shall have
      received, as applicable, payment of an amount equal to the outstanding principal of its Loans, accrued interest thereon, accrued fees and all other amounts payable to it hereunder and under the other Loan Documents from the assignee or the Borrower,
      as applicable; and

   

  (ii)                the applicable assignee shall have consented
      to the applicable amendment, waiver or consent.

   

  A Lender shall not be required to make any such assignment or delegation if, prior
      thereto, as a result of a waiver by such Lender or otherwise, the circumstances entitling the Agent to require such assignment and delegation cease to apply.

   

  
     

    33

    
      
 

  

   

  		12.7	Counterparts; Integration; Effectiveness; Electronic Execution.

   

  (a)           This Agreement may be executed in counterparts
      (and by different parties hereto on different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. This Agreement, the other Loan Documents and any separate letter
      agreements with respect to fees payable to the Agent \constitute the entire contract among the parties relating to the subject matter hereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject
      matter hereof. Except as provided in Section 3.1, this Agreement shall become effective when it shall have been executed by the Agent and when the Agent shall have received counterparts hereof which, when taken together, bear the signatures
      of each of the other parties hereto, and thereafter shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns.

   

  (b)          Delivery of an executed counterpart of a
      signature page of this Agreement by telecopy, emailed pdf. or any other electronic means that reproduces an image of the actual executed signature page shall be effective as delivery of a manually executed counterpart of this Agreement. The words
      “execution,” “signed,” “signature,” “delivery,” and words of like import in or relating to any document to be signed in connection with this Agreement and the transactions contemplated hereby or thereby shall be deemed to include electronic
      signatures, deliveries or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping
      system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act or any other similar state laws based on the Uniform Electronic Transactions Act;
      provided that nothing herein shall require the Agent to accept electronic signatures in any form or format without its prior written consent.

   

  12.8        Survival. All covenants, representations and
      warranties made in this Agreement shall continue in full force and effect so long as any Obligations (other than inchoate indemnification and reimbursement obligations and other obligations which, by their terms, survive termination of this
      Agreement) remain outstanding or Lenders have any obligation to make any Credit Extension to Borrower. The obligations of Borrower to indemnify Lenders with respect to the expenses, damages, losses, costs and liabilities described in Section 12.2
      shall survive until all applicable statute of limitations periods with respect to actions that may be brought against Lenders have run.

   

  12.9         Confidentiality. In handling any confidential
      information, Agent and Lenders and all employees and agents of Agent and Lenders shall exercise the same degree of care that each Lender exercises with respect to its own proprietary information of the same types to maintain the confidentiality of
      any non-public information thereby received or received pursuant to this Agreement except that disclosure of such information may be made (i) to the subsidiaries or Affiliates of Lenders in connection with their present or prospective business
      relations with Borrower, (ii) to prospective transferees or purchasers of any interest in the Loans provided they have entered into a confidentiality agreement with terms no less restrictive than those set forth herein in favor of Borrower and have
      delivered a copy to Borrower, (iii) as required by law, regulations, rule or order, subpoena, judicial order or similar order, (iv) as may be required in connection with the examination, audit or similar investigation of Lender, (v) to Lenders’
      accountants, auditors and regulators, and (vi) as Lender may reasonably determine necessary in connection with the enforcement of any remedies hereunder. Confidential information hereunder shall not include information that either: (a) is in the
      public domain or in the knowledge or possession of Lender when disclosed to Lender, or becomes part of the public domain after disclosure to Lender through no fault of Lender; or (b) is disclosed to Lender by a third party, provided Lender does not
      have actual knowledge that such third party is prohibited from disclosing such information.

   

  
     

    34

    
      
 

  

   

  12.10      SPAC Business Combination. The parties
      hereto agree to negotiate in good faith to amend this agreement as needed permit a SPAC Business Combination on terms acceptable to all such parties provided that all information related thereto requested by Agent or any Lender has been provided by
      Borrower and provided that any such amendment, including, without limitation, any amendments to the negative covenants set forth in Article 8 of this Agreement, shall be subject to the Agent’s and Lender’s reasonably business judgement.

   

  12.11      Application of Payments and Proceeds. Upon the
      occurrence and during the continuance of an Event of Default and after the acceleration of the principal amount of any of the Revolving Loans, all payments and proceeds in respect of any of the Obligations received by the Agent or any Lender under
      any Loan Document, including any proceeds of any sale of, or other realization upon, all or any part of the Collateral, shall be applied as follows:

   

  first, to all fees, costs, indemnities, liabilities, obligations and
      expenses incurred by or owing to the Agent and/or each L/C Issuer with respect to this Agreement, the other Loan Documents or the Collateral;

   

  second, to all fees, costs, indemnities, liabilities, obligations and
      expenses incurred by or owing to any other Lender with respect to this Agreement, the other Loan Documents or the Collateral;

   

  third, to accrued and unpaid interest on the Obligations (including any
      interest which, but for the provisions of Title 11 of the United States Code entitled “Bankruptcy,” as now and hereafter in effect, or any successor statute, would have accrued on such amounts);

   

  fourth, to the principal amount of the Obligations, including to cash
      collateralize existing obligations with respect to Letters of Credit in compliance with this Agreement,

   

  fifth, to the Obligations owing to any counterparty in respect of any Lender
      Hedging Agreement;

   

  sixth, to any other Obligations owing to the Agent or any other Lender under
      the Loan Documents; and

   

  seventh, to the Borrower or to whoever may be lawfully entitled to receive
      such balance or as a court of competent jurisdiction may direct.

   

  
     

    35

    
      
 

  

   

  In carrying out the foregoing, (a) amounts received shall be applied in the
      numerical order provided until exhausted prior to the application to the next succeeding category, and (b) each of the Persons entitled to receive a payment in any particular category shall receive an amount equal to its pro rata share of amounts
      available to be applied pursuant thereto for such category.

   

  		12.12	Adjustments; Set-off.

   

  (a)           If any Lender (a “benefitted Lender”) shall
      at any time exercise any set-off right or receive any payment of all or part of its Revolving Loans, or its participations in Letters of Credit, or interest thereon, or fees, or receive any collateral in respect thereof (whether voluntarily or
      involuntarily, by set-off, pursuant to bankruptcy or insolvency proceedings or otherwise), in a greater proportion than any such payment to or collateral received by any other Lender, if any, in respect of such other Lender’s Revolving Loans, its
      participation in Letters of Credit, or interest thereon, or fees, such benefitted Lender shall purchase for cash from the other Lenders such portion of each such other Lender’s Revolving Loans or fees, or shall provide such other Lenders with the
      benefits of any such collateral, or the proceeds thereof, as shall be necessary to cause such benefitted Lender to share the excess payment or benefits of such collateral or proceeds ratably with each of the Lenders; provided, however, that if all or
      any portion of such excess payment or benefits is thereafter recovered from such benefitted Lender, such purchase shall be rescinded, and the purchase price and benefits returned, to the extent of such recovery, but without interest. The Borrower
      agrees that each Lender so purchasing a portion of another Lender’s Loans or its participation in Letters of Credit may exercise all rights of payment (including, without limitation, rights of set-off) with respect to such portion as fully as if such
      Lender were the direct holder of such portion, provided that, for the avoidance of doubt but subject to the foregoing provisions of this Section 12.12(a), any Lender shall have the right (without further consent of the Borrower, the
      Agent or any other Lender), exercisable upon the occurrence and during the continuance of an Event of Default, without prior notice to the Borrower, any such notice being expressly waived by the Borrower to the extent permitted by applicable law, to
      set-off and appropriate and apply against any such Obligations any and all deposits (general or special, time or demand, provisional or final), in any currency, and any other credits, indebtedness or claims in any currency, in each case whether
      direct or indirect, absolute or contingent, matured or unmatured, at any time held or owing by such Lender or any branch or agency thereof or bank controlling such Lender to or for the credit or the account of the Borrower.

   

  (b)           In addition to any rights and remedies of the Agent
      provided by law, the Agent shall have the right (without further consent of the Borrower or any other Lender), exercisable upon the occurrence and during the continuance of an Event of Default, without prior notice to the Borrower, any such notice
      being expressly waived by the Borrower to the extent permitted by applicable law, to set-off and appropriate and apply against any such Obligations any and all deposits (general or special, time or demand, provisional or final), in any currency, and
      any other credits, indebtedness or claims in any currency, in each case whether direct or indirect, absolute or contingent, matured or unmatured, at any time held or owing by the Agent or any branch or agency thereof or bank controlling the Agent to
      or for the credit or the account of the Borrower.

   

  
     

    36

    
      
 

  

   

  		12.13	Taxes.

   

  (a)           All sums payable by or on behalf of any Loan
      Party under the Loan Documents shall, except to the extent required by applicable law, be paid free and clear of, and without any deduction or withholding on account of, any Taxes. If any Loan Party or any other Person (acting as a withholding agent)
      is (in such withholding agent’s reasonable good faith discretion) required by applicable law to make any deduction or withholding on account of any Tax from any sum paid or payable by any Loan Party to the Agent or any Lender (which term for purposes
      of this Section 12.13 shall include any L/C Issuer and any assignee of a Lender, L/C Issuer) under any of the Loan Documents: (i) such Loan Party or other withholding agent shall be entitled to make such deduction or withholding; (ii) if a Loan Party
      is the applicable withholding agent, the applicable Loan Party shall timely pay any such Tax to the relevant Governmental Authority in accordance with applicable law; and (iii) in the case of Indemnified Taxes, the sum payable by such Loan Party in
      respect of which the relevant deduction, withholding or payment is required shall be increased to the extent necessary to ensure that, after the making of such deduction, withholding or payment, the Agent or such Lender, as the case may be, receives
      on the due date a net sum equal to what it would have received had no such deduction, withholding or payment been required or made.

   

  (b)           The Loan Parties shall timely pay to the
      relevant Governmental Authority in accordance with applicable law, or at the option of the Agent timely reimburse it for the payment of, any Other Taxes.

   

  (c)           Within thirty (30) days after the due date of
      payment of any Tax which it is required by this Section 12.13 to pay, if a Loan Party is the applicable withholding agent, such Loan Party shall deliver to the Agent the original or certified copy of a receipt issued by the relevant Governmental
      Authority evidencing such payment or other evidence reasonably satisfactory to the Agent of such deduction, withholding or payment and of the remittance thereof to the relevant Governmental Authority.

   

  (d)           The Loan Parties shall jointly and severally
      indemnify the Agent and each Lender, within ten (10) days after demand therefor, for the full amount of Indemnified Taxes (including any Indemnified Taxes imposed or asserted on or attributable to amounts payable under this Section 12.13)
      payable or paid by the Agent or any such Lender or any of their respective Affiliates arising in connection with payments made under any Loan Document, and any reasonable expenses arising therefrom or with respect thereto, whether or not such
      Indemnified Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment or liability delivered to such Loan Party by a Lender (with a copy to the Agent), or by the Agent
      on its own behalf or on behalf of a Lender, prepared in reasonable detail shall be conclusive absent manifest error. Any such certificate must be provided within six (6) months of incurrence of such tax liability by the Agent or Lender.

   

  
     

    37

    
      
 

  

   

  (e)           Each Lender shall severally indemnify the Agent,
      within 10 days after demand therefor, for (i) any Indemnified Taxes attributable to such Lender (but only to the extent that a Loan Party has not already indemnified the Agent for such Indemnified Taxes and without limiting the obligation of such
      Loan Party to do so), and (ii) any Excluded Taxes attributable to such Lender, in each case, that are payable or paid by the Agent in connection with any Loan Document, and any reasonable expenses arising therefrom or with respect thereto, whether or
      not such Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment or liability delivered to any Lender by the Agent shall be conclusive absent manifest error. Each
      Lender hereby authorizes the Agent to set off and apply any and all amounts at any time owing to such Lender under any Loan Document or otherwise payable by the Agent to the Lender from any other source against any amount due to the Agent under this
      paragraph (c).

   

  (f)                 The Loan Parties’ obligations under this Section

        12.13 shall survive the resignation or replacement of the Agent or any assignment of rights by, or the replacement of, a Lender, the termination of the Revolving Loan Commitments, the expiration of the Letters of Credit and the repayment,
      satisfaction or discharge of all Obligations.

   

  		13.	AGENT

   

  13.1         Appointment and Duties. For the avoidance of
      doubt and notwithstanding anything else herein:

   

  (a)           Each Lender hereby appoints Agent (together with
      any successor Agent) as agent hereunder and authorizes Agent to (i) execute and deliver the Loan Documents and accept delivery thereof on its behalf from any Loan Party, (ii) take such action on its behalf and to exercise all rights, powers and
      remedies and perform the duties as are expressly delegated to Agent under such Loan Documents and (iii) exercise such powers as are incidental thereto.

   

  (b)           Without limiting the generality of clause (a)
      above, Agent shall have the sole and exclusive right and authority (to the exclusion of the other Lenders), and is hereby authorized, to (i) act as the disbursing and collecting agent for Lenders with respect to all payments and collections arising
      in connection with the Loan Documents, and each Person making any payment in connection with any Loan Document to any Lender is hereby authorized to make such payment to Agent, (ii) file and prove claims and file other documents necessary or
      desirable to allow the claims of Lenders with respect to any Obligation in any Insolvency Proceeding or any other bankruptcy, insolvency or similar proceeding (but not to vote, consent or otherwise act on behalf of such Person), (iii) act as
      collateral agent for each Lender for purposes of the perfection of all Liens created by such agreements and all other purposes stated therein, (iv) manage, supervise and otherwise deal with the Collateral, (v) take such other action as is necessary
      or desirable to maintain the perfection and priority of the Liens created or purported to be created by the Loan Documents, (vi) except as may be otherwise specified in any Loan Document, exercise all remedies given to Agent and the other Lenders
      with respect to the Collateral, whether under the Loan Documents, applicable law or otherwise and (vii) execute any amendment, consent or waiver under the Loan Documents on behalf of any Lender that has consented in writing to such amendment, consent
      or waiver; provided, however, that Agent hereby appoints, authorizes and directs each Lender to act as collateral sub-agent for Agent, Lenders for purposes of the perfection of Liens with respect to any deposit account maintained by a Loan Party
      with, and cash and cash equivalents held by, such Lender, and may further authorize and direct Lenders to take further actions as collateral sub-agents for purposes of enforcing such Liens or otherwise to transfer the Collateral subject thereto to
      Agent, and each Lender hereby agrees to take such further actions to the extent, and only to the extent, so authorized and directed.

   

  
     

    38

    
      
 

  

   

  (c)           Under the Loan Documents, Agent (i) is acting
      solely on behalf of Lenders, with duties that are entirely administrative in nature, notwithstanding the use of the defined term “Agent”, the terms “agent”, “Agent” and “collateral agent” and similar terms in any Loan Document to refer to Agent,
      which terms are used for title purposes only, (ii) is not assuming any obligation under any Loan Document other than as expressly set forth therein or any role as agent, fiduciary or trustee of or for any Lender or any other Person and (iii) shall
      have no implied functions, responsibilities, duties, obligations or other liabilities under any Loan Document, and each Lender, by accepting the benefits of the Loan Documents, hereby waives and agrees not to assert any claim against Agent based on
      the roles, duties and legal relationships expressly disclaimed in clauses (i) through (iii) above.

   

  13.2         Binding Effect. Each Lender, by accepting the
      benefits of the Loan Documents, agrees that (i) any action taken by Agent in accordance with the provisions of the Loan Documents and (ii) the exercise by Agent of the powers set forth herein or therein, together with such other powers as are
      incidental thereto, shall be authorized and binding upon all of Lenders.

   

  		13.3	Use of Discretion.

   

  (a)           Agent shall not have any duty to take any
      discretionary action or exercise any discretionary powers, except discretionary rights and powers expressly contemplated hereby or by the other Loan Documents that Agent is required to exercise; provided, that Agent shall not be required to take any
      action that, in its opinion or the opinion of its counsel, may expose Agent to liability or that is contrary to any Loan Document or applicable requirement of law.

   

  (b)           Agent shall provide copies of the various
      deliverables provided to it by the Borrower pursuant to clauses 5.6, 5.12, 6.2 hereof to the other Lenders; provided that Agent shall not, except as expressly set forth herein and in the other Loan Documents, have any duty to disclose, and shall not
      be liable for the failure to disclose, any information relating to any Loan Party or its Affiliates that is communicated to or obtained by Agent or any of its Affiliates in any capacity other than its capacity as Agent hereunder.

   

  (c)           Notwithstanding anything to the contrary
      contained herein or in any other Loan Document, the authority to enforce rights and remedies hereunder and under the other Loan Documents against Loan Parties or any of them shall be vested exclusively in, and all actions and proceedings at law in
      connection with such enforcement shall be instituted and maintained exclusively by, Agent in accordance with the Loan Documents for the benefit of all Lenders; provided that the foregoing shall not prohibit (i) Agent from exercising on its own behalf
      the rights and remedies that inure to its benefit (solely in its capacity as Agent) hereunder and under the other Loan Documents, (ii) any Lender from exercising set-off rights in accordance with the terms hereof or (iii) any Lender from filing
      proofs of claim or appearing and filing pleadings on its own behalf during the pendency of a proceeding relative to any Loan Party under any bankruptcy or other debtor relief law.

   

  
     

    39

    
      
 

  

   

  13.4         Delegation of Rights and Duties. Agent may,
      upon any term or condition it specifies, delegate or exercise any of its rights, powers and remedies under, and delegate or perform any of its duties or any other action with respect to, any Loan Document by or through any trustee, co-agent,
      employee, attorney-in-fact and any other Person (including any Lender), provided that Agent shall be liable for all acts or failures to act of any such Person to the same extent as Agent would be if Agent performed such action. Any such Person shall
      benefit from this Article 13 to the extent provided by Agent.

   

  		13.5	Reliance and Liability.

   

  (a)           Agent may, without incurring any liability
      hereunder, (i) treat the payee of any note issued hereunder as its holder until such note has been assigned in accordance with the terms of this Agreement, (ii) rely on the Register, (iii) consult with any advisors, accountants and other experts
      (including advisors to, and accountants and experts engaged by, any Loan Party) and (iv) rely and act upon any document and information (including those transmitted by electronic transmission) and any telephone message or conversation, in each case
      believed by it to be genuine and transmitted, signed or otherwise authenticated by the appropriate parties.

   

  (b)           None of Agent and its officers, employees,
      affiliates or agents shall be liable for any action taken or omitted to be taken by any of them under or in connection with any Loan Document, and each Lender, each Borrower and each other Loan Party hereby waive and shall not assert (and each
      Borrower shall cause each other Loan Party to waive and agree not to assert) any right, claim or cause of action based thereon, except to the extent of liabilities resulting from the gross negligence or willful misconduct as determined by a court of
      competent jurisdiction by final and nonappealable judgment of Agent or, as the case may be, such officers, employees, affiliates or agents (each as determined in a final, non-appealable judgment by a court of competent jurisdiction) in connection
      with the duties expressly set forth herein.

   

  (c)           Each Lender (i) acknowledges that it has performed
      and will continue to perform its own diligence and has made and will continue to make its own independent investigation of the operations, financial conditions and affairs of Loan Parties and (ii) agrees that is shall not rely on any audit or other
      report provided by Agent.

   

  13.6         Agent Individually. Agent and its
      Affiliates may make loans and other extensions of credit to, acquire Equity Interests of, engage in any kind of business with, any Loan Party or Affiliate thereof as though it were not acting as Agent and may receive separate fees and other payments
      therefor. To the extent Agent or any of its Affiliates makes any Loan or otherwise becomes a Lender hereunder, it shall have and may exercise the same rights and powers hereunder and shall be subject to the same obligations and liabilities as any
      other Lender and the term “Lender” and any similar terms shall, except where otherwise expressly provided in any Loan Document, include, without limitation, Agent or such Affiliate, as the case may be, in its individual capacity as Lender.

   

  
     

    40

    
      
 

  

   

  13.7         Lender Credit Decision. Each Lender
      acknowledges that it shall, independently and without reliance upon Agent, any Lender or upon any document (including any offering and disclosure materials in connection with the syndication of the Loans) solely or in part because such document was
      transmitted by Agent, conduct its own independent investigation of the financial condition and affairs of each Loan Party and make and continue to make its own credit decisions in connection with entering into, and taking or not taking any action
      under, any Loan Document or with respect to any transaction contemplated in any Loan Document, in each case based on such documents and information as it shall deem appropriate. Except for documents expressly required by any Loan Document to be
      transmitted by Agent to Lenders, Agent shall not have any duty or responsibility to provide any Lender with any credit or other information concerning the business, prospects, operations, property, financial and other condition or creditworthiness of
      any Loan Party or any Affiliate of any Loan Party that may come in to the possession of Agent or any of its Related Persons, except to the extent of any costs and expenses resulting from the gross negligence or willful misconduct as determined by a
      court of competent jurisdiction by final and nonappealable judgment of Agent or, as the case may be, such officers, employees, affiliates or agents (each as determined in a final, non-appealable judgment by a court of competent jurisdiction).

   

  		13.8	Expenses; Indemnities.

   

  (a)            Each Lender agrees to reimburse Agent and each
      of its Related Persons (to the extent not reimbursed by any Loan Party) promptly upon demand, severally and ratably, for any costs and expenses (including fees, charges and disbursements of financial, legal and other advisors and Taxes paid in the
      name of, or on behalf of, any Loan Party) that may be incurred by Agent or any of its Related Persons in connection with the preparation, syndication, execution, delivery, administration, modification, consent, waiver or enforcement of, or the taking
      of any other action (whether through negotiations, through any work-out, bankruptcy, restructuring or other legal or other proceeding (including, without limitation, preparation for and/or response to any subpoena or request for document production
      relating thereto) or otherwise) in respect of, or legal advice with respect to its rights or responsibilities under, any Loan Document.

   

  (b)           Each Lender further agrees, within thirty (30)
      days after demand therefor, to indemnify Agent (to the extent not reimbursed by any Loan Party), severally and ratably, from and against liabilities that may be imposed on, incurred by or asserted against Agent in any matter relating to or arising
      out of, in connection with or as a result of any Loan Document or any other act, event or transaction related, contemplated in or attendant to any such document, or, in each case, any action taken or omitted to be taken by Agent or any of its Related
      Persons under or with respect to any of the foregoing except to the extent of liabilities resulting from the gross negligence or willful misconduct as determined by a court of competent jurisdiction by final and nonappealable judgment of Agent or, as
      the case may be, such officers, employees, affiliates or agents (each as determined in a final, non-appealable judgment by a court of competent jurisdiction). A certificate as to the amount of such payment or liability delivered to any Lender by
      Agent shall be conclusive absent demonstrable error. Each Lender hereby authorizes Agent to apply any and all amounts at any time owing to such Lender under any Loan Document or otherwise payable by Agent to such Lender from any other source against
      any amount due to Agent under this Section 13.8(b).

   

  
     

    41

    
      
 

  

   

  		13.9	Resignation of Agent.

   

  (a)           Agent may resign at any time by delivering
      notice of such resignation to Lenders and Borrower, effective on the date set forth in such notice or, if no such date is set forth therein, upon the date such notice shall be effective in accordance with the terms of this Section 13.9. If
      Agent delivers any such notice, Lenders shall have the right to appoint a successor Agent. If, after thirty (30) days after the date of retiring Agent’s notice of resignation, no successor Agent has been appointed by Lenders that has accepted such
      appointment, then the retiring Agent may, on behalf of Lenders, appoint a successor Agent from among Lenders.

   

  (b)           Effective immediately upon its resignation, (i)
      the retiring Agent shall be discharged from its duties and obligations under the Loan Documents, (ii) Lenders shall assume and perform all of the duties of Agent until a successor Agent shall have accepted a valid appointment hereunder, (iii) the
      retiring Agent shall no longer have the benefit of any provision of any Loan Document other than with respect to any actions taken or omitted to be taken while such retiring Agent was, or because such Agent had been, validly acting as Agent under the
      Loan Documents and (iv) the retiring Agent shall take such action as may be reasonably necessary to assign to the successor Agent its rights as Agent under the Loan Documents. Effective immediately upon its acceptance of a valid appointment as Agent,
      a successor Agent shall succeed to, and become vested with, all the rights, powers, privileges and duties of the retiring Agent under the Loan Documents.

   

  13.10      Release of Collateral or Guarantors. Each Lender
      hereby consents to the release and hereby directs Agent to release or subordinate the following:

   

  (a)           any Subsidiary of Borrower from its guaranty of any
      Obligation if all of the equity interests of such Subsidiary are sold or transferred in a transaction permitted by the Loan Documents; and

   

  (b)          any Lien held by Agent for the benefit of Lenders
      against (i) any Collateral that is sold, transferred, conveyed or otherwise disposed of by a Loan Party in a transaction permitted by the Loan Documents (including pursuant to a waiver or consent), (ii) any property subject to a Lien permitted under clause (n) of the definition of Permitted Lien and (iii) all of the Collateral and all Loan Parties, upon termination of the Revolving Line or the occurrence of the
      Revolving Maturity Date.

  

  
     

    42

    
      
 

  

   

  Each Lender hereby directs Agent, and Agent hereby agrees,
      upon receipt of notice from the Borrower, to execute and deliver or file such documents and to perform other actions reasonably necessary to release the guaranties and Liens when and as directed in this Section 13.10.

   

  [Balance of Page Intentionally Left Blank]

   

  
     

    43

    
      
 

  

   

  IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the date first
      above written. 

   

  	 	CUE HEALTH INC. as Borrower
	 	 	 
	 	By:	/s/ Ayub Khattak
	 	Name: Ayub Khattak
	 	Title: President, Chief Executive Officer, Secretary and Treasurer

   

  Signature Page to Loan and Security
        Agreement  

  
     

    
      
 

  

   

  	 	EAST WEST BANK as Agent and Lender
	 	 	 
	 	By:	/s/ Maytal Shainberg
	 	Name: Maytal Shainberg
	 	Title: Senior Vice President

    

  Signature Page to Loan and Security
        Agreement 

  
     

    
      
 

  

   

  	 	COMERICA BANK as Lender
	 	 	 
	 	By:	/s/ Robert Hernandez
	 	Name: Robert Hernandez
	 	Title: SVP, Group Manager

  

   

  
     

    
      
 

  

   

  

  	 	SILICON VALLEY BANK as Lender
	 	 	 
	 	By:	/s/ R. Michael White 
	 	 	Name:     R. Michael White 
	 	 	Title:       Head of BD, SVB LS&HC

   

  
     

    
      
 

  

  
   

  EXHIBIT A 

   

  DEFINITIONS

   

  “Accounts” means all presently existing and hereafter arising
      “accounts,” as such term is defined in Section 9102 of the Code, contract rights, instruments (including those evidencing indebtedness owed to Borrower by its Affiliates), general intangibles, payment intangibles, chattel paper (including electronic
      chattel paper) and all other forms of obligations owing to Borrower arising out of the sale or lease of goods or inventory (including, without limitation, the licensing of digital content, software and other technology) or the rendering of services
      by Borrower and any and all credit insurance, guaranties, and other security therefor, as well as all merchandise returned to or reclaimed by Borrower and Borrower’s Books relating to any of the foregoing.

   

  “Advance” or “Advances” means a cash advance or cash advances or
      issuance of a Letter of Credit under the Revolving Line.

   

  “Affiliate” means, with respect to any Person, any Person that owns or
      controls directly or indirectly such Person, any Person that controls or is controlled by or is under common control with such Person, and each of such Person’s senior executive officers, directors, and partners.

   

  “Approved Fund” means any Fund that is administered or managed by (a) a
      Lender, (b) an Affiliate of a Lender or (c) an entity or an Affiliate of an entity that administers or manages a Lender.

  “Borrower State” means Delaware, the state under whose laws Borrower is organized.
      “Borrower’s Books” means all of Borrower’s books and records including: ledgers;

  records concerning Borrower’s assets or liabilities, the Collateral, business operations or
      financial condition; and all computer programs, or tape files, and the equipment, containing such information.

   

  “Business Day” means any day that is not a Saturday, Sunday, or other
      day on which banks in the State of California or the State of New York are authorized or required to close.

   

  “Cash” means Unrestricted Cash and Cash Equivalents that are not subject
      to any Lien other than Lien under the Loan Documents.

   

  “Cash Equivalents” means (a) any readily-marketable securities (i)
      issued by, or directly, unconditionally and fully guaranteed or insured by the United States federal government or

  (ii)    issued by any agency of the United States federal government the
      obligations of which are fully backed by the full faith and credit of the United States federal government, (b) any readily- marketable direct obligations issued by any other agency of the United States federal government, any state of the United
      States or any political subdivision of any such state or any public instrumentality thereof, in each case having a rating of at least “A-1” from S&P or at least “P-1” from Moody’s, (c) any commercial paper rated at least “A-1” by S&P or “P-1”
      by Moody’s and issued by any Person organized under the laws of any state of the United States, (d) any Dollar- denominated time deposit, certificate of deposit, overnight bank deposit or bankers’ acceptance issued or accepted by any Lender or any
      commercial bank that is, in each case, rated investment grade by both S&P and Moody’s, (e) interests in any money market fund registered under the Investment Company Act of 1940 that (i) has substantially all of its assets invested continuously
      in the types of investments referred to in clause (a), (b), (c) or (d) above with maturities as set forth in the proviso below, (ii) has net assets in excess of [**] Dollars ($[**]) and (iii) has obtained from either S&P or Moody’s the highest
      rating obtainable for money market funds in the United States, and (f) other cash equivalents determined by the Agent to have a risk equivalent to items rated at least “A-1” by S&P or “P-1” by Moody’s and otherwise acceptable from time to time to
      the Agent; provided, however, that the maturities of all obligations specified in any of clauses (a) through (d) above shall not exceed 365 days.

   

  
     

    Exhibit A – Page 1

    
      
 

  

   

  “Cash Management Obligations” means the obligations of the Loan Parties
      to the Agent or any Lender under one or more credit cards, debit cards, cash management agreements, deposit account agreements, treasury agreements, sweep agreements or similar agreements pertaining to cash management services.

   

  “Change in Control” shall mean a transaction in which any “person” or
      “group” (other than Borrower’s existing investors) (within the meaning of Section 13(d) and 14(d)(2) of the Securities Exchange Act of 1934) becomes the “beneficial owner” (as defined in Rule 13d-3 under the Securities Exchange Act of 1934), directly
      or indirectly, of a sufficient number of shares of all classes of stock then outstanding of Borrower ordinarily entitled to vote in the election of directors, empowering such “person” or “group” to elect a majority of the Board of Directors of
      Borrower, who did not have such power before such transaction.

   

  “Change in Law” means the occurrence, after the date of this Agreement,
      of any of the following: (a) the adoption or taking effect of any law, rule, regulation or treaty, (b) any change in any law, rule, regulation or treaty or in the administration, interpretation, implementation or application thereof by any
      Governmental Authority or (c) the making or issuance of any request, rule, guideline or directive (whether or not having the force of law) by any Governmental Authority; provided that notwithstanding anything herein to the contrary, (x) the
      Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (y) all requests, rules, guidelines or directives promulgated by the Bank for International
      Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to Basel III, shall in each case be deemed to be a “Change in Law”,
      regardless of the date enacted, adopted or issued.

   

  “Chief Executive Office State” means California, where Borrower’s chief
      executive office is located.

   

  “Closing Date” means the date of this Agreement.

   

  “Code” means the California Uniform Commercial Code as amended or
      supplemented from time to time.

   

  
     

    Exhibit A – Page 2

    
      
 

  

   

  “Collateral” means all of Borrower’s right, title and interest in and to
      the property described on Exhibit B attached hereto and all Intellectual Property Collateral except to the extent (i) any such property is nonassignable by its terms without the consent of the licensor thereof or another party (but only to
      the extent such prohibition on transfer remains in place and is enforceable under applicable law, including, without limitation, Sections 9406 and 9408 of the Code) provided that upon the cessation of any such restriction or prohibition, such
      property shall automatically become part of the Collateral, (ii) the granting of a security interest therein is contrary to applicable law, provided that upon the cessation of any such restriction or prohibition, such property shall automatically
      become part of the Collateral, (iii) constitutes the equity interests of a controlled foreign corporation (as defined in the IRC), in excess of such amount of the voting power of all classes of equity interests of such controlled foreign corporations
      entitled to vote as would result in materially adverse tax consequences to the Loan Parties if such amount was included as Collateral hereunder, (iv) is an intent-to-use trademark, or (v) is an asset as to which the costs of creating or perfecting a
      security interest or pledge exceeds the benefit to Agent and Lenders to be obtained therefrom, as determined by Agent from time to time; provided that in no case shall the definition of “Collateral” exclude any Accounts, proceeds of the disposition
      of any property, or general intangibles consisting of rights to payment.

   

  “Collateral State” means the state or states where the Collateral is
      located, which is California.

   

  “Collection Account” has the meaning set forth in Section 4.4.

   

  “Contingent Obligation” means, as applied to any Person, any direct or
      indirect liability, contingent or otherwise, of that Person with respect to (i) any indebtedness, lease, dividend, letter of credit or other obligation of another, including, without limitation, any such obligation directly or indirectly guaranteed,
      endorsed, co-made or discounted or sold with recourse by that Person, or in respect of which that Person is otherwise directly or indirectly liable; (ii) any obligations with respect to undrawn letters of credit, corporate credit cards or merchant
      services issued for the account of that Person; and (iii) all obligations arising under any interest rate, currency or commodity swap agreement, interest rate cap agreement, interest rate collar agreement, or other agreement or arrangement designated
      to protect a Person against fluctuation in interest rates, currency exchange rates or commodity prices; provided, however, that the term “Contingent Obligation” shall not include endorsements for collection or deposit in the ordinary course of
      business or customary indemnity obligations entered into in connection with any acquisition or any disposition permitted hereunder. The amount of any Contingent Obligation shall be deemed to be an amount equal to the stated or determined amount of
      the primary obligation in respect of which such Contingent Obligation is made or, if not stated or determinable, the maximum reasonably anticipated liability in respect thereof as determined by such Person in good faith; provided, however, that such
      amount shall not in any event exceed the maximum amount of the obligations under the guarantee or other support arrangement.

   

  “Credit Extension” means each Advance or any other extension of credit
      by Lenders to or for the benefit of Borrower hereunder.

   

  “Default” means any event or condition that constitutes an Event of
      Default or that, with the giving of any notice, the passage of time, or both, would be an Event of Default.

   

  
     

    Exhibit A – Page 3

    
      
 

  

   

  “Disqualified Stock” means any equity, stock or stock equivalent which,
      by its terms, or upon the happening of any event or condition (a) matures or is mandatorily redeemable or redeemable at the option of the holder thereof (in whole or in party) on or prior to the date that is ninety-one (91) days following the
      Revolving Maturity Date, (b) is convertible into or exchangeable for debt securities, any equity, stock or stock equivalents described in clause (a), in each case, at any time on or prior to the date that is ninety (90) days following the Revolving
      Maturity Date, or (c) is entitled to receive scheduled dividends or distributions in cash prior to the time that the Obligations (other than unasserted claims of contingent indemnification obligations) are paid in full.

   

  “Eligible Accounts” means those Accounts that arise in the ordinary
      course of Borrower’s business that comply with all of Borrower’s representations and warranties to Agent set forth in Section 5.3; provided, that, subject to Section 12.6, Agent may change the standards of eligibility by giving Borrower prior
      written notice. Unless otherwise agreed to by Agent, Eligible Accounts shall not include the following:

   

  (a)                Accounts that the account debtor has failed to pay in
      full (i) within ninety (90) days of invoice date or (ii) within sixty (60) days of the original due date;

   

  (b)                credit balances over ninety (90) days;

   

  (c)                Accounts with respect to an account debtor [**]
      percent ([**]%) of whose Accounts the account debtor has failed to pay (i) within ninety (90) days of invoice date or (ii) within sixty (60) days of the original due date;

   

  (d)               Account with respect to an account debtor whose total
      obligations to Borrower exceed [**] percent ([**]%) of all Accounts, except as approved in writing by Agent and Agent has approved Accounts owing from the U.S. Department of Defense and the U.S. Department of Health & Human Services to exceed
      such percentage;

   

  (e)                Accounts with respect to which the account debtor
      does not have its principal place of business in the United States;

   

  (f)                 Accounts with respect to which the account debtor is
      the United States or any department, agency, or instrumentality of the United States, except for (i) Accounts of the United States if the payee has assigned its payment rights to Bank and the assignment has been acknowledged under the Assignment of
      Claims Act of 1940 (31 U.S.C. 3727), (ii) Accounts owing from the U.S. Department of Defense and the U.S. Department of Health & Human Services pursuant to contracts in place as of the Closing Date, and (iii) Accounts approved by the Required
      Lenders in writing;

   

  (g)                Accounts with respect to which Borrower is liable to
      the account debtor for goods sold or services rendered by the account debtor to Borrower, but only to the extent of any amounts owing to the account debtor against amounts owed to Borrower;

   

  (h)                Accounts with respect to which goods are placed on
      consignment, guaranteed sale, sale or return, sale on approval, bill and hold, demo or promotional, or other terms by reason of which the payment by the account debtor may be conditional;

   

  
     

    Exhibit A – Page 4

    
      
 

  

   

  (i)                  Accounts with respect to which the account debtor
      is an officer, employee, agent, Subsidiary or Affiliate of Borrower;

   

  (j)                 Accounts that have not yet been billed to the
      account debtor or that relate to deposits (such as good faith deposits) or other property of the account debtor held by Borrower for the performance of services or delivery of goods which Borrower has not yet performed or delivered and
      unconditionally accepted by the account debtor;

   

  (k)                Accounts with respect to which the account debtor
      disputes liability or makes any claim with respect thereto that there may be a basis for dispute (but only to the extent of the amount subject to such dispute or claim), or is subject to any Insolvency Proceeding, or becomes insolvent, or goes out of
      business;

   

  (l)                  Accounts the collection of which Agent reasonably
      determines after inquiry and consultation with Borrower to be doubtful; and

   

  (m)                retentions and hold-backs.

   

  “Environmental Laws” means all laws, rules, regulations, orders and the
      like issued by any federal state, local foreign or other Governmental Authority pertaining to the environment or to any hazardous materials or wastes, toxic substances, flammable, explosive or radioactive materials, asbestos or other similar
      materials.

   

  “ERISA” means the Employee Retirement Income Security Act of 1974, as
      amended, and the regulations thereunder.

   

  “Event of Default” has the meaning assigned in Article 8.

   

  “Excluded Accounts” means deposit accounts exclusively used for payroll,
      payroll taxes and other employee wage and benefit payments to or for the benefit of Borrower’s employees.

   

  “Excluded Taxes” means, with respect to the Agent, any Lender or any
      other recipient of any payment made by or on account of any obligation of any Loan Party under any Loan Document, Taxes imposed on or measured by its net income or net profits (however denominated), franchise Taxes imposed on it in lieu of net income
      Taxes and branch profits Taxes imposed on it, in each case, by any jurisdiction (or any political subdivision thereof) (a) as a result of the recipient being organized under the laws of, or having its principal office located in, or, in the case of
      any Lender, its applicable lending office in such jurisdiction, or (b) as a result of any other present or former connection between such recipient and such jurisdiction (other than connections arising solely from such recipient having executed,
      delivered, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to or enforced any Loan Document, or sold or assigned an interest in
      any Advance or Loan Document).

   

  “Existing Indebtedness” is the Indebtedness of Borrower to Comerica Bank
      in the aggregate principal outstanding amount as of the Closing Date of approximately [**] Dollars ($[**]) pursuant to that certain Loan and Security Agreement, dated May 18, 2015, entered into by and between Comerica Bank and Borrower.

   

  
     

    Exhibit A – Page 5

    
      
 

  

   

  “Existing Letters of Credit” means, individually and collectively, (a)
      that certain Irrevocable Standby Letter of Credit No. OSB16721C issued December 20, 2018 by Comerica Bank in the amount of $[**] with BMR-MODA Sorrento, LP as the Beneficiary and Cue Health Inc. as the Applicant, (b) that certain Irrevocable Standby
      Letter of Credit No. OSB11611C issued December 29, 2016 by Comerica Bank in the amount of $[**] with ARE-SD Region No. 2, LLC as the Beneficiary and Cue Health Inc., formerly known as Cue Inc., as the Applicant, and (c) that certain Irrevocable
      Standby Letter of Credit No. OSB19688C issued June 3, 2020 by Comerica Bank in the amount of $[**] with ARE-SD Region No. 67, LLC as the Beneficiary and Cue Health Inc. as the Applicant.

   

  “Fund” means any Person (other than a natural person) that is (or will
      be) engaged in making, purchasing, holding or otherwise investing in commercial loans, bonds and similar extensions of credit in the ordinary course of its activities.

   

  “GAAP” means generally accepted accounting principles, consistently
      applied, as in effect from time to time.

   

  “Governmental Authority” means any federal, state, municipal, national,
      supranational or other government, governmental department, commission, board, bureau, court, agency or instrumentality or political subdivision thereof or any entity, officer or examiner exercising executive, legislative, judicial, regulatory or
      administrative functions of or pertaining to any government or any court, in each case whether associated with the United States of America, any State thereof or the District of Columbia or a foreign entity or government.

   

  “Guarantor” means any Person that has guaranteed the Obligations of
      Borrower under the Loan Documents pursuant to a document in form and substance satisfactory to Agent in its reasonable discretion.

   

  “Hedging Agreements” means any and all agreements, devices or
      arrangements designed to protect at least one of the parties thereto from the fluctuations of interest rates, commodity prices, exchange rates or forward rates applicable to such party’s assets, liabilities or exchange transactions, including
      dollar-denominated or cross-currency interest rate exchange agreements, forward currency exchange agreements, interest rate cap or collar protection agreements, forward rate currency or interest rate options, puts and warrants or any similar
      derivative transactions.

   

  “Indebtedness” means (a) all indebtedness for borrowed money or the
      deferred purchase price of property or services, including without limitation reimbursement and other obligations with respect to surety bonds and letters of credit (to the extent not cash collateralized), (b) all obligations evidenced by notes,
      bonds, debentures or similar instruments (c) all capital lease obligations that have been or required to be accounted for as a capital lease on a balance sheet prepared in accordance with GAAP and (d) all Contingent Obligations, if any.

   

  “Indemnified Taxes” means (i) Taxes, other than Excluded Taxes, imposed
      on or with respect to any payment made by or on account of any obligation of any Loan Party under any Loan Document and (ii) to the extent not otherwise described in (i), Other Taxes.

   

  
     

    Exhibit A – Page 6

    
      
 

  

   

  “Insolvency Proceeding” means any proceeding commenced by or against any
      Person or entity under any provision of the United States Bankruptcy Code, as amended, or under any other bankruptcy or insolvency law, including assignments for the benefit of creditors, formal or informal moratoria, compositions, extension
      generally with its creditors, or proceedings seeking reorganization, arrangement, or other relief.

   

  “Intellectual Property Collateral” means all of Borrower’s right, title,
      and interest in and to the following:

   

  (a)               copyrights, trademarks and patents;

   

  (b)               Any and all trade secrets, and any and all
      intellectual property rights in computer software and computer software products now or hereafter existing, created, acquired or held;

   

  (c)               Any and all design rights which may be available to
      Borrower now or hereafter existing, created, acquired or held;

   

  (d)               Any and all claims for damages by way of past, present
      and future infringement of any of the rights included above, with the right, but not the obligation, to sue for and collect such damages for said use or infringement of the intellectual property rights identified above;

   

  (e)               All licenses or other rights to use any of the
      copyrights, trademarks and patents, and all license fees and royalties arising from such use to the extent permitted by such license or rights;

   

  (f)                All amendments, renewals and extensions of any of the
      copyrights, trademarks and patents; and

   

  (g)               All proceeds and products of the foregoing, including
      without limitation all payments under insurance or any indemnity or warranty payable in respect of any of the foregoing.

   

  “Investment” means any beneficial ownership of (including stock,
      partnership or limited liability company interest or other securities) any Person, or any loan, advance or capital contribution to any Person.

   

  “IRC” means the Internal Revenue Code of 1986, as amended, and the
      regulations thereunder.

   

  “L/C Issuer” means, as applicable (a) in the case of the Existing
      Letters of Credit, Comerica Bank in its capacity as the issuer of each Existing Letter of Credit and (b) in the case of all other Letters of Credit, East West Bank, in its capacity as the issuer of each such other Letter of Credit.

   

  “Lender Expenses” means all reasonable documented out-of-pocket costs or
      expenses (including reasonable documented attorneys’ fees and out-of-pocket expenses, generated by outside counsel) incurred in connection with the preparation, negotiation, administration, and enforcement of the Loan Documents; reasonable Collateral
      audit fees; and Agent and Lenders’ reasonable documented attorneys’ fees and out-of-pocket expenses (generated by outside counsel) incurred in amending, enforcing or defending the Loan Documents (including fees and expenses of appeal), incurred
      before, during and after an Insolvency Proceeding, whether or not suit is brought.

   

  
     

    Exhibit A – Page 7

    
      
 

  

   

  “Lender Hedging Agreement” means any Hedging Agreement entered into
      between (i) the Borrower or any Subsidiary thereof and (ii) the Agent, any Affiliate of the Agent, any Lender, or any Affiliate of any Lender.

   

  “Lien” means any mortgage, lien, deed of trust, charge, pledge, security
      interest or other encumbrance.

   

  “Loan Documents” means, collectively, this Agreement, any note or notes
      executed by Borrower, and any other document, instrument or agreement entered into in connection with this Agreement, all as amended, restated, amended and restated, modified, supplemented or extended from time to time.

   

  “Loan Party” means any Borrower or Guarantor.

   

  “Material Adverse Effect” means (a) a material impairment in the
      perfection or priority of Agent’s Lien in the Collateral or in the value of such Collateral (taken as a whole); (b) any event, change, circumstance, effect or other that either individually or in the aggregate with all other events, changes,
      circumstances, effects or other matters, has been materially adverse to the to the business, assets, liabilities, results of operations or financial condition of Borrower or prevents or materially delays or materially impairs the ability of Borrower
      to perform its obligations under this Agreement; or (c) a material impairment of the prospect of repayment of any portion of the Obligations when due, each of the foregoing as determined by the Agent or the Required Lenders in their reasonable
      discretion.

   

  “Moody’s” means Moody’s Investors Service, Inc., or any successor to its
      rating agency business.

   

  “Negotiable Collateral” means Collateral regarding which a security
      interest under the Code is or may be perfected by possession or control.

   

  “Non-Consenting Lender” means any Lender that does not approve any
      consent, waiver or amendment that (a) requires the approval of all or all affected Lenders in accordance with the terms of Section 12.6 and (b) has been approved by the Required Lenders.

   

  “Obligations” means all debt, principal, interest, Lender Expenses and
      other amounts owed to Lenders by Borrower pursuant to this Agreement or any other Loan Document, including any and all obligations under Lender Hedging Agreements and any and all Cash Management Obligations, whether absolute or contingent, due or to
      become due, now existing or hereafter arising, including any interest that accrues after the commencement of an Insolvency Proceeding and including any debt, liability, or obligation owing from Borrower to others that Lenders may have obtained by
      assignment or otherwise.

   

  “OFAC” means the Office of Foreign Asset Control of the United States
      Treasury Department.

   

  
     

    Exhibit A – Page 8

    
      
 

  

   

  “Other Connection Taxes” means, with respect to the Agent, any Lender or
      any other recipient of any payment made by or on account of any obligation of any Loan Party under any Loan Document, Taxes imposed as a result of a present or former connection between such recipient and the jurisdiction imposing such Tax (other
      than connections arising from such recipient having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to or
      enforced any Loan Document, or sold or assigned an interest in any Advance or Loan Document).

   

  “Other Taxes” means all present or future stamp, court or documentary,
      intangible, recording, filing or similar Taxes that arise from any payment made under, from the execution, delivery, performance, enforcement or registration of, from the receipt or perfection of a security interest under, or otherwise with respect
      to, any Loan Document, except any such Taxes that are Other Connection Taxes imposed with respect to an assignment (other than an assignment at the request of a Loan Party).

   

  “Periodic Payments” means all installments or similar recurring payments
      that Borrower may now or hereafter become obligated to pay to Agent pursuant to the terms and provisions of any instrument, or agreement now or hereafter in existence between Borrower and Lenders.

   

  “Permitted Indebtedness” means:

   

  		(a)	Indebtedness of Borrower in favor of Lenders arising under this Agreement or any
            other Loan Document;

   

  		(b)	Indebtedness existing on the Closing Date and disclosed in the Schedule;

   

  		(c)	Indebtedness (i) owing by any Loan Party to any other Loan Party, (ii) owing by
            any Subsidiary that is not a Loan Party to any other Subsidiary that is not a Loan Party, and (iii) owing by any Subsidiary that is not a Loan Party to any Loan Party in an amount not to exceed [**] Dollars ($[**]) at any time outstanding;

   

  		(d)	Reimbursement obligations in connection with corporate credit cards or in the
            ordinary course of business;

   

  		(e)	Subordinated Debt;

   

  		(f)	Indebtedness of any Acquired Subsidiary incurred prior to the date of its
            acquisition by Borrower in an amount not to exceed [**] Dollars ($[**]);

   

  		(g)	Endorsements of negotiable instruments for deposit or collection in the ordinary
            course of business;

   

  		(h)	Indebtedness in an amount not to exceed [**] Dollars ($[**]) in the form of deferred purchase price adjustments, customary indemnification
            obligations and working capital adjustments and similar obligations (including all seller notes), hold-backs, earn-outs and other contingent payment obligations not yet due and payable in connection with the acquisition of an Acquired
            Subsidiary, in each case on subordination terms reasonably acceptable to Agent;

   

  
     

    Exhibit A – Page 9

    
      
 

  

   

  		(i)	Indebtedness to trade creditors incurred in the ordinary course of business;

   

  		(j)	Indebtedness of Borrower secured by a lien described in clause (n) of the defined
            term “Permitted Liens,” provided such Indebtedness does not exceed the lesser of the cost or fair market value of the equipment financed with such Indebtedness;

   

  		(k)	Indebtedness with respect to any interest rate, currency or commodity swap
            agreement, interest rate cap agreement, interest rate collar agreement or other agreement or arrangement designed to protect Borrower against fluctuation in interest rates, currency exchange rates or commodity prices maintained with Agent or
            any Lender (or any of their Affiliates);

   

  		(l)	Indebtedness in respect of netting services, overdraft protections and other
            customary bank products in connection with deposit accounts;

   

  		(m)	Indebtedness in respect of performance bonds, bid bonds, appeal bonds, surety
            bonds and similar obligations, in each case provided in the ordinary course of business

   

  		(n)	Indebtedness incurred in connection with the financing of insurance premiums,
            provided, that the Borrower shall not finance more than one (1) year’s premiums at any time;

   

  		(o)	Indebtedness, direct or indirect, not otherwise permitted hereunder not to exceed
            [**] Dollars ($[**]) in the aggregate at any one time outstanding; and

   

  		(p)	Extensions, refinancings and renewals of any items of Permitted Indebtedness
            otherwise permitted by this definition, provided that the principal amount is not increased or the terms modified to impose more burdensome terms upon Borrower or its Subsidiary, or less favorable to Agent and Lenders, as the case may be.

   

  “Permitted Investment” means:

   

  		(a)	Investments existing on the Closing Date disclosed in the Schedule;

   

  		(b)	(i) Marketable direct obligations issued or unconditionally guaranteed by the United States of America or any agency or any
            State thereof maturing within one (1)   year from the date of acquisition thereof, (ii) commercial paper maturing no more than one (1) year from the date of creation thereof and currently having rating of at least A-1 or P-1 from either
            Standard & Poor’s Corporation or Moody’s Investors Service, (iii) Lenders’ certificates of deposit maturing no more than one (1) year from the date of investment therein, (iv) Lenders’ money market accounts and (v) other Cash Equivalents;

   

  
     

    Exhibit A – Page 10

    
      
 

  

   

  		(c)	Repurchases of stock from existing, former employees, officers or directors of
            Borrower under the terms of applicable repurchase agreements (i) in an aggregate amount not to exceed [**] Dollars ($[**]) in any fiscal year, provided that no Event of Default has occurred, is continuing or would immediately exist after giving
            effect to the repurchases, or (ii) in any amount where the consideration for the repurchase is the cancellation of indebtedness owed by such existing former employees, officers or directors to Borrower regardless of whether an Event of Default
            exists;

   

  		(d)	Investments of (i) Borrower or its Subsidiaries in Borrower or Subsidiaries that
            are Guarantors, (ii) Subsidiaries that are not Guarantors in Subsidiaries that are not Guarantors and (iii) Borrower or Subsidiaries that are Guarantors in Subsidiaries that are not Guarantors not to exceed [**] Dollars ($[**]) in the aggregate
            in any fiscal year;

   

  		(e)	Investments not to exceed [**] Dollars ($[**]) in the aggregate in any fiscal year
            consisting of (i) travel advances and employee relocation loans and other employee loans and advances in the ordinary course of business, and (ii) loans to employees, officers or directors relating to the purchase of equity securities of
            Borrower or its Subsidiaries pursuant to employee stock purchase plan agreements approved by Borrower’s Board of Directors;

   

  		(f)	(i) loans to employees existing on the Closing Date and specified on the Schedule,
            and (ii) Investments not to exceed an aggregate principal amount of [**] Dollars ($[**]) during the term of this Agreement consisting of loans to employees not in the ordinary course of business;

   

  		(g)	Investments (including debt obligations) received in connection with the
            bankruptcy or reorganization of customers or suppliers and in settlement of delinquent obligations of, and other disputes with, customers or suppliers arising in the ordinary course of Borrower’s business;

   

  		(h)	Investments consisting of deposit or securities accounts, which are maintained in
            accordance with the terms of this Agreement;

   

  		(i)	the formation of a Subsidiary (“Formed Subsidiary”) or (ii) the consensual acquisition of all equity interests in any other entities (each an
            “Acquired Subsidiary”); provided that Borrower shall be in pro forma compliance with the financial covenants set forth in Section 6.7 hereof prior to and after giving effect to such acquisition, no Event of Default shall have occurred
            or would result from such acquisition or formation and the representations and warranties set forth in the Loan Documents are true and correct in all material respects after giving effect thereto; provided further that, Borrower shall deliver
            financial information requested by Agent or the Lenders with respect to any Acquired Subsidiary ten (10) Business Days prior to such acquisition; provided that such acquisition shall not be a “hostile” acquisition and shall have been approved
            by the board of directors (or equivalent) and/or shareholders (or equivalent) of the Borrower and the Acquired Subsidiary and shall be in the same line of business as the Borrower or a line of business that is incidental, ancillary or
            complementary thereto or a natural extension thereof; provided further that any such Formed Subsidiary or Acquired Subsidiary shall become a Guarantor hereunder concurrently with such transaction (for the avoidance of doubt, no entity which
            becomes a direct or indirect parent or equity holder of Borrower as a result of a SPAC Business Combination shall be required to become a Guarantor) and Borrower shall otherwise comply with the requirements set forth in Section 6.10 of
            this Agreement with respect to such Formed Subsidiary or Acquired Subsidiary;

   

  
     

    Exhibit A – Page 11

    
      
 

  

   

  		(j)	Investments of any Person existing at the time such Person becomes an Acquired
            Subsidiary of the Borrower, so long as such Investments were not made in contemplation of such Person becoming a Subsidiary and provided that such Investments do not exceed [**] Dollars ($[**]) in the aggregate; and

   

  		(k)	Investments not otherwise permitted hereunder not to exceed [**] Dollars ($[**])
            in the aggregate in any fiscal year.

   

  “Permitted Liens” means the following:

   

  		(a)	Any Liens existing on the Closing Date and disclosed in the Schedule (excluding
            Liens to be satisfied with the proceeds of the Advances) or arising under this Agreement or the other Loan Documents or any other Lien in favor of Agent for the benefit of Lenders;

   

  		(b)	Liens for taxes, fees, assessments or other governmental charges or levies, either
            not delinquent or being contested in good faith by appropriate proceedings and for which Borrower maintains adequate reserves, provided the same have no priority over any of Agent’s security interests;

   

  		(c)	Carrier’s, warehousemen’s, mechanic’s, materialmen’s, repairmen’s, suppliers’,
            utilities or other like Liens arising in the ordinary course of business which are not overdue for a period for more than 10 days or which are being contested in good faith and by appropriate proceedings diligently conducted, if adequate
            reserves with respect thereto are maintained on the books of the applicable Person;

   

  		(d)	Pledges or deposits in the ordinary course of business in connection with workers’
            compensation, unemployment insurance and other social security legislation, other than any Lien imposed by ERISA;

   

  		(e)	Deposits to secure the performance of bids, trade contracts and leases (other than
            Indebtedness), statutory obligations, surety bonds, performance bonds and other obligations of a like nature incurred in the ordinary course of business;

   

  
     

    Exhibit A – Page 12

    
      
 

  

   

  		(f)	Liens affecting the interest of the landlords and licensors (any underlying
            landlords and licensors) of any real property leased, licensed or occupied by a Borrower or any of their Subsidiaries;

   

  		(g)	Liens of a collection bank on items in the course of collection arising under
            Section 4-208 of the Code or other normal and customary rights of set-off and banker’s liens in favor of banks or other depository institutions arising in the ordinary course of business;

   

  		(h)	The title and interests of a lessor or sublessor in and to personal property
            leased or subleased, in each case, extending only to such personal property and only to the extent such lease or sublease is permitted hereunder;

   

  		(i)	Liens on premium refunds and insurance proceeds granted in favor of insurance
            companies (or their financing affiliates) solely in connection with the financing of insurance premiums permitted hereunder;

   

  		(j)	non-exclusive licenses of intellectual property rights in the ordinary course of
            business that have been disclosed to Agent in writing and are permitted hereunder;

   

  		(k)	Precautionary financing statements filed in connection with operating leases
            permitted by this Agreement;

   

  		(l)	Liens incurred in connection with the extension, renewal or refinancing of the
            indebtedness secured by Liens of the type described in clauses (a) through (c) above, provided that any extension, renewal or replacement Lien shall be limited to the property encumbered by the existing Lien and the principal amount of the
            indebtedness being extended, renewed or refinanced does not increase;

   

  		(m)	Liens arising from judgments, decrees or attachments in circumstances not
            constituting an Event of Default under Sections 8.5 (attachment) or 8.9 (judgments);

   

  		(n)	Liens not to exceed [**] Dollars ($[**]) in the aggregate (i) upon or in any Equipment acquired or held by Borrower or any of its Subsidiaries to secure the purchase price of such Equipment or indebtedness incurred solely for the
            purpose of financing the acquisition or lease of such Equipment, or (ii) existing on such Equipment at the time of its acquisition, provided that the Lien is confined solely to the property so acquired and improvements thereon, and the proceeds
            of such Equipment;

  

  

  		(o)	Security deposits securing real estate leases;

   

  		(p)	Liens securing Subordinated Debt; and

   

  		(q)	Liens attaching solely to cash earnest money deposits in connection with an
            acquisition of an Acquired Subsidiary as permitted hereunder or an acquisition of property otherwise permitted hereunder.

   

  
     

    Exhibit A – Page 13

    
      
 

  

   

  “Permitted Transfer” means the conveyance, sale, lease, transfer or
      disposition by Borrower or any Subsidiary of:

   

  		(a)	Inventory of the Borrower in the ordinary course of business;

   

  		(b)	Non-exclusive licenses and similar arrangements for the use of the property of
            Borrower or its Subsidiaries in the ordinary course of business and licenses that could not result in a legal transfer of title of the licensed property, that may be exclusive in respects other than territory and that may be exclusive as to
            territory only as to discrete geographical areas outside of the United States, in each case, not interfering in any material respect with the business of Borrower or its Subsidiaries;

   

  		(c)	Worn-out, surplus or obsolete equipment;

   

  		(d)	Dispositions of equipment or real property to the extent that (i) such property is
            exchanged for credit against the purchase price of replacement property or (ii) the proceeds of such disposition are reasonably promptly applied to the purchase price of such replacement property;

   

  		(e)	Dispositions or transfers of property by Borrower or any Subsidiary of Borrower
            that is a Guarantor to Borrower or to another Subsidiary that is a Guarantor;

   

  		(f)	Dispositions of cash and cash equivalents in the ordinary course of business;

   

  		(g)	Sale, assignment, transfer, disposition or discount of accounts receivable arising
            in the ordinary course of business in connection with the compromise or collection thereof;

   

  		(h)	sales of common equity of the Borrower for cash that do not cause or result in a
            Change in Control, provided that such equity is not Disqualified Stock.; and

   

  		(i)	Other assets of Borrower or its Subsidiaries that do not in the aggregate exceed
            [**] Dollars ($[**]) during any fiscal year.

   

  “Person” means any individual, sole proprietorship, partnership, limited
      liability company, joint venture, trust, unincorporated organization, association, corporation, institution, public benefit corporation, firm, joint stock company, estate, entity or governmental agency.

   

  “Prime Rate” means, for any particular day, the variable rate of
      interest, per annum, most recently announced by Agent, as its “prime rate,” whether or not such announced rate is the lowest rate available from Agent.

   

  “Prohibited Territory” means any person or country listed by OFAC as to
      which transactions between a United States Person and that territory are prohibited.

   

  “Required Lenders” means, unless all of the Lenders and Agent agree
      otherwise in writing, at any time (x) only one Lender holds the total commitments under this Agreement, such Lender and (y) there is more than one Lender which are not Affiliates, then at least two such Lenders who are not Affiliates who together
      hold more than [**] percent ([**]%) of the commitments of all Lenders; provided that, for the purposes of this clause (y), the total commitments of the Lenders held or deemed held by, any Defaulting Lender shall be excluded for purposes of
      making a determination of Required Lenders; provided further that a Lender and its Affiliates shall be deemed one Lender.

   

  
     

    Exhibit A – Page 14

    
      
 

  

   

  “Responsible Officer” means each of the Chief Executive Officer, the
      Chief Operating Officer, the Chief Financial Officer and the Controller of Borrower.

   

  “Revolving Line” means revolving Credit Extensions of up to One Hundred
      Thirty Million Dollars ($130,000,000.00) in aggregate original principal amount at any time outstanding, which may be reduced from time to time in accordance with the terms of this Agreement.

   

  “Revolving Loan” is defined in Section 2.1(b) hereof.

   

  “Revolving Loan Commitment” means the commitment of a Lender listed
      below, or in the Assignment and Assumption in the form attached hereto as Exhibit I pursuant to which it becomes a Lender hereunder, to make Credit Extensions and participate in Letters of Credit hereunder, as the same may be adjusted pursuant to the
      provisions hereof. For the avoidance of doubt, no Lender shall have any liability for the commitment of any other Lender.

   

  	Lender	Revolving Loan 

              Commitment	Revolving Loan 

              Commitment Percentage
	East West Bank	[**]	[**]
	Comerica Bank	[**]	[**]
	Silicon Valley Bank	[**]	[**]
	TOTAL	$130,000,000.00	100%

   

  “Revolving Loan Commitment Percentage” means, with respect to each
      Lender, the percentage equivalent of the ratio which such Lender’s Revolving Loan Commitment bears to the Revolving Line.

   

  “Revolving Maturity Date” means February 5, 2023.

   

  “S&P” means S&P Global Ratings, or any successor to its rating agency business.

   

  “Schedule” means the schedule of exceptions attached hereto and approved by Agent, if any.

   

  “SOS Reports” means the official reports from the Secretaries of State of each Collateral
      State, Chief Executive Office State and the Borrower State and other applicable federal, state or local government offices identifying all current security interests filed in the Collateral and Liens of record as of the date of such report.

   

  
     

    Exhibit A – Page 15

    
      
 

  

   

  “SPAC Business Combination” means any transaction or series of
      transactions effected pursuant to an agreement or series of agreements entered into by the Borrower with a publicly traded blank check or special purpose acquisition company (“SPAC”), or by the Borrower with a SPAC and/or one or more of such SPAC’s
      subsidiaries and/or other entities, for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or other business combination with such SPAC (including, without limitation and for the avoidance of doubt,
      any such SPAC Business Combination as a result of which the Borrower or any other entity with which the Borrower merges or is otherwise combined in such SPAC Business Combination becomes or otherwise continues as a direct or indirect subsidiary of
      the SPAC and/or any other new parent entity or entities formed in connection with such SPAC Business Combination) provided that the Borrower is the surviving entity from such merger (and for the avoidance of doubt, a parent or holding entity of
      Borrower in connection with such SPAC Business Combination need not be a Borrower or Guarantor hereunder), and all of the foregoing in the form contemplated by the letter of intent with respect to the SPAC Business Combination in the form provided to
      Agent prior to the Closing Date.

   

  “Subordinated Debt” means any debt now or hereafter incurred by any Loan
      Party that is subordinated in writing to the debt owing by Borrower to Agent and Lenders on terms, including any security therefor, acceptable to Agent and the Required Lenders in their sole discretion.

   

  “Subsidiary” means any corporation, partnership or limited liability
      company or joint venture in which (i) any general partnership interest or (ii) more than fifty percent (50%) of the stock, limited liability company interest or joint venture of which by the terms thereof ordinary voting power to elect the Board of
      Directors, managers or trustees of the entity, at the time as of which any determination is being made, is owned by Borrower, either directly or through an Affiliate.

   

  “Taxes” means all present or future taxes, levies, imposts, duties,
      deductions, withholdings (including backup withholding), assessments, fees or other charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto.

   

  “Unrestricted Cash” means cash that is not subject to any lien or
      security interest (other than the those granted pursuant to the this Agreement) and that is on deposit with a Lender or its Affiliates in an account that is subject to a perfected security interest in favor of the Agent for the benefit of the Lenders
      and in respect of which the relevant Loan Party has entered into an account control agreement reasonably satisfactory to the Agent.

   

  Exhibit A – Page 16

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00333-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00333-of-00352.parquet"}]]